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ABSTRACT
The family of runt related transcription factors (RUNX/CbfaiAML/PEBP2)
are essential for cellular differentiation and fetal development. RUNX factors are
distrjbuted throughout the nucleus jn punctate focj that are assocjated with the nuclear
matrix/scaffold and generally correspond with sjtes of active transcrjption.
Truncations of RUNX proteins that eliminate the C-terminus including a 3l-amino
acid segment designated the nuclear matrix targeting signal (NMTS) lose nuclear
matrix association and result in lethal hematopoietic (RUNX1) and skeletal (RUNX2)
phenotypes in mice. These findings suggest that the targeting of RUNX factors to
subnuclear foci may mediate the formation of multimeric regulatory complexes and
contribute to transcriptional control. In this study, we hypothesized that RUNX
transcription factors may dynamjcally move through the nucleus and associate with
subnuclear domains in a C-terminal dependent mechanism to regulate transcription.
Therefore , we investigated the subnuclear distdbution and mobHity of RUNX
transcription factors in living cells using enhanced green fluorescent protein (EGFP)
fused to RUNX proteins. The RUNX C-terminus was demonstrated to be necessary
for the dynamic association of RUNX with stable subnuclear domains. Time-lapse
fluorescence microscopy showed that RUNX1 and RUNX2localize to punctate foci
that remain stationary in the nuclear space in livjng cells. By measuring fluorescence
recovery after photobleaching, both RUNX1 and RUNX2 were found to dynamically
and rapidly associate with these subnuclear foci wjth a half-time of recovery in the
ten-second time scale. A large immobile fraction of RUNX1 and RUNX2 proteins
was observed in the photobleaching experiments , which suggests that this fraction of
RUNX1 and RUNX2 proteins are immobilized through the C-terminal domain by
interacting with the nuclear architecture. Truncation of the C-terminus of R UNX2
which removes the NMTS as well as several co-regulatory protein interaction
domains , increases the mobility of RUNX2 by at least an order of magnitude
resulting in a half-time of recovery equivalent to that of EGFP alone.
Contributions of the NMTS sequence to the subnuclear distribution and
mobility of RUNX2 were further assessed by creating point mutations in the NMTS
of RUNX2 fused to EGFP. The results show that these point mutations decrease, but
do not abolish , assodation with the nuclear matrix compared to wild-type EGFP-
RUNX2. Three patterns of subnuclear distribution were similarly observed in living
cells for both NMTS mutants and wild-type RUNX2. Furthermore , the NMTS
mutations showed no measurable effect on the mobility of RUNX2. However, the
mobilty of RUNX proteins in each of the different subnuclear distributions observed
in living cells were significantly different from each other. The punctate distribution
appears to correlate with higher fluorescence intensity, suggesting that the protein
concentration in the cell may have an effect on the formation or size of the fod.
These findings suggest that the entire NMTS and/or the co-regulatory protein
interaction domains may be necessary to immobilize RUNX2 proteins.
Because RUNX factors contain a conserved intranuclear targeting signal , we
examined whether RUNX1 and RUNX2 are targeted to common subnuclear domains.
The results show that RUNXl and RUNX2 colocalized in common subnuclear foci.
Furthermore , RUNX subnuclear foci contain the co-regulatory protein CBF , which
heterodimerizes with RUNX factors, and nascent transcripts as shown by BrUTP
incorporation. These results suggest that RUNX subnuclear foci may represent sites
of transcription containing multi-subunit transcription factor complexes.
RUNX2 transcription factors induce expression of the osteocalcin promoter
during osteoblast differentiation and to study both RUNX2 and osteocalcin function
it would be helpful to have transgenic mice in which OC expression could be easily
evaluated. Therefore , to assess the in vivo regulation of osteocalcin by RUNX
protein , we generated transgenic mice expressing EGFP controlled by the osteocalcin
promoter. Our results show that EGFP is expressed from the OC promoter in a
cultured osteosarcoma cell line, but not in a kidney cell line , and is induced by
vitamin D3. Furthermore , the OC-EGFP transgeniC mice specifically express EGFP
in osteoblasts and osteocytes in bone tissues. Moreover, EGFP is expressed in
mineralized bone nodules of differentiated bone marrow derived from transgenic
mice. Thus , these mice produce a good model for studying the in vivo effects of
RUNX-mediated osteocalcin regulation and fordeveloping potential drug therapies
for bone diseases.
Taken together, our results in living cells support the conclusion that RUNX
transcription factors dynamically associate with stationary subnuclear foci in a C-
terminal dependent mechanism to regulate gene expression. Moreover, RUNX
subnuclear foci represent transcription sites containing nascent transcripts and co-
regulatory interacting proteins. These conclusions provide a mechanism for how
RUNX transcription factors may associate with subnuclear foci to regulate gene
expression. Furthermore , the OC-EGFP transgenic mice now provide a useful tool
for studying the in vivo function and regulation of osteocalcin by RUNX proteins
during osteoblast differentiation and possibly for developing therapeutic drugs for
treatment of bone diseases in the future.
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The Nucleus: Organizing Center for Transcriptional Regulation
The nucleus has several biological functions including gene expression, DNA
replication and DNA repair. The nucleus is compartmentalized and factors involved
in several ofthese cellular functions are localized to specific punctate subnuclear
domains (Nickerson et al. , 1995; Stein et aI. , 2000b; Lamond and Earnshaw , 1998;
Cook, 1999; Berezney et aI. , 2000; Misteli and Spector, 1998; Davie et aI. , 1997).
Transcription is a necessary cellular process that synthesizes mRNA in the nucleus.
Sites of active transcription are visualized by labeling nascent transcripts with 5-
bromouridine 5' triphosphate (BrUTP) (Wansink et aI. , 1993). Transcription requires
the assembly of co-regulatory proteins and the RNA polymerase holoenzyme on the
promoter region of a specific gene (Strouboulis and W olffe , 1996; NiUir et aI. , 2001).
To activate transcription, a conformational change in chromatin structure is required
for the assembly of transcription factor machinery.
Chromatin is organized in chromosomal terrtories in the nucleus.
Transcription and splicing occur in the functional compartment called the
perichromatin fibrils , which are found at the boundaries of condensed chromatin
domains. Active genes are positioned in euchromatin located in the interior of the
nucleus and inactive genes are localized to condensed heterochromatin on the
periphery of the nucleus (Strouboulis and Wolffe, 1996; Jackson et aI. , 1997; NiUir et
aI. , 2001). Inactive chromatin is tightly packaged into higher order 30 nm chromatin
fibers (Figure 1). Active chromatin opens into 10 nm chromatin fibers and is
sensitive to nuclease digestion as shown by the appearance of nuclease hypersensitive
sites (Jackson, 1997; Davie et al. , 1997; Naar et aI. , 2001). Chromatin fibers are
Figure 1. Nuclear Organization and Structure. Inactive chromatin is organized
into highly condensed 30 ru fibers. Active chromatin is organized into chromatin
loops , which attach to the nuclear matrix (purple filaments, shown below) at matrix
attachment regions (MAR). Histone acetylation and chromatin remodeling factors
associate with chromatin to open active chromatin into 10 ru fibers , which have the
appearance of 'beads-on-a-string . The 10 ru fibers are composed of 200 bp of DNA
wrapped around a histone octamer. The histone octamer consists of two copies each
of the histones H2A, H2B , H3 and H4. Histone HI associates with the DNA linker
sequence. Promoters in an open conformation contain nucleotide sequences that are
recognized by transcription factors. Histone acetylation and chromatin remodeling
factors disassociate nucleosomes from active promoters, so transcription factors can
bind to DNA and regulate gene expression (shown in image below). (Adapted from
Stein et al. (2003). J. Cell Biochem. 340-355.
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organized into loop domains with matrix attachment regions (MARs) attaching to the
nuclear matrix at the base of the loops (Davie , 1997; Stein et aI. , 2003; Galande and
Kohwi-Shigematsu 2000). Transcriptionally active genes are localized to
decondensed chromatin loops (Figure 1; Davie , 1997; Stein et aI. , 2003). The 10 
chromatin fibers have the appearance of 'beads-on-a-string ' which are composed of
200 bp DNA segments tightly wrapped around a histone octamer to form a
nucleosome. The nucleosome octamer consists ofa histone (H3-H4)2 tetramer
surrounded on either side by two H2A-H2B dimers (Figure 1). Histone HI binds to
the linker DNA that groups the nucleosomes together and stabilizes the chromatin
into the 30 ru fibers (Davie , 1997; N Uir et al. , 2001; Jackson et al. , 1997).
Transcriptional activation requires the opening of condensed chromatin
which is the result of acetylation of the N-terminal tails ofthe core histones (Davie
1997; N Uir et aI. , 2001). The level of acetylation is related to the balance between the
activities of histone acetyltransferases (HATs) and histone deacetylases (HDACs).
In general , transcriptionally active chromatin has hyperacetylated histones, whereas
inactive chromatin is hypoacetylated. Acetylation of his tones weakens the
nucleosome interaction with the DNA, allowing for chromatin to open so
transcription factors can bind (Davie , 1997; Naar et aI. , 2001). Furthermore
chromatin remodeling factors , such as SWI/SNF complexes open chromatin by
disassociating DNA from nucleosomes or by sliding nucleosomes along the DNA in
an A TP-dependent mechanism to make gene promoters accessible to the transcription
machinery (Morales et aI. , 2001; Naar et aI. , 2001). The order in which histone
acetyltransferases , chromatin remodeling factors and the transcription machinery
.-d
associate with gene promoters is specific for each promoter (Narlikar et al. , 2002).
One family oftranscription factors , RUNX , is the focus of our study and has been
shown to interact with a histone acetyltransferase , p300/CBP , to activate t anscripti
and a histone deacetylase , HDAC6 , to repress transcription (Kibatayshi et aI. , 1 998;
Sierra et aI. , 2003; Westendorf et al. , 2002).
Traffckjng of Protejns by Nuclear Transport
Nucleo-cytoplasmic transport of proteins and RNA occurs through nuclear
pore complexes (NPC), which connect the cytoplasm to the nucleus and are located in
the nuclear envelope (Wente, 2000). The NPC is formed from a family of proteins
called nucleoporins. Small molecules (':40 kDa) passively diffuse through the NPCs
(Ossareh-Nazari et al. , 2001). Larger proteins and RNA molecules move through the
NPCs through controlled mechanisms. Larger nuclear proteins can enter the nucleus
through the presence of a simple or bipartite basic amino acid sequence called the
nuclear localization sequence (NLS), which actively transports the molecule against
the concentration gradient. Import of nuclear proteins (cargo) requires the NLS to
bind to an adaptor protein (karyopherins/ importins ex) that interacts with a transport
receptor (karyopherins/ importins ). The cargo-karyopherin complex then interacts
with the nucleoporins in the NPC , associates with small guanosine triphosphatase Ran
(RanGTP) protein and is transported to the nucleus (Wente, 2000).
Nuclear export involves the presence of a nuclear export signal (NES), which
was originally discovered in the human immunodeficiency virus (HIV)- l Rev protein
is a 10-amino acid hydrophobic leucine-rich sequence (Ossareh-Nazari et al.
2001). NESs are present in several cellular and viral proteins involved in
transcription , cell cycle and signal transduction. The export of proteins from the
nucleus requires the export receptors (termed exportins), which have a similar
sequence and function to importins and belong to the same karyopherin superfamily.
RUNX transcription factors are nuclear proteins , which are localized to the nucleus
through a NLS.
RUNX Family of Transcription Factors Regulate Tissue-Specific Gene
Expression
RUNX transcription factors belong to the Runt homology family of proteins
which is composed of at least two members in Drosophila melanogaster namely runt
and lozenge. There are three mammalian RUNX family members encoded by
independent genes: RUNX1/AML1/Cbfa2/PEBP2aB
RUNX2/ AML3/CbfallPEBP2aA and RUNX3/ AML2/Cbfa3/PEBP2aC (Figure 2;
Levanon et aI. , 1994). Gene disruptions in mice show that each ofthe RUNX
proteins has a tissue-specific phenotype (Komori et al. , 1997; Otto et al. , 1997; Wang
et aI. , 1996a; Okuda et. al. , 1996; North et al. , 1999; Li et aI. , 2002; Levanon et aI.
2002). RUNX proteins share several functionally conserved domains including the
Runt Homology Domain (RHD), the nuclear localization signal (NLS) and a
subnuclear localization signal called the nuclear matrix targeting signal (NMTS)
(Speck and Stacy, 1995; Zeng et aI. , 1997; Zaidi et aI. , 2001). RUNX factors share
66% homology with Drosophila runt protein and over 90% homology with each other
within the 128-amino acid RHD (Speck and Stacy, 1995). RUNX proteins are shown
Figure 2. Structure and Nomenclature of RUNXlCBF/AML/PEBP2 Proteins.
(A) There are three RUNX a-subunit proteins , RUNX1 , RUNX2 and RUNX3. , The
three RUNX proteins contain conserved amino acid sequences in the following
functional domains: 1) the runt homology domain (RHD); 2) nuclear localization
signal (NLS); 3) nuclear matrix targeting signal (NMTS); and 4) the repression
domain (VWRPY). RUNX2 has a unique domain of a glutamine-alanine amino acid
stretch (QA). The AML- 1B isoform of the RUNX1 protein is 480 amino acids; the
PEBP2aA isoform of RUNX2 is 513 amino acids and the p44 isoform of RUNX2 is
415 amino acids. (B) The nomenclature for the RUNX factors produced three names
that were given from different laboratories for the same protein. RUNX was the
agreed upon nomenclature by the Human Genome Organization. AML was
designated for its involvement in Acute Myeloid Leukemia (Levanon et al. , 1994).
CBF was designated as Core Binding Factor for its ability to bind to the core binding
sequence in the Moloney murine leukemia virus enhancer and the SL3-3 murine
leukemia virus enhancer (Speck and Stacy, 1995). PEPB2 was designated as Polyoma
Enhancer Binding Protein 2 for its association with the polyoma virus enhancer A
(Bae et aI. , 1994). Human chromosomes on which the RUNX and CBF genes are
located are shown in the last column.
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to function in a heterodimeric complex that contains an (X-subunit and a -subunit.
The (X-subunit or RUNX recognizes and binds to the DNA consensus sequence
Pu/TACCPuCA (Meyers et aI. , 1993; Speck and Stacy, 1995). This core sequence is
present in a variety of gene promoters that control cellular differentiation. The RHD
is responsible for RUNX interaction with DNA and heterodimerization with the 
subunit (CBF ) (Meyers et aI., 1993; Speck and Stacy, 1995). CBF does not bind 
directly to DNA yet its interaction with RUNX proteins enhances DNA binding
affnity of RUN X (Speck and Stacy, 1995; Wang et aI. , 1993; Ogawa et al. , 1993a;
Harada et aI. , 1999).
Each RUNX family member has several isoforms resulting from alternative
splicing and usage of different promoters , a distal promoter (P l) and a proximal
promoter (P2) (Xiao et al. , 1999; Fujiwara et aI. , 1999; Miyoshi et al. , 1995; Rini and
Calabi , 2001; Bangsow et al. , 2001). The RUNX2 gene encodes at least two mRNA
isoforms, which produce proteins with different N-termini. One isoform, PEBP2aA
(Type I), uses the proximal promoter and produces a 513 amino acid protein starting
with the amino acids MRIPV (Ogawa et aI. , 1993b). The other isoform til- (Type
II), uses the distal promoter and generates a 528 amino acid protein with a 15 amino
acid extension at its N-terminus compared to Type I and begins with the amino acids
MASNS (Stewart et aI. , 1997). It is possible that the N-terminal extensions have the
potential of differentially regulating tissue specific genes. However, it is more likely
that these N-termini are simply a vestige of the requirement to regulate RUNX
proteins from two different promoters.
RUNX transcription factors function to regulate certain genes required for
tissue-specific development (Okuda et aI. , 1996; Wang et aI. , 1996a; Komori et aI.
1997; Otto et aI. , 1997; Ducy et aI. , 1997; Javed et aI. , 2001; Westendorf and Hiebert
1999; Ito, 1999; Lutterbach and Hiebert; 2000). The C-termini of RUN X factors
have both activation and inhibitory domains that are important for transcriptional
regulation of specific genes. The boundaries of the domains responsible for
transcriptional regulation are specific depending on the context of the promoter
(Westendorf and Hiebert, 1999; Ito , 1999; Lutterbach and Hiebert; 2000). RUNX
proteins were originally thought to be transcriptional activators; however they can
also function as repressors (Meyers et al. , 1995; Javed et aI. , 2000). RUNX
transcription factors regulate many hematopoietic, osteogenic and gastro-intestinal
genes involved in growth and differentiation. Among the bone-related genes
regulated by RUNX proteins are osteocalcin (OC), osteopontin, bone sialoprotein
collagenase- , collagen Type as well as the RUNX2 gene itself (Harada et al.
1999; Selvamurugan et aI. , 1998; Ducy et aI. , 1997; Javed et aI. , 2001; Cohen, 2001;
Lian et aI. , 2001; Drissi et aI. , 2000).
Several co-regulatory factors interact with RUNX to form multi subunit
transcription regulatory complexes and regulate tissue-specific gene expression
(Westendorf and Hiebert, 1999; Ito, 1999). The regions in RUNX1 where several co-
regulatory proteins interact are shown in Figure 3. Regulation of specific genes may
depend on the co-regulatory proteins that interact with RUNX proteins (Westendorf
and Hiebert, 1999; Ito, 1999). Moreover, the spatial and temporal organization of
transcription factor multisubunit complexes is important for gene regulation (Stein et
i!.!
Figure 3. Schematic of the Interacting Regions of Co-regulatory Proteins with
RUNXI. A schematic of RUN Xl and the regions of RUN Xl that several 'co-
regulatory proteins interact with are shown. The regions are labeled by a line with the
indicated name of the interacting protein under or over the line. The conserved
RUNX domains , including the runt homology domain (RHD), the nuclear localization
signal (NLS), the nuclear matrix targeting signal (NMTS) and the repression domain
(VWRPY) are labeled. Several of the co-regulatory proteins, which are ilustrated
that have been shown to interact with RUNX1 , RUNX2 and/or RUNX3 include
Smads (Hanai et al. , 1999), Ear-2 (Ah et al. , 1998), AL Y (Bruhn et al. , 1997), c-Fos
and c-Jun (D'Alonzo et al. , 2002; Hess et al. , 2001), Ets (Erman et ai. , 1998), C/EBP
, and 8 (Zhang etai. , 1996; Hohaus et ai. , 1995; Gutierrez et ai. , 2002), TLE
(Imai et ai. , 1998; Javed et ai. , 2000; Thirunavukkarasu et al. , 1998), Hes1 (McLarren
et al. , 2001), p300/CBP (Kitabayashi et ai. , 1998); HDAC6 (Westendorf et ai. , 2002),
mSin3 (Lutterbach et ai. , 2000), MITF (Ogihara et al. , 1999), MEF (Mao et ai.
1999), CBF (Ogawa et al. , 1993a; Wang et al. , 1993) and YAP (Yagi et al. , 1999).
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aI. 2000b). For example , a model for the three-dimensional organization of the OC
promoter allows for the interaction and cooperation of RUN X with co-regulatory
proteins and their association with the nuclear matrix (Stein et aI. , 1996). Specific
combinations of transcription factors assemble onto tissue-specific promoters
producing an elaborate network of protein-protein and protein-DNA interac ions to
regulate gene expression (Ito , 1999). The combination of transcription factors may
depend on the gene to be regulated, the specific cell type , and whether the gene wil
be activated or repressed. For example , the repressor proteins TLE and histone
deacetylase can interact with RUNX to inactivate the OC promoter, whereas CBF
C/EBP and histone acetyltransferases , such as p300/CBP , can interact with RUNX to
activate the OC promoter (Westendorf and Hiebert, 1999; Gutierrez et a1. , 2002;
Javed et aI. , 2000; Sierra et aI. , 2003). Thus, the spatial and temporal availability of
specific transcription factors and co-factors at a particular place and time in the
nucleus may determine which genes are expressed.
Role of RUNX Factors in Development and Disease
The function of RUNX proteins during embryonic development has been
studied through gene ablation (Komori et aI. , 1997; Otto et a1. , 1997; Wang et al.
1996a; Okuda et a1. , 1996; North et aI. , 1999; Li et a1. , 2002; Levanon et aI. , 2002).
RUNX1 was the first family member to be studied by knockout experiments, which
established that RUNX1 is essential for hematopoiesis (Wang et aI. , 1996a; Okuda et
a1. 1996). RUNX1 null mice are embryonic lethal and die in utero (E12.5) from
hemorrhaging of the central nervous system and failure of definitive hematopoiesis.
;c,
iJ'
Furthermore , mice deficient in the heteromeric protein CBF are also embryonic
lethal and show a similar spectrum of abnormalities as RUNX1 null mice (Sasaki et
aI. , 1996; Wang et aI. , 1996b; Niki et aI. , 1997), indicating that CBF is required for
biological function of RUN Xl. Recently, CBF has been shown to be involved in
bone development of CBF disrupted knock-in mice (Kundu et aI. , 2002; Yoshida et
aI. , 2002; Miler et al. , 2002). Ablation of the RUNX2 gene in mice results in
complete lack of bone formation because of a maturational arrest of osteoblast
differentiation. RUNX2 null mice die just after birth due to the inability to breathe
and the absence of mineralized skeleton indicates that RUNX2 is required for
osteogenesis (Komori et aI. , 1997; Otto et al. , 1997). RUNX3 has recently been
shown to be important for the regulation of gastric epithelia and the development of
gut and TrkC dorsal root ganglia neurons in RUNX3 knockout mice (Li et aI. , 2002;
Levanon et al. , 2002).
The implication of RUNX family members in tissue development is further
demonstrated in humans. Mutation of RUN X genes results in a variety of diseases.
RUNX1 , located on human chromosome 21 , is involved in chromosomal
translocations that induce acute leukemias. About 40% of human acute leukemias
result from translocation of the RUNX1 gene (Westendorf and Hiebert, 1999). The
most common RUNX1 chromosomal translocations are t(8;21), t(3;21) and t(12;21),
which cause acute myeloid, acute lymphoblastic , and therapy-related leukemias
respectively (Figure 4; Speck and Stacy, 1995; Westendorf and Hiebert, 1999; Ito
1999). Furthermore , the translocation referred to as inv(l6), which involves the
fusion of the CBF gene (located on human chromosome 16) with the gene for
Figure 4. RUNXlIAML- l Chromosomal Translocations and the Result
Fusion Proteins. Chromosomal translocations ofRUNXl/AML- 1B result in a
variety of human acute leukemias. The sites of the translocation on the
RUNX1/AML- 1B protein are shown as t(8;21), t(3;21) and t(12;2l) with arrow to
show the amino acid number at the site of translocation. The fusion proteins, which
are the result of the translocations are shown below. AML- l/ETO fusion protein is
caused by the t(8;21) chromosomal translocation resulting in the fusion of the N-
terminal 206 amino acids of AML- 1 to amino acid 30 of the eight-twenty-one (ETO)
protein. The t(3 ;21) translocation results in a fusion protein between the first 270
amino acids of AML- 1 and the EVI- 1 transcription factor. The AML1/ETO and
AML1/EVI translocations result in loss of the C-terminal region of AML- , which
contains several co-regulatory protein interaction domains and the NMTS. The
t(12;2l) translocation results in the fusion of the TEL protein to amino acid 21 of
AML- 1. This fusion protein retains all of R UNX 1 except the N - terminal 21 amino
acids. The inv(16) chromosomal translocation , which also results in leukemia is
caused by the fusion of the N-terminal165 amino acids ofCBF with the myosin
heavy chain protein.
. .
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smooth muscle myosin heavy chain results in acute myelomonocytic leukemia with
eosinophilia (Liu et al. , 1993). The levels of RUN Xl proteins also appear to be very
important in regulating hematopoiesis as recent studies have shown that RUNX1
haplo-insuffcinency induces thrombocytopenia with a predisposition to acute
leukemias in humans (Song et aI. , 1999; Barton and Nucifora, 2000).
Haplo-insuffciency ofRUNX2 results in a human autosomal dominant bone
disease called cleidocranial dysplasia (CCD). CCD is characterized by patients with
open fontanelles and sutures, hypoplastic and aplastic clavicles , short stature and
supernumerary teeth (Lee et aI. , 1997). Several patients with CCD have mutations in
the RUNX2 gene , indicating that mutations in RUNX2 cause CCD (Mundlos et aI.
, .
1997; Zhang et aI. , 2000). Overexpression ofRUNX2 in mesenchymal cells inhibits
osteoblast maturation and causes osteopenia with multiple fractures in mice (Liu ' et
aI. , 2001), suggesting that the cellular levels ofRUNX2 in mesenchymal cells are
very important for normal bone development. RUNX3 has been implicated in cancer
since loss of RUNX3 expression correlates with the onset of gastric cancer (Li et aI.
2002). Taken together, these results show that RUNX proteins are essential for
development of hematopoietic , skeletal , neural and gastro-intestinal tissues and that
variations in the levels of RUN X expression or disruption of the RUNX genes can
lead to serious tissue malformations or cancer.
Nuclear Localization and Nuclear Matrix Association of RUNX Transcription
Factors
The nuclear matrix is a nuclear scaffold characterized by electron microscopy
as a fibrous n twork of 1 O-nm intermediate filaments , and consists of insoluble
proteins , nuclear RNAs and 5% DNA (Berezney and Coffey, 1974; Fey et aI. , 1984
1986). This internal nuclear matrix scaffold is surrounded by the nuclear envelope
consisting oflamins AlC arid B and nuclear pore cqmplexes (Stein et aI. , 2000b). A
large network of intermediate fiaments connects the internal nuclear matrix to the
nuclear envelope surface (Nickerson et al. , 1995). The nuclear matrix and
intermediate filaments , referred to as the nuclear matrix-intermediate filament
complex (NMIF), are integrated into a single structure encompassing the whole cell
and have the appearance and structure of an intact cell after extraction of soluble
proteins and DNA (Nickerson et al. , 1995).
The nucleus is organized into multiple subnuclear compartments including the
nucleolus , transcription domains , replication domains , splicing factor domains, PML
domains and coiled bodies (Xing et aI. , 1993; Carter et al. , 1993; Nickerson et aI.
1995; Lamond and Earnshaw, 1998). The nuclear matrix appears to be the structural
support that organizes these functional nuclear compartments for nuclear metabolism
(Nickerson et aI. , 1995). Sites of transcription, replication and RNA processing
associate with the nuclear matrx in a punctate subnuclear distribution (Nickerson et
aI. , 1995; Stein et aI. , 2000b; Lamond and Earnshaw, 1998; Cook, 1999; Berezney et
aI. , 2000; Misteli and Spector, 1998). The nuclear matrix may act as an organizing
scaffold for the dynamic assembly and disassembly of transcription factor complexes
and may contribute to the regulation of gene expression by concentrating and
localizing transcription factors in a specific place in the nucleus (i. , subnuclear foci)
(Stein et al. , 2000b; Zeng et aI. , 1997).
RUNX2 was originally defined as an osteoblast specific nuclear matrix
protein, NMP-2 (Merriman et aI. , 1995). Studies by the SteiniLian laboratory have
shown that RUNX110calizes to the nucleus and associates with the nuclear matrix in
a punctate subnuclear distribution in fixed cells using immunofluorescence
microscopy (Zeng et aI. , 1997). Two traffcking signals are necessary for the
subnuclear targeting of RUN X proteins , one is a nuclear localization signal (NLS),
which is located C-terminal to the RHD and is required for nuclear import, and the
second is a 31 or 38 amino acid nuclear matrix targeting signal (NMTS) (Zeng et aI.
1997; Zaidi et aI. , 2001; Stein et aI. , 1998). The NMTS is a conserved sequence
the three RUNX proteins and is located in the C-termini of RUN X factors (amino
acids 351-381 ofRUNXlIAML- 1B and amino acids 397-434 ofRUNX2/til-
(Figure 5A; Zeng .et aI. , 1997; Zaidi et aI. , 2001). The NMTS has been characterized
to be necessary and sufficient for RUNX proteins to associate with the nuclear matrix
by immunofluorescence microscopy and biochemical fractionation experiments
(Zeng et aI. , 1997; Zaidi et aI. , 2001). These results show that RUNXlIAML- , but
not a C-terminal deleted AML- 1B (amino acids l-290), is associated with the nuclear
matrix. Moreover, proteins in which the NMTS sequence is fused to either AML-
290 (AML- 1B 1-290/351-381) or the GAL4 DNA binding domain are associated
with the nuclear matrix , suggesting that the NMTS is necessary and sufficient to
target RUNX1 to the nuclear matrix (Zeng et aI. , 1997). These findings using
immunofluorescence microscopy are based on fixed cell preparations and it has been
argued that punctate foci observed in nuclear matrix preparations may be an artifact
from the fixation or extraction procedures (Pederson, 2000). Therefore , it would be
interesting to aetermine the subnuclear distribution of RUNX factors in living cells.
A subset of RUN Xl foci are associated with sites of active transcription on
the nuclear matrix (Zeng et aI. , 1998). The crystal structure of the RUNX1 NMTS
reveals a two-finger structure model , which is composed of two loops connected by a
flexible V-shaped peptide (Figure 5B; Tang et aI. , 1999). It was thought that the
NMTS might interact with the nuclear matrix at the tips of the loops (Tang et al.
1999). Deletion ofthe C-terminus of RUN Xl or RUNX2 , which removes the NMTS
and several co-regulatory interaction domains, results in a loss of nuclear matrix
association and a reduction in transactivation of the TCR enhancer and osteocalcin
(OC) promoter, respectively (Zeng et al. , 1997; Zaidi et al. , 2001; Tang et aI. , 1999).
Furthermore , deletion of the C-terminus ofRUNX2 in gene-replacement mice, which
introduced a stop codon at amino acid 376 before the NMTS and several co-
regulatory protein interaction domains , resulted in a phenotype similar to RUNX2
null mice, lack of bone formation and maturation of osteoblasts , indicating that the C-
terminus ofRUNX2 is required for osteogenesis (Choi et aI. , 2001). Therefore , these
findings suggest a functional role for nuclear matrix association in the regulation of
tissue-specific gene expression.
Figure 5. Sequence and Crystal Structure of the Nuclear Matrix Targeting'
Signal (NMTS). (A) The sequence of the NMTS is shown for RUNX1 (AML- 1B),
RUNX2 (AML3) and RUNX3 (AML2). The NMTS is highly conserved between
RUNX proteins in several different species. Conserved amino acids are highlignted.
(Adapted from Zeng et al. (1997). PNAS 
6746-51.) (B) The crystal structure ofthe
RUNX1 NMTS is ilustrated. The NMTS structure shows two loop domains, Loop I
and Loop II , separated by a glycine-rich a-helical turn. (Adapted from Tang et al.
(1999). J. BioI. Chern. 274 , 33580-
r-
-
-
 
-
-
-
-
R
U
N
X
1
R
U
N
X
2
R
U
N
X
3
AM
lI 
hl
ln
cb
ic
lw
n
-
.
.
.
.
t
A
M
3
A
H
2
hU
I
ch
ic
ke
n
23
8
Lo
op
 I
Lo
ap
 :u
N
ul
.A
N
at
iK
 T
.
ge
tin
g 
Si
gn
l
Lo
op
 II
:!o
26
8
St
ra
nd
 II
Tu
rn
PD
Q!
 27
4
PD
Q!
PD
Q!
'P
D
Q!
'P
D
Q!
PD
Q
Functional Relationship between Gene Regulation and Nuclear Architecture:
Spatial and Temporal Targeting of RUNX Proteins
The interrelationship between gene regulation and nuclear matrix ssociation
is an evolving concept. The association of genes and transcription factors with , the
nuclear matrix at subnuclear domains may facilitate transcriptional control (Stein et
al. , 1998). The ability to regulate transcription and associate with the nuclear matrix is
different for the RUNX deletion mutants. RUNX2 , which lacks the C-terminus of
RUNX2 , is not associated with the nuclear matrix in calvarial cells extracted from
homozygous RUNX2 C mutant knock-in mice, whereas in calvarial cells from wild-
type mice RUNX2 is associated with the nuclear matrix (Choi et al. , 2001). A
decrease in the transactivation of the OC promoter is observed in HeLa cells after
removal of the RUNX2 C-terminus (Choi et aI. , 2001). Furthermore, the full-length
RUNX1 isoform, AML- , contains a promoter-context dependent transactivation
domain and is associated with the nuclear matrix (Zeng et aI. , 1997; Lutterbach and
Hiebert, 2000). Conversely, a C-terminal trncated RUNX1 protein (AML- 1B 1-
290) and the AML- 1 isoform are transcriptionally inactive and not associated with the
nuclear matrix (Zeng et al. , 1997; Speck and Stacy, 1995). Taken together, these
results suggest that there is functional relationship between gene regulation and
nuclear matrix association.
Directing nuclear proteins to the correct place in the nucleus is important for
proper control of transcription (Stein et al. , 1998). The t(8;21) chromosomal
translocation results in the fusion of the RUNX1/AML- 1 gene after the RHD with the
ETO (eight-twenty-one) or MTG8 gene creating the protein product AML- 1/ETO
",-
(see Figure 4; Erickson et al. , 1992; Miyoshi et aI. , 1993), which lacks the RUNXl
subnuclear targeting signal (the NMTS) and co-regulatory protein interaction sites.
The Stein/Lian laboratory has shown that AML- 1/ETO is not targeted to
RUNX1/AML- 1B subnuclear sites (McNeil et aI. , 1999). Instead, AML- lIETO is
redirected to ETO nuclear matrix associated foci. The 8;2l translocation of the
RUNXlI AML- l gene in acute myelogenous leukemia modifies the intranuclear
trafficking of RUNXlIAML- lB proteins by the misrouting ofRUNXlIAML- IB to
alternate subnuclear sites (McNeil et aI. , 1999). This result suggests that localization
to the right place in the nucleus is very important for proper cellular function.
Green Fluorescent Protein
Bioluminescence is common in many marine invertebrates, including several
cnidarians and ctenophores. Light emitted from cnidarians is primarily green
whereas that from ctenophores is blue. Green fluorescent protein (GFP) was
originally discovered as a glowing green fluorescence in the jellyfish Aequorea
victoria which emits light as a defense mechanism (Prasher et aI. , 1992). In vivo
GFP is excited when calcium ions bind to the photoprotein aequorin resulting in the
emission of blue light (Prasher et al. , 1992; Chalfie et al. , 1994). The energy emitted
from the aequorin proteins is then transferred to the GFP molecule, which is then
excited and emits green light Wild-type GFP has a major excitation peak of 395 nm
and a minor peak at 475 nm and gives an emission peak at 508 nm (Tsien, 1998).
After many years of collecting jellyfish from the ocean and painstakingly
extracting GFP protein to be used in experimental studies, this task was facilitated
when GFP from the Aequorea victoria jellyfish was cloned and sequenced (Prasher et
al. , 1992) and when GFP was demonstrated to express in eukaryotic and prokaryotic
cells (Chalfie et al. , 1994). GFP was determined to be a 238-amino acid protein with
a molecular mass of 27 kDa (Prasher et al. , 1992). Expression vectors for GFP
became readily available after GFP was cloned. GFP could be expressed in living
cells and excited by fluorescence microscopy with blue light resulting in the emission
of green light from the GFP molecule.
GFP must be properly folded in order to emit the green light (Tsien, 1998).
The region of GFP that is responsible for the emission of green light is the
chromophore , which consists of the hexapeptide from amino acids 64-69 (Figure 6A;
Prasher et aI. , 1992). Cyclization of the trimer Ser-dehydroTyr-Gly (amino acids 64-
67) in the chromophore is required for light emission (Cody et aI. , 1993). For the
cyclization mechanism, GFP folds into a nearly native conformation and the
imidazolinone is formed by nucleophilic attack of the amide group of Gly67 on the
carbonyl group ofSer65 followed by dehydration and oxidation of Tyr66 (Figure 6B;
Tsien, 1998). The crystal structure of GFP shows a barrel structure of eleven -sheets
surrounding the helical chromophore, which has been referred to as 'paint in a can
(Figure 6C; Ormo et aI. , 1996; Yang et aI. , 1996a). Two GFP -'barrel monomers can
homodimerize (Ormo et aI. , 1996; Yang et aI. , 1996a).
Multiple variations of GFP have been generated to change its color, to
increase its intensity and to increase the expression of properly folded fluorescent
protein at 37 C (Yang et aI. , 1998). Several different colored fluorescent proteins
have been created by generating point mutations in GFP yielding proteins with shifted
Figure 6. Structure of Green Fluorescent Protei and its Chromophore. (A) The
chromophore of Green Fluorescent Protein (GFP) is the region ofthe protein
responsible for emitting green light and is a hexapeptide from amino acids 64-69.
Cyclization of the trimer Ser-Tyr-Gly (amino acids 65-67) in the chromophore is
necessary for the fluorescence ofGFP. The cyclic Ser-dehydroTyr-Gly structure is
shown. (B) The mechanism to create the cyclic Ser-dehydroTyr-Gly structure is to
first fold GFP into a nearly native conformation, then cyclization occurs by the
formation of an imidazolinone group by nucleophilic attack of Gly67 on Ser65
followed by dehydration and oxidation of the cyclic group of Tyr66. (C) The crystal
structure of GFP reveals a p-barrel structure , which is very stable. The p-barrel
-=-
contains 11-p-sheets surrounding an a-helical chromophore in the center.
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Crystal Structure of GFP
Adapted from Gura , 1. (1996). Science 273 , 1336.
emission spectra, including cyan fluorescent protein (CFP), which has major and
minor excitation and emission peaks at 433 (453) nm and 475 (501) nm, yellow
fluorescent protein (YFP), which has excitation and emission maxima at 513 nm and
527 nm, and blue fluorescent protein (BFP), which has excitation and emission peaks
at 380 nm and 440 nm. The long desired red fluorescent protein ( drFP583) was
cloned from the Anthozoa species of coral and has an absorption peak at 558 nm and
an emission peak at 583 nm (Matz et aI. , 1999). However, red fluorescent protein has
the disadvantage that it can form protein aggregates when expressed in cells as a
fusion protein. One variant of GFP is enhanced green fluorescent protein (EGFP;
Clontech, Palo Alto, CA), which is mammalian codon optimized for increased
translational efficiency in mammalian cells and has Ser65Thr and Phe64Leu
mutations that increase its brightness 35-fold. EGFP has an excitation peak at 488
nm and an emission peak similar to wild-type GFP at 509 nm (Yang et al. , 1996b;
Cormack et al. , 1996). In this study, we have used EGFP fused to RUNX factors to
assess the intranuclear trafficking of RUNX proteins in living cells.
Several advantages of using GFP are that it has an intrinsic fluorescence in
which no antibodies , substrates or cofactors are required, it is very stable , does not
photobleach easily, it is species independent, and can be monitored in living cells and
whole animals (Kain et aI. , 1995). GFP has several applications including as a
protein tag, monitoring gene expression in living cells and tissues, drg and genetic
screens, and studying protein dynamics in subcellular compartments (Misteli and
Spector, 1997; Gerdes and Kaether, 1996). Tagging nuclear proteins with GFP to
determine their mobility has recently advanced the way we think of the nucleus.
Protein Dynamics
Detennining the mobility of proteins and lipids in membranes, such as the
plasma membrane, the mitochondrial inner membrane and liposomes, began 25 years
ago using Fluorescence Recovery After Photobleaching (FRAP) analysis by
microinjection of proteins and lipids labeled with fluorophores and fluorescent
antibodies (Axelrod et aI. , 1976). FRAP has several other names such as
fluorescence photobleaching recovery, fluorescenc photobleaching redistribution
(FPR) and fluorescence microphotolysis. Most recently, GFP has been fused to
proteins to detennine their mobility using FRAP since GFP exhibits much less
photodamage to cells than other fluorophores (Spector et aI. , 1998).
In a typical FRAP assay, an image is captured using confocal microscopy
before photobleaching and then the fluorescence in a small area of the cell is
photobleached using a short pulse of a high-powered laser. The recovery of the
fluorescence resulting from movement ofthe unbleached molecules into the
photobleached area is, detennined by capturing images at certain time intervals after
photobleaching (Spector et aI. , 1998). Two parameters can be calculated from FRAP
analysis: 1) the mobile fraction of the fluorescent molecules; and 2) the rate of the
mobility (Reitsand Neefjes, 2001). The mobile fraction and the rate of mobility are
measurements of the exchange of the unbleached molecules outside the
photobleached area for the bleached molecules inside the photobleached area. The
calculations of the mobile fraction and rate of the mobility are assessed from the
graph of the recovery curves (fluorescence intensity vs. time) (Spector et aI. , 1998).
'''
FRAP analysis can determine the mobility of cytoplasmic and nuclear
proteins in addition to proteins that are membrane bound. The mobility of proteins in
the nucleus may reflect a diffusional mechanism, which does not require e!1ergy or a
directional mechanism, which may be targeted by specific signals (Misteli , 200,1).
Nuclear proteins that collide with other proteins or with the nuclear architecture may
move more slowly than freely diffusing proteins (Misteli , 2001). Therefore , FRAP
analysis provides a very useful tool to determine the dynamics of nuclear proteins.
The Present Study
Previous results have shown that RUNX factors have a punctate subnuclear
distribution and that the nuclear matrix targeting signal (NMTS) of RUNX proteins is
necessary to associate with the nuclear matrix in fixed cells (Zeng et al. , 1997; Zaidi
et aI. , 2001; Tang et aI. , 1999). However, the localization of RUN X proteins in living
cells is unkown. Therefore , in this study we determined the subnuclear distribution
of RUNX proteins in living cells and whether the subnuclear distribution is dependent
on the C-terminus , which contains the NMTS. To assess whether RUNX nuclear
proteins move through the nucleus quickly or slowly to the subnuclear domains and
whether the mobility of RUN X proteins is constrained by the nuclear matrx, we
examined the dynamics of RUN X proteins in living cells using fluorescence recovery
after photobleaching (FRAP) analysis and determined the effect of deleting the C-
terminus and mutating the nuclear matrix targeting signal (NMTS) on the mobility of
RUNX2. To understand the subnuclear organization of RUN X proteins in live cells
we assessed whether there are a fixed number of sites in the nucleus or whether the
number of sites is variable and whether RUNX sites are saturable after forced
expression of RUN X proteins. Furthermore, since the subnuclear targeting signals in
the three RUNX proteins are conserved (Zeng et al. , 1997), we assessed whether
RUNXl and RUNX2 are directed to the same subnuclear sites in the nuclear matrix.
These studies will provide insight into the formation and maintenance of RUN 
subnuclear sites and the intranuclear trafficking of RUNX transcription factors into
and out of subnuclear foci.
Overall Goal
The overall goal of this study is to assess the intranuclear trafficking of and
the possible mechanism by which RUNX transcription factors move to subnuclear
domains in living cells to understand the spatial-temporal localization of RUN X
proteins.
Hypothesis
We hypothesize that RUNX transcription factors dynamically move through
the nucleus and associate with subnuclear domains in a C-terminal dependent
mechanism to regulate transcription. The biological questions we address are: 1)
What are the subnuclear distribution and dynamics of RUNX proteins in living cells
and the effect of the C-terminus of RUN X on the mobility; 2) What effect does
mutation of the nuclear matrix targeting signal have on the subnuclear distribution
and mobility of RUN X transcription factors; and 3) Are RUNX subnuclear foci
saturable and are RUNX1 and RUNX2 targeted to common subnuclear domains?
Transcription Factors RUNXI/ AMLI
and RUNX2/Cbfal Dynamically
Associate with Stationary Subnuclear
Domains in a C-terminal Dependent
Mechanism
INTRODUCTION
Regulatory factors involved in cellular processes that include gene
transcription, DNA replication and RNA processing, are localized to distinct domains
in the nucleus (Nickerson et aI. , 1995; Stein et aI. , 2000b; Lamond and Earnshaw
1998; Cook, 1999; Berezney et aI. , 2000; Misteli and Spector, 1998). One example is
the family of runt-related transcription factors (R X), which localize within the
nucleus to punctate foci and associate with the subnuclear scaffold designated as the
nuclear matrix (Zeng et aI. , 1997; Zeng et al. , 1998; McNeil et al. , 1999; Tang et aI.
1999; Stein et al. , 2000b). A subset of RUN Xl subnuclear foci are involved in
transcriptional control as shown by colocalization of RUNX1 foci with sites of active
transcription (Zeng et al. , 1998). Endogenous and overexpressed RUNX proteins
both have a punctate subnuclear distrbution and are nuclear matrix associated (Zeng
et aI. , 1997; Tang et aI. , 1999; Prince et al. , 2001). 
RUNX1 and RUNX2 each contain a conserved C-terminal nuclear matrx
targeting signal (NMTS) that is necessary for directing these proteins to intranuclear
foci (Stein et aI. , 2000b; Zeng et al. , 1997; Zaidi et aI. , 2001). The C-terminus of
RUNX factors is also a functional domain for transcriptional modulation by several
co-regulatory proteins (Lutterbach and Hiebert, 2000). RUNX proteins are required
for tissue-specific gene expression in hematopoiesis (RUNX1) and skeletogenesis
(RUNX2) (Okuda et al. , 1996; Wang et al. , 1996a; Stewart et aI. , 1997; Komori et aI.
1997; Otto et aI. , 1997; Choi et aI. , 2001). Recently, knock-in mice which deleted the
termini of RUN Xl and RUNX2 were used to demonstrate that the C-terminal
domain of either RUNX1 or RUNX2 , which contains the NMTS , is essential for
hematopoiesis and bone formation, respectively (Choi et aI. , 2001; North et al. , 1999).
Thus , the C-terminus of RUNX factors appears to be involved in both intr ear
traffcking and transcriptional regulation.
The dynamics by which proteins traverse and localize within the nucleus may
be critical for their biological activity. One important question relates to the relative
mobility and compartmentalization of RUNX transcription factors in subnuclear foci
in living cells. Mobility studies that began 27 years ago used Fluorescence Recovery
After Photobleaching (FRAP) assays to determine the dynamics of proteins and lipids
in cellular membranes (Axelod et aI. , 1976; Spector et al. , 1998). Fluorophores and
fluorescent antibodies were conjugated to proteins and lipids and microinjected into
cells to determine their mobility. The discovery of green fluorescent protein (GFP),
which contained intrinsic green fluorescence, facilitated the use of FRAP analysis by
expressing nuclear and cytoplasmic proteins fused to GFP. An emerging concept is
that the mobility of proteins is directly coupled to their function and whether they are
architecturally linked to specific subnuclear compartments. Association with the
nuclear architecture may slow the mobility of nuclear proteins down. The dynamics
of RUN X transcription factors may reflect the movement to and from subnuclear foci
that are involved with transcription. RUNX may assemble into functional
transcription factor complexes at these subnuclear foci to regulate gene expression.
To understand the relative mobility of RUN X transcription factors in the
nucleus and the dynamics of their association with subnuclear sites, we used time-
lapse microscopy and FRAP analysis. Our key result is that RUNX1 and RUNX2
transcription factors are targeted to and dynamically associate with subnuclear foci
that remain stationary within the nuclear space. Furthermore , we show that a C-
terminal truncation ofRUNX2 that removes the subnuclear targeting signal increases
the mobility of the protein to that of EGFP alone and results in the loss of nuclear
matrix association and interaction with subnuclear foci. Moreover, we show that
RUNX1 and RUNX2 proteins are targeted to common subnuclear domains. RUNX
subnuclear foci may represeht sites of transcription which contain co-regulatory
factors and nascent transcripts. These findings together with others suggest that the
dynamic association of RUN X proteins in stationary foci provides a mechanism for
formation of regulatory complexes that are essential for RUNX dependent cell
differentiation and embryonic development.
MATERIALS AND METHODS
Cell Culture
Human osteosarcoma SaOS-2 cells (American Type Culture Collection
(A TCC), Manassas , V A) were maintained in McCoy s 5A medium supple ented
with 15% (v/v) fetal bovine serum (FBS), human cervical carcinoma HeLa cells
. (ATCC) were maintained in Dulbecco s modified eagle medium (DMEM) with 10%
FBS and rat osteosarcoma ROS 17/2.8 cells (Majeska et aI. , 1980) were maintained in
F 12 media with 5% FBS at 37 C in a humidified 5% C02 incubator. All media: was
supplemented with 100 Units/ml Penicilin, 1 00 g/ml Streptomycin and 2 mM L-
glutamine and changed every other day.
Plasmids
Generally, the Enhanced Green Fluorescent Protein (EGFP; Clontech, Palo
Alto , CA) gene was cloned into pcDNA3 (Invitrogen, Carlsbad, CA) and fused to the
genes for the full-length mouse PEBP2aA isoform ofRUNX2 (amino acids 1-513),
the C-terminal deleted PEBP2aA isoform RUNX2 361 (amino acids 1-361) and the
human AML1B isoform of RUN Xl (amino acids 27-480). EGFP-RUNX2 and
EGFP-RUNX2 361 were generated by inserting a PCR amplified EGFP cDNA into
pcDNA3 and then cloning either RUNX2 or RUNX2 361 genes. Specifically, the
NheI/EcoRI fragment of the pEGFP-C3 vector (Clontech) was used as a template
and PCR was performed as follows: 5 min at 94 C; 30 cycles of 1 min at 94 , 3 min
at 42 C and 3 min at 72 C; and then extended for 10 min 72 C using the forward
primer 5' TCTAGAGGTACCATGGTGAGCAAGGGC-3' which contains a
KpnI/Acc65I restriction site and the reverse primer 5'
ATAGAATTCGGATCCCTTGTACAGCTCGTC-3' with engineered BamHI and
EcoRI sites. In a final volume of 50 /-l, the PCR reaction contained a final
concentration of 1 ng template DNA , IX Thermopol Buffer (New England Biolabs
Beverly, MA), 4.5 mM MgS0 (New England Biolabs), 0.5 /-M of each primer, 0.
mM dATP , dCTP , dGTP and dTTP mixture (Amhersham Pharmacia, Piscataway,
NJ), lO% (v/v) glycerol and 2.5 units of Vent polymerase (New England Biolabs).
The KpnI/ Acc65I and EcoRI sites were used to insert the amplified EGFP cDNA
fragment into the dephosphorylated pcDNA3 vector. RUNX2 and RUNX2 361
genes (Javed et aI. , 2001) were subsequently sub cloned into this plasmid at the 3' end
of EGFP using the BamHI site and either XbaI or XhoI sites , respectively.
Similarly, the EGFP-RUNXl plasmid was generated by inserting a PCR
amplified EGFP DNA product into pcDNA3 and then adding the RUNX1 DNA.
EGFP was amplified by PCR using the oligonucleotides 5'
GGA TCCGGT ACCA TGGTGAGCAAGGGCGAGGAG-3' as the forward primer
which contained the generated KpnI/ Acc65I site and 5'
GAA TTCTCT AGACTTGT ACAGCTCGTCCA TGCC-3' as the reverse primer , in
which an XbaI site was created. In a final volume of 50 /-1 , the PCR reaction
contained a final concentration of 1 ng template DNA, 1 X cloned Pfu reaction
buffer (Stratagene, La Jolla, CA), 0.5 /-M of each primer, 0.2 mM dATP , dCTP
dGTP and dTTP mixture (Amhersham Pharmacia, Piscataway, NJ), 10% (v/v)
glycerol and 3.75 Units ofPfu polymerase (Stratagene, La Jolla, CA). The PCR
T''
product was digested with Acc65I and XbaI and then ligated to a similarly digested
pcDNA3 vector to generate pcDNA3-EGFP. The XbaIlXbaI fragment of RUN 
(amino acids 27-480; Zeng et aI. , 1997) was then inserted into this plasmid.
Orientation ofthe RUNX1 cDNA was determined by digesting with HindIII. A
clones were manually sequenced using Sequenase version 2.0 kit (Amersha
Pharmacia, Piscataway, NJ).
Restriction Digestion of DNA
Restriction digestions for cloning EGFP-RUNX fusion constructs were'
slightly different for each construct produced. Briefly, for creating pcDNA3-EGFP
pcDNA3 and the EGFP PCR product were digested in a total volume of 70 J.I
containing 10 f.g DNA or half of (30 f.l) the PCR product, Ix Buffer #3 (NEB), '100
f.g/ml bovine serum albumin (BSA), and 3 f.l Acc65I enzyme (NEB) for 3 hours at
37 DC. The enzyme was heat inactivated at 65 for 20 minutes. One microliter of
digested DNA was loaded on a 0.7% agarose gel to check for complete digestion.
The completely linearized DNA was ethanol precipitated with 5 volumes of 100%
ethanol (350 f.l) and 1/10 volume of3 M sodium acetate pH 5.2 (7 f.l) on dry ice for
20 minutes, centrifuged at 14 000 rpm for 30 minutes at 4 washed with 70%
ethanol , centrifuged at 14 000 rpm for 10 minutes, air dred for 5- 10 minutes and
resuspended in 20 f.l of ddH 0 or TE buffer (10 mM Tris-HCl, pH 8.0; 0. 1 mM
EDTA). The Acc65I digested DNA was then digested with EcoRI in a volume of30
f.l using Ix EcoRI buffer (NEB), and 2 f.l of EcoRI enze (NEB) for 3 hours at 37
C. The enzyme was heat inactivated at 65 for 20 minutes.
Isolatjon of Djgested DNA Fragments
Digested PCR products and plasmid DNA were loaded on a 0.7% agarose gel.
The appropriate size bands were excised with a clean scalpel and purified using the
QIAquick gel extraction kit (Qiagen, Valencia, CA) according to the manufacturer
suggested protocol. The weight of the gel slice was determined. Three volumes of
Buffer QG were added to 1 volume of the gel slice in a 1.5-ml microcentrifuge tube
(1 00 mg 100,.11). The gel slice was dissolved at 59 oc for 10 minutes. One volume
of isopropanol was added to the sample and mixed. The DNA was bound to the
QIAquick gel extraction column by centrifugation of750 11 of the sample at a time
for 1 minute at 14 000 rpm until the entire sample was centrifuged into the column.
The flow-through was discarded; 0.5 ml of Buffer QG was added to the column and
centrifuged for 1 minute. The column was washed with 0.75 ml of Buffer PE and
centrifuged for 1 minute. The flow-through was discarded and the column was spun
for an additional 1 minute to remove the residual ethanol from Buffer PE. The
column was then placed in a clean microcentrifuge tube and the DNA was eluted with
30-50 JIl of Buffer EB (10 mM Tris-HCl , pH 8.5) or ddHzO and centrifuged for 
minute.
DephosphorylaHon of DNA
Before ligation with the insert, the digested pcDNA3 vector was treated with
calf intestine alkaline phosphatase (CIP) to prevent the vector from self-ligating and
to reduce the background. Dephosphorylation of the 5' phosphate group on the DNA
was performed in the NEB buffer used for digestion. 1.5 JIl of CIP enzyme (NEB; 10
ilK
. ,
Units/ill) was added to the reaction and incubated at 37 for 2 hours. To inactivate
the reaction, 3- 5 mM EDT A was added and incubated at 75 for 20 minutes.
DNA Ligation Reactions
Ligation of vector and insert was perfoTIlled at 1:3 and l: 1 weight ratios
(vector: insert). Gel-extracted digested vector and insert DNA (1 III each) 'were
loaded on a 0.7% agarose gel and the amount of each DNA in 1 III was estimated by
eye. The ligation was perfonned using 50 ng of vector 50 or 150 ng of insert, 2 III
T4 DNA ligase buffer t50 mM Tris-HCl (pH 7.5), 10 mM MgCb, 10 mM DTT, 1
mM ATP , 25 mg/ml BSA (NEB)) and 400 Units T4 DNA ligase (NEB) at 22 for
3 hours or at 16 overnight ( 16 hours).
Transformations
Competent DH5a, HB 1 01 or XL- 1 0 Gold (Stratagene) bacterial cells were
thawed on ice for lO minutes. Ligated DNA (2 Ill; 0. 1 volume) was mixed with 50 III
of cells and incubated on ice for 15- 30 minutes. Cells were heat shocked at 42 for
2 minutes and placed on ice for 5 minutes. 500 III ofLB without antibiotics was
added to the cells and incubated at 37 for 1 hour. The cells were centrifuged
quickly, resuspended in 50 III ofLB , spread on LB Ampicilin (50- 100 Ilg/ml) plates
and incubated at 37 overnight for l6 hours.
::../:;
Small Scale DNA Preparations
An overnight culture (5ml) of Luria-Bertani (LB) medium (10 g/L bacto-
tryptone 5 g/L bacto-yeast extract, lO g/L NaCl) with 50- 100 g/ml of Ampicilin
was initiated from 1 colony and grown at 37 C. Plasmid DNA was isolated using
QIAprep spin miniprep kit (Qiagen). Cell pellets (from 3ml of the culture) were
resuspended in 250 l of Buffer PI (50 mM Tris- , pH 8. 0; 10 mM EDTA; 10 g/ml
RNase A). Buffer P2 (250 l; 200 mM NaOH; 1 % SDS) was added to each tube
which was inverted 4-6 times and cells were lysed for 5 minutes at room temperature.
Buffer N3 (350 l; contains guanidine hydrochloride to bind the DNA to the silica in
column; Qiagen) was added to the lysed cells and the tube was inverted 4-6 times to
mix. The sample was then was centrifuged for 10 minutes to remove the white
precipitate formed. The supernatant was loaded on a QIAquick spin column attached
to a vacuum manifold and the vacuum was applied to bind the DNA to the column.
The column was then washed with 0.5 ml of buffer PB (a wash buffer that contains
guanidine hydrochloride and isopropanol; Qiagen) and the vacuum was applied. 0.
ml of Buffer PE (a low salt buffer containing 80% ethanol; Qiagen) was added to the
column and the vacuum was applied. To remove the residual ethanol from Buffer PE
the column was centrifuged for 1 minute at 14 000 rpm. The DNA was then eluted in
a new tube with 50 l of Buffer EB (10 mM Tris-HCl , pH 8.5) or ddHzO by
centrifugation for 1 minute at 14 000 rpm.
- ,
Large Scale DNA Preparations
. A small culture (5 ml) was first generated from 1 colony and grown for 5-8 '
hours at 37 oC in a shaking incubator. A large culture (200 ml of LB with 50- 100
g/ml Amp) was then inoculated from the small culture and grown 16 hours at.3 7 o
in a shaking incubator. The bacterial cells were centrifuged in a Beckman JA,- l0 rotor
at 6 000 rpm for 15 minutes. Plasmid DNA was extracted using the Qiagen Maxiprep
kit (Qiagen). Each pellet was resuspended in lO ml of Buffer PI containing RNase A
and transferred to a 50 ml plastic tube. The cells were lysed with 10 ml of Buffer P2
inverted 4-6 times and incubated for 5 minutes at room temperature. The cell debris
was then precipitated with 10 ml of Buffer P3 (3.0 M potassium acetate , pH 5.5),
incubated on ice for 20 minutes and centrifuged for 30 minutes at 15 000 rpm in a
Beckman JA-20 rotor at 4 oC. The supernatant was transferred to a new 50 ml plastic
tube and centrifuged for another 15 minutes at 15 000 rpm. The tip-500 column was
equilibrated with 10 ml of Buffer QBT (750 mM NaCl; 50 mM MOPS , pH 7.0; 15%
isopropanol; 0. 15% Triton X- lOO). The supernatant was added to the column to bind
the DNA. The column was washed 3 times with Buffer QC (1.0 NaCl; 50 mM
MOPS , pH 7.0; 15% isopropanol) and the DNA was eluted with 15 ml of Buffer QF
(1.25 M NaCl; 50 mM Tris-Cl pH 8.5; 15% isopropanol) in a 30 ml corex tube. 10.
ml of isopropanol was added to the eluted DNA and the DNA was centrifuged at
000 rpm for 45 minutes at 4 oC. The pellet was washed with 5 ml of70% ethanol
and centrifuged at 10 000 rpm for lO minutes. The DNA was air dred fot 5-
minutes and resuspended in 500 Jll ofTE, pH 8.
Sequencing
Cloned plasmid DNA was sequenced using T7 Sequenase version 2.0 DNA
sequencing kit (Amhersham Pharmacia, Piscataway, NJ). To denature the DNA , 5 Ilg
of maxi prep DNA was incubated in 12 III total volume with 333 mM NaOH and
333 mM EDT A for 5 minutes at room temperature. 2 M ammonium acetate (2 Ill)
was added and placed on ice. The DNA was ethanol precipitated with 5 volumes of
100% ethanol , incubated on dr ice for 15 minutes centrifuged at 14 000 rpm for 15
minutes , washed with 70% ethanol , centrifuged for 1 0 nutes and air dried on ice for
10 minutes. The DNA was resuspended in a 10 III volume using 20 ng of primer
tT7 primer (5' TAATACGACTCACTATAGGG- ), Sp6 primer (5'
TATTTAGGTGACACTATAG- ), SITE C top strand primer (5'
GTCACCAACCACAGCATCCTTTG- ), 3' EGFP primer (5'
GCAAGACCCCAACG- ) or 5'pcDNA3 primer (5' GCTAACTAGAGAACC-
) J and 2 Jil 5X T7 sequencing reaction buffer. To anneal the primers to the DNA
DNA-primer reaction mix was heated at 65 C for 2 minutes and slow cooled on the
bench to C. Individual tubes were filled with 2.5 Jil of each termination mix
(ddG, ddA, ddT, ddC), capped and heated to 37 oC. For the each labeling reaction, a
mixture containing 1 III 0. 1 M DTT , 2 Jil1X labeling mix, 1 JiCi adATP (NEN),
1 Unit inorganic pyrophosphate, and 2 Jil of 6X diluted T7 Sequenase version 2.
polymerase (13 Units/Jil undiluted) in enzyme dilution buffer was added to the
annealed DNA mixture (3.5 Ill) and incubated for 4- 10 minutes at 37 C. Stop
solution (4 Ill) was added to each tube to stop the labeling reaction. Samples were
heated to 95 OC and loaded (5 Jil) on a 6% polyacrylamide Sequagel (National
Diagnostics, Atlanta, Georgia), which was pre-run at 50W for 30 minutes. The gel
was dred and exposed to autoradiograph XAR-5 film (Kodak, Rochester, NY)
overnight at -70 o
Tran ent Transfuctions
LipoJectamine Plus: At 60-90% confluence, SaOS-2 cells were trailsfected
using LipofectAMINE Plus reagents (Invitrogen, Carlsbad, CA). DNA and Plus
reagent were pre.,complexed in serum-free DMEM for 15 minutes at room
temperature. LipofectAMINE reagent was diluted in serum-free DMEM. The pre-
complexed DNA-Plus mix was then combined with the LipofectAMINE mix and
incubated at room temperature for 15 minutes. Cell cultures were washed with
serum-free DMEM and replaced with serum-free DMEM. The DNA-Plus-
LipofectAMINE complexes were added to the cells and incubated at 37 oC for 2
hours. Cells were washed twice with serum-free McCoy s 5A medium and fed with
completed McCoy s 5A medium. The amounts of each reagent, DNA and medium
are shown in the table below for each well in 6-well plates , 100 mm plates and T25
flasks.
Culture DNA PLUS Serum- LipofectAMINE Transfection Transfection
dish (llg) Reagent free Reagent (Ill) medium (ml) volume (ml)
(Ill) Dilution
media (Ill)
6-well 25- 1.0 100 1.0
100 mm 750
T -25 flask 250
Superfect: ROS 17/2.8 or HeLa cells were grown to 50-80% confluence.
DNA was diluted in serum-free DMEM and Superfect (Qiagen) was added and
incubated for lO minutes at room temperature. Cells were washed with serum-free
DMEM. Completed DMEM was added to the complexes and the complexes were
incubated with the cells for 2 hours at 37 C. Cells were washed with serum-free
DMEM medium for HeLa cells or serum-free F12 medium for ROS 1712. cells , fed
with completed media and incubated overnight at 37 C. The amounts of Superfect
reagent, DNA and medium are shown in the table below for each well in 6-well plates
and 1 OO-mm plates.
Culture DNA Superfect Serum- free Transfection Transfection
dish (f.lg) Reagent Dilution medium (ml) volume (ml)
011) media 011)
6-well 100
100 mm lO- 300
Transcription Assays
HeLa cells were plated in 6-well plates at a density of 0.6 x 10 cells per plate
and transiently transfected at 50-80% confluency using in each well 5 l Superfect
reagent (Qiagen, Valencia, CA), 500 ng of each expression vector (as shown in
Chapter 1 , Figure lD), 50 ng of the minimal osteocalcin (OC) promoter -83-0C-
Luciferase (Towler et aI. , 1994), used as a control for transfection efficiency, and 2.
g of the rat -1.1 kb OC promoter-CAT reporter gene (Schepmoes et aI. , 1991).
Reporter activities were determined 36-40 hours following transfection. Cells were
lysed with 250 l of IX Reporter lysis buffer per well (Promega, Madison, WI) for 30
minutes at room temperature. Chloramphenicol acetyltransferase (CAT) activities
were determined using 50 Jll of cell lysate , 4 mg/ml acetyl coenzyme A (in H20),
25 JlCi Chloramphenicol, and 0.25 M Tris-HCI pH 7.8 per reaction. , CAT
reactions were incubated at 37 for 5 hours. To stop the reactions , 1 mlofEthyl
acetate was added, vortexed and centrifuged for l- 3 minutes. The top organic layer
was transferred to a fresh tube and dred in the hood overnight. Twenty Jll of ethyl
acetate was used to dissolve the residue, which was spotted on a TLC plate
(Whatmann, Clifton, NJ). Thin layer chromatography was performed in 285 ml
methanol and 15 ml of chloroform (97:3 ratio) for 1 hour. CAT activities were
determined on the Betascope 630 blot analyzer (Betagen, Mountain View, CA) or the
Storm 840 Phosphoimager (Molecular Dynamics, Sunnyvale, CA) and normalized to
luciferase values. Luciferase reagent (100 JlI) from the Luciferase assay system
(Promega Corp. , Madison, WI) was added to lO-20 Jll of cell lysate to determine
luciferase values using a 30 second exposure time in the Monolite TM 2010
luminometer (Analytical Laboratory, San Diego , CA). Significance of the results was
assessed using the analysis of variance (ANOV A) test and the error bars are shown as
the standard error of the mean (SEM.
Western Blot Analysis
HeLa cells were plated at a density of 0.7 x 10 in 100 mm plates and
transfected with 10 Jlg of expression plasmid and 40 JlI of Superfect reagent (Qiagen).
Cell pellets were collected 20 hours after transfection and lysed in 300 JlI of lysis
buffer containing 8 M urea, 0. 1 M NaH , 0. 1 M Tris-HCI , pH 8.0 and a cocktail
of protease inhibitors including, 1.2 mM phenylmethanesulfonyl fluoride (PMSF), 0.
Ilg/m11eupeptin, 0.7 Ilg/ml pepstatin, 10 Ilg/m1 trypsin inhibitor, 2 Ilg/ml TPCK, 40
Ilg/ml bestatin, 17 Ilg/m1 calpain inhibitor I , and 1 Ilg/m1 E64 (Roche , Indianapolis
IN). For each sample 20 Ilg of total proteins were separated on a lO% SDS-PAGE
gel. EGFP proteins were detected using a mouse GFP monoclonal antibody
(Clontech; 1: 1 0 000 dilution). RUNX proteins were detected with rabbit polyclonal
antibodies to either RUNX2 (1 :10 000 dilution) or RUNX1 (1 :3 000 dilution) kindly
provided by Scott Hiebert (Meyers et aI. , 1996). Approp ate HRP-conjugated
secondary antibodies (1: 10 000 dilution) were detected using the Renaissance
chemiluminescence kit (NEN , Boston, MA). Cdk2 protein was detected using a rabbit
polyclona1 a-cdk2 antibody (1 :5 000 dilution) as a control for protein loading. The
HRP-conjugated secondary antibodies and the cdk2 antibody were purchased from
Santa Cruz Biotechnology (Santa Cruz, CA).
In situ Immunofluorescence
SaOS-:2 or ROS 17/2.8 cells were grown on 0. 5% (w/v) gelatin-coated
covers1ips and cultured to 70% confluency. SaOS-2 cells were transiently transfected
with 0.25- 5 Ilg of expression plasmid, 3 III Plus reagent and 2.5 III Lipofectamine
reagent (Invitrogen, Car1sbad, CA) as above. Cells were harvested 18-20 hours post
transfection. Whole cell (WC), cytoskeleton (CSK) and nuclear matrix-intermediate
fiament (NMIF) preparations were performed as previously described (Javed et aI.
2000). Briefly, cells were fixed using formaldehyde (3.7%), then permeablized with
Flowchart A. Schematic of Subcellular Fractionation Methods for In Situ
Immunofluorescence Microscopy. Cell were transiently transfected on 0.
gelatin-coated coverslips in 6-well plates. In each 6-well plate , 2 wells were used for
whole cell (WC) preparations , 2 wells for cytoskeleton (CSK) preparations and 
wells for nuclear matrix-intermediate filament (NMIF) preparations. Briefly, WC '
cells were fixed with 3.7% formaldehyde and the permabilized with 0.5% Triton X-
100. Both CSK and NMIF cells were extracted twice for 15 minutes each with CSK
buffer. The CSKprepared cells were then fixed with 3.7% formaldehyde. The DNA
in the NMIF prepared cells was digested twice for 30 minutes each with DNase I in
digestion buffer. The chromatin was then extracted from NMIF preparations with
250 mM ammonium sulfate. The nuclear matrix-intermediate fiament scaffold
including insoluble proteins and RNA remains and was fixed with 3.
formaldehyde. Proteins were then detected with specific antibodies when
appropriate.
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5% Triton X- IOO for whole cell preparations (Flowchart A). CSK and NMIF
preparations were extracted twice for 15 minutes each with CSK buffer (100 mM
NaCl , 0. 3 M sucrose, 10 mM pipes , 3 mM MgClz, 1 mM EGTA, 0.5% Triton X- lOO
pH 6. , 2 mM Vanadyl Ribonucleoside Complex (VRC), 0. 8 mM 4-(2-
Aminoethyl)benzenesulfonyl floride (AEBSF)). CSK preparations were fixed in
7% formaldehyde in CSK buffer and NMIF preparations were digested twice for 30
minutes each with 400-600 Units/ml of RNase-free DNase I (Roche , Indianapolis
IN) in digestion buffer (CSK buffer with 50 mM NaCl). NMIF prepared cells were
extracted with 0.25 M ammonium sulfate in digestion buffer for 10 minutes and fixed
with 3.7% formaldehyde in digestion buffer for 10 minutes. Xpress (XPR)-tagged
RUNX2 was detected using a primary monoclonal a-mouse Xpress antibody
(Invitrogen; 1 :800 dilution) and a Texas red-conjugated donkey a-mouse secondary
antibodies (Jackson ImmunoResearch Laboratories, Inc. , West Grove, P A; 1 :200
dilution). Endogenous RUNX2 was detected in SaOS-2 and ROS 17/2.8 cells using a
rabbit polyclonal RUNX2 antibody (Oncogene, San Diego , CA; Cat # PC287L; 1 :200
dilution, 2. 5 ng/ml final concentration) and an Alexa-595 ru goat a-rabbit secondary
antibody (Molecular Probes, Eugene , OR; 1 :500 dilution). CBFp was detected using a
mouse monoclonal CBFp antibody (Wang et aI. , 1996b; 1:20 dilution). Endogenous
Sp 1 was detected in ROS 1712. cells using the mouse monoclonal Sp 1 (IC6)
antibody (Santa Cruz Biotechnologies , Santa Cruz, CA; Cat # sc-420; 1: 1 00 dilution).
Cells were mounted in Vectashield antifade mounting media (Vector Laboratories
Burlingame , CA). Fluorescence and transmitted light images were captured using a
Zeiss Axioplan 2 microscope with a 63X Zeiss Plan-Apochromat objective (1.4
A.), a 100 W Hg lamp and a Hamamatsu digital charged-couple device (CCD)
camera interfaced with the MetaMorph Imaging System (Universal Imaging Corp.
Downingtown, P A). Cells were counted for extent of colocalization between either
RUNXl and RUNX2 or RUNX2 with two different tags using a dual band pass
fluorescence fiter (Chroma Technology Corp. , Brattleboro , VT , #51006). The
software applications used to prepare digital images were Adobe Photoshop and
Microsoft PowerPoint.
BrUTP Labeling
SAOS-2 cells were transfected with 0.25 f.g EGFP-RUNX2 as described
above and labeled for BrUTP incorporation 18-20 hours following transfection. Cells
were incubated for 3 minutes with glycerol buffer (20 mM Tris-HCI pH 7.4 5 mM
MgClz, 0.5 mM EGTA, 25% glycerol) and then for 3 minutes with glycerol buffer
supplemented with 0.05% Triton X- l 00 and 4 mM AEBSF. Nascent transcripts were
labeled with BrUTP for 30 minutes at room temperature in transcription buffer i2X
Synthesis buffer (100 mM Tris-HCl pH 7.4, 20 mM MgClz, 1 mM EGTA , 200 mM
KCl, 50% ,glycerol), 25 f.M S-adenosylmethionine (SAM), 500 f.M each of ATP
CTP and GTP (Roche , Indianapolis, IN), 750 f.M BrUTP (Sigma, St. Louis, MO), 4
mM AEBSF and 40 Units/ml RNase Inhibitor (Roche)J. NMIF extractions were
performed on cells as described above. A rat monoclonal a-BrdU antibody (Accurate
Chemical and Scientific Corp. , Westbury, NY; 1:20 dilution) and an Alexa-568 a-rat
secondary antibody (Molecular Probes, Eugene , OR; 1 :500 dilution) were utilized to
detect BrUTP labeling. A Leica SP 1 laser scanning confocal microscope interfaced
with Scanware software and a Leica 100X Plan Apo 1.4 N.A. objective were used to
capture confocal images. Images were taken using an average of 4-6 sections per
cell and 0. 365 microns per section. The line scan function in MetaMorph as used to
show points of colocalization in a particular area of the nucleus. The extent of 
colocalization was determined using the colocalization function in MetaMorph (mean
:! SEM).
Time-Lapse Imaging
SaOS-2 cells were plated at a cell density of 2 x 10 in 100 mm plates
containing gelatin-coated 40 mm coverslips (Bioptechs , Butler, P A). Cells were then
transiently transfected using 4 J.g of either EGFP , EGFP-RUNXl , EGFP-RUNX2, or
EGFP-RUNX2il361 expression plasmids , 10 J.l Lipofectamine reagent and 20 J.I Plus
reagent (Invitrogen, Carlsbad, CA). Mitochondria were stained 15- 18 hours
following transfection with 100 nM of Mitotracker Red CM-H2XRos dye (Molecular
Probes , Eugene , OR) in pre-warmed completed McCoy s SA media for 30 minutes at
C. The Mitotracker Red dye was used as a marker for viability before and after
capturing images. Coverslips were then assembled into the FCS-2 closed cell
chamber (Bioptechs , Butler, P A) in which a peristaltic pump (Instech Laboratories
Inc , Plymouth Meeting, PA) was used to perfuse complete L- 15 media without
phenol red (Life Technologies) and 10nM Mitotracker Red dye through the chamber.
Cells were maintained at 37 C using the chamber controller and objective heater
controller (Bioptechs). Time-lapse images were captured every lO-30 seconds for 20-
30 minutes using the Zeiss Axioplan 2 microscope and a 63X Zeiss Plan-Apochromat
objective with a 1.4 N.A. Exposure times for EGFP fusion proteins were 100-200
miliseconds and for the Mitotracker Red dye were 100-500 milliseconds. Adobe
Photoshop, MetaMorph, Microsoft PowerPoint and Adobe Ilustrator software were
used to prepare the digital images.
Fluorescence Recovery After Photobleaching (FRAP) Analysis
SaOS-2 cells were plated in T-25 flasks at a density of 1.2 x l06 cells/flask
and cultured until 70% confluency. Expression plasmids (2 Jlg) were transiently
transfected using 5 Jll of Lipofectamine and 4 Jll Plus reagents (Invitrogen, Carlsbad
CA). Transfected cells were incubated at 37 C for 6 hours, trysinized using 1 nil
Trypsin-EDTA (Life Technologies) and plated in coverslip live cell chambers. Cells
were incubated overnight at 37 C. The Zeiss Axiovert- 10 light microscope was used
with a Zeiss 100X Plan-NeofluorN.A. 1.30 lens, adapted with a Roper Scientific
(Trenton, NJ) cooled CCD camera with a ST- 133 controller and an EEV Type 57
back-iluminated frame transfer chip to capture images. Pre-bleached images were
captured using a 200 milisecond exposure time. A small area of the nucleus was
photobleached using a 476.5 nm Argon ion laser at 100 mW of power for 100
miliseconds. Images of fluorescence recovery were captured every second for 45
seconds using 200 milisecond exposure times.
The half-time of recovery (t ) was determined by plotting ln (ioo iD vs. time
where ioo is the fluorescent intensity at infinity, it is the fluorescent intensity in the
bleached area at time (t) and then was calculated as tv, = In 2 * , where t
= (-
lIslope)
for the punctate distributions. Alternatively for the diffuse distributions, t was
calculated from the formula:
1- (J out) = e -t/ te
where , Iin is the intensity at time t in the photobleached area, and lout is the i tensity at
time t outside the photobleached area. The % immobile fraction (F) was calculated
using the formula:
pos
pre ioo
pre
pre
pos
\ -
ioo+ e
pre
The ratio (Ipost pre), where pre is the pre-bleached intensity over the whole cell and
pos is the post-bleached intensity of the whole cell, was used to correct for the extent
of photo bleaching. pre is the fluorescent intensity in the pre-bleached area of the
nucleus and is they- intercept ofthe graph ln (ioo iD vs. t. We calculated the
recovery rates for both the entire photobleached area and for specific foci in the
bleached area. Adobe Photoshop and Microsoft PowerPoint were used to assemble
the digital images. Standard errors were determined as the standard error of the mean
(SEM).
Movies on Supplementary CD
QuickTime Movies lA-D (available on CD accompanying thesis or at
jcs.biologists.org/supplemental) show the time-lapse images corresponding to Figues
7A-D. Time-lapse images were captured for Movie lA, every 20 seconds for 20
minutes; Movie 1B , every 10 seconds for 30 minutes; Movie 1C , every 20 seconds
for 30 minutes; and Movie 1D, every 30 seconds for 30 minutes. QuickTime Movies
2A-D show cells corresponding to those captured in Figure 8A-D for FRAP analysis.
Movie 2D (EGFP alone) shows sequential images captured before bleaching and for
every second for the first 10 seconds after photobleaching. Movies 2A-C (EGFP-
RUNX fusion proteins) show sequential images caI?tured before bleaching and every
second for 45 seconds after photobleaching.
RESUL TS
Generation of Functional EGFP-RUNX Fusion Proteins
To assess intranuclear dynamics of RUNX proteins in living cells, we 
prepared a panel of Enhanced Green Fluorescent Protein (EGFP)-RUNX fusion
proteins (Figure 1A). We first determined their expression levels and functionality in
subnuclear targeting and transcription assays. EGFP was fused to full-length human
RUNX1 (amino acids 27-480), mouse RUNX2 (amino acids 1-513) and C-terminal
deleted RUNX2 361 (amino acids 1-361) (Figure 1A). Western blot analysis with
antibodies against EGFP, RUNX1 and RUNX2 using whole celllysates from
transfected HeLa cells demonstrates that EGFP-RUNX fusion proteins are expressed
at the expected molecular masses (Figure 1 B and C). Cdk2 antibody was utilized as 
control for protein loading (Figure 1B and C). Functional activity of the EGFP-
RUNX fusion proteins was determined by assessing chloramphenicol acetyl
transferase (CAT) reporter gene activity under control ofthe RUNX-dependent
osteocalcin (OC) promoter, which contains three RUNX binding sites (Figure 1D).
Transient transfections with RUNX expression vectors were performed with HeLa
cells because these cells do not produce endogenous RUNX proteins. EGFP-RUNX1
and EGFP-RUNX2 induce activity of the OC promoter by 12 to IS-fold, whereas
non-tagged RUNX1 and RUNX2 produce a 4 to 8-fold activation (Figure 1D). The
modest differences in transcriptional induction reflect the higher levels of the EGFP-
tagged RUNX proteins relative to the native RUNX proteins (compare Figures 1C
and 1D). EGFP alone does not induce OC promoter activity, proving that this protein
Figure 1. Structure and Expression of Function lIy Active EGFP-RUNX Fusion
Proteins. (A) Schematic ofEGFP-RUNX expression constructs. EGFP proteins were
fused to the N-termini of RUN Xl , RUNX2 and RUNX2 361. These constructs were
generated using the restriction sites listed above each diagram as described in the
Materials and Methods. EGFP-RUNX2 361lacks theC-terminal152 amino acids
ofRUNX2 , which removes the NMTS , but retains the RHD and NLS. Conserved
functional domains of the fusion proteins are labeled as follows: EGFP: Enhanced
Green Fluorescent Protein; QA: Glutamine-Alanine amino acid stretch, specific to
RUNX2; RHD: Runt Homology Domain; NLS: Nuclear Localization Signal; NMTS:
Nuclear Matrix Targeting Signal; VWRPY: conserved interacting sequence for
TLE/Groucho , a repression protein.
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Figure 1. Structure and Expression of Functionally Active EGFP-RUNX Fusion
Proteins. (B and C) Western blot analyses are shown of HeLa cells extracts after
transfection with either EGFP-RUNX1 , EGFP- , EGFP-RUNX2 361 , or
EGFP constructs. pcDNA3 empty vector, CMV-RUNX1 and CMV-RUNX2
expression vectors were used as controls. Proteins were detected using either a
monoclonal EGFP antibody (B top), a polyclonal RUNX1 antibody (C right) or a
polyclonal RUNX2 (C left) antibody. Cdk-2 antibody was used as a control for equal
protein loading (B and C bottom panels). Positions of molecular weight markers are
indicated on the right side of each blot. (D) CAT activity was assessed from HeLa
cell extracts co-transfected with each reporter construct (OC promoter-CAT reporter
construct and -83-0C-LUC construct) and each expression vector (EGFP , EGFP-
RUNX2 , EGFP-RUNX2 361 , RUNX2, EGFP-RUNX1 or RUNX1) as indicated.
CAT values were normalized to the luciferase values and fold induction was
calculated as CAT activity over the empty vectors. Results are means of 15 to 21
samples:! SEMp':O. OOOl.
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is transcriptionally inert. Deletion ofthe C-tenninus ofRUNX2 (EGFP-
RUNX2 361) reduced transactivation of the OC promoter by 3-fold (Figure 1D).
This result is in agreement with previous studies showing that the C-tenninus of
RUNX2 is required for transcriptional activity (Javed et ai. 2000; Zaidi et ai. , 2001).
Taken together, these results show that the EGFP moiety does not interfere with the
transcriptional activity of RUNX proteins.
To detennine the subnuclear localization an9 distribution of the EGFP-RUNX
fusion proteins, we expressed the fusion proteins in SaOS-2 cells and examined their
subnuclear distribution by fluorescence microscopy (Figure 2). Cells were analyzed
following either detergent extraction (whole cell , WC) or high salt extraction and
nuclease digestion of chromatin (nuclear matrix-intennediate fiament preparations
NMIF). The results show that EGFP-RUNX1 and EGFP-RUNX2 proteins produce a
punctate nuclear pattern (Figure 2 , WC). Both proteins remain in the nucleus
following the removal of soluble proteins and chromatin (NMIF). In contrast, the
EGFP-RUNX2 361 protein, which lacks the subnuclear targeting signal , produces a
diffuse fluorescence pattern in both the cytoplasm and the nucleus (WC). Moreover
EGFP-RUNX2 361 does not remain in the NMIF fraction, indicating that it is not
associated with the nuclear matrix, which is consistent with the observations in Zaidi
et al. (2001). Taken together with our previous findings, these results indicate that
our panel ofEGFP-RUNX fusion proteins is functional , and that the EGFP tag does
not interfere with the subnuclear targeting of RUNX proteins.
Since EGFP-RUNX1 and EGFP-RUNX2 were localized into punctate
subnuclear foci and were associated with the nuclear matrix, we assessed the
Figure 2. Absence of SubnucIear Organization of a Mutant RUNX Protein in
Fixed Cells. SaOS-2 cells were transfected with either the wild-type EGFP-RUNX1
EGFP-RUNX2 or the mutant EGFP-RUNX2 361 expression vectors. Both whole.
cell (WC) and nuclear matrix-intermediate filament (NMIF) preparations were
performed as described in the Materials and Methods and show punctate foci for
RUNX1 and RUNX2. The green fluorescence ofEGFP was captured with a FITC
filter (center images). Inserts show DAPI stained nuclei (top left corners) and
transmitted light photographs 
(lower right corners) of each cell. The scale bar equals
10 /lm.
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localization of endogenous RUNX2 protein by in situ immunofluorescence
microscopy. Untransfected SaOS-2 cells were stained with a rabbit polyclonal
RUNX2 antibody (Oncogene , San Diego , CA; 1 :200 dilution, 2.5 ng/ml final
concentration). The results show that endogenous RUNX2 is retained in the mJ,clear
matrix and is expressed in punctate subnuclear foci (Figure 3). We note that it is not
possible to assess colocalization ofEGFP-RUNX2 and endogenous RUNX2 because
the RUNX2 antibodies do not discriminate between exogenous and endogenous
RUNX proteins. These results indicate that endogenous RUNX proteins have a
similar subnuclear distribution as EGFP-tagged RUNX proteins (compare Figure 3 to
Figure 2 in Chapter 1).
RUNXI and RUNX2 Are Targeted to Common SubnucIear Domains
RUNXI and RUNX2 have analogous subnuclear targeting signals in their C-
termini that are highly conserved (Zeng et aI. , 1997; Zaidi et aI. , 2001). Therefore , in
situ immunofluorescence microscopy was used to assess whether RUNX1 and
RUNX2 are directed to the same subnuclear domains. We also examined as a control
whether RUNX2 proteins with different epitope tags are localized in the same
subnuclear foci. EGFP- and Xpress (XPR)-tagged RUNX2 proteins (Figure 4A) or
EGFP-RUNX1 and XPR-RUNX2 proteins (Figure 4B) were co-expressed in SaOS-
cells and their subnuclear distribution in whole cell (WC) and nuclear matrix-
intermediate filament (NMIF) preparations was monitored. XPR-tagged RUNX
proteins were visualized using a Texas red-conjugated secondary antibody and this
signal was compared with the intrinsic green fluorescence ofEGFP-RUNX proteins.
, I
Figure 3. Endogenous RUNX2 has a Punctate Subnuclear Distribution and Is
Associated with the Nuclear Matrix. Whole cell (WC) and nuclear matrix-
intennediate fiament (NMIF) extractions were perfonned in untransfected SaOS-
cells. Endogenous RUNX2 was labeled with a rabbit polyclonal RUNX2 antibody
(Oncogene; 2.5 ng/ml final concentration) and an Alexa-595 ru goat a-rabbit
secondary antibody (Molecular Probes; 1 :500 dilution). DNA was stained with 0.
j.g/ml DAPI.
Jii
NMIF
RUNX2 DAPI
Figure 4. RUNXI and RUNX2 CoJocalize in Common SubnucJear Domains.
SaOS-2 cells were co-transfected with 0.5 /-g each of (A) EGFP-RUNX2 and Xpress
(XPR)-RUNX2 (control) and (B) EGFP-RUNXl and XPR-RUNX2. Whole cell
(WC) and nuclear matrix-intermediate filament (NMIF) preparations were
performed. The yellow fluorescence in the merged images indicates colocalization
between the EGFP- and XPR- tagged RUNX proteins. Cells were stained with 0.
/-g/ml DAPI. Chromatin-extracted NMIF preparations do not present any DAPI
staining as expected. Scale bars equallO 
I-m. (C) Endogenous RUNX2 (green) and
Sp 1 (red) transcription factors in WC preparations of ROS l7/2.8 cells were detected
using a rabbit polyclonal RUNX2 antibody and a mouse monoclonal Sp 1 antibody,
respectively. The merged image shows the RUNX2 and Sp 1 are not colocalized (lack
of yellow fluorescence). Images for RUNX2
, Spl and Merged were deconvoluted
by 2-dimensional nearest neighbor method using MetaMorph imaging software.
Localization of RUNX2 and Sp 1 in Figure 4C was performed by S. Kaleem Zaidi.
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Randomly selected transfected cells (50) were quantitated and evaluated for the
extent of signal overlap. The analysis included only those cells that exhibited
comparable fluorescence intensities. The results show that RUNX2 protei!1s with two
different epitope tags are extensively colocalized in WC preparations (40% of c;ells:
:;90% signal overlap of red and green fluorescence; 60% of cells: 60-90% signal
overlap) and NMIF preparations (30% of cells: :;90% signal overlap; 70%' of cells:
60-90% signal overlap). The extent of co localization of RUN Xl and RUNX2 proteins
is very similar to that observed for RUNX2 proteins carring two distinct tags
(compare Figures 4A and B); all cells in which both proteins were expressed
displayed extensive or complete signal overlap. The colocalization of red and green
fluorescence is observed by the yellow fluorescence in the merged images (Figures
4A and B). Since RUNX1 and RUNX2 proteins are widely distributed and some
signal overlap may be expected due to random chance , we compared the localization
ofRUNX2 with another transcription factor, which is also widely distributed, Sp1
(Figure 4C). This result showed little or no signal overlap between RUNX2 and Sp 1
suggesting that colocalization of RUN Xl and RUNX2 is specific. Taken together
these results demonstrate that RUNX1 and RUNX2 are targeted to common
subnuclear domains , which reflects the amino acid sequence similarities of their
targeting signals (Zeng et aI. , 1997; Zaidi et aI. , 2001). Our findings are consistent
with the concept that RUNX1 and RUNX2 bind to a common acceptor protein at
nuclear matrix-associated subnuclear sites.
\:"
EGFP-RUNX2 Colocalizes with the CBF Binding Partner
To assess whether EGFP-RUNX2 and the RUNX interacting partner protein
CBF are targeted to common subnuclear domains , we transiently co-transfected
SaOS-2 cells with EGFP-RUNX2 and CBF expression plasmids and isolated WC
and NMIF preparations. CBF is present in the cytoplasm and the nucleus in whole
cell (WC) preparations (Figure 5). In addition, CBF is observed as a nuclear
protein in WC and NMIF preparations. Whether CBF is present in the cytoplasm
and nucleus or only in the nucleus may depend on the ratio ofEGFP-RUNX2 and
CBF protein concentrations expressed (Figure 5; Kundu et aI.
, 2002). CBF and
EGFP-RUNX2 colocalize in common subnuclear domains as shown by the
appearance of yellow foci in the merged images and the coincidence of red and green
signal maxima in the line scans in the nucleus ofWC and NMIF preparations (Figure
5). These results are consistent with the findings that RUNX2 and CBF physically
interact by immunoprecipitation assays and colocalize in HeLa and ROS l712. cells
using immunofluorescence microscopy (Kundu et aI.
, 2002).
RUNX Domains Are Associated with Sites of Active Transcription
Since RUNX proteins and the CBF binding parter localize in common
subnuclear domains and form a transcription factor complex
, we evaluated whether
transcription was occurrng at these subnuclear foci. SaOS-2 cells were transfected
with either EGFP-RUNX1 or EGFP-RUNX2. Nascent transcripts were labeled by
incorporation of BrUTP into newly made transcripts and NMIF preparations were
performed. The BrUTP labeled transcripts were detected by immunofluorescence
Figure 5. EGFP-RUNX2 and CBF Are Targeted to Common Sub nuclear
Domains. SaOS-2 cells were transiently transfected with 0.25 J.g ofEGFP-RUNX2
and CBF expression constructs and WC and NMIF preparations were performed.
CBF was detected using a mouse monoclonal CBF antibody (Wang et aI. , 1996b;
1 :20 dilution). EGFP-RUNX2 (green) is a nuclear protein whereas CBF (red) 
localized to the cytoplasm and is translocated into the nucleus by association with
RUNX proteins. WC images are shown for CBF localized to the cytoplasm and
nucleus and only to the nucleus. Merged images show colocalization of EGFP-
RUNX2 and CBF in the nucleus as yellow fluorescence. The white line in the
merged images represents the area of the nucleus that the extent of colocalization was
determined by the line scan function from MetaMorph. Line scans images show
colocalization ofEGFP-RUNX2 and CBF when the green and red peaks line up at
the same nuclear position.
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microscopy using a rat monoclonal a-BrdU antibody and an Alexa-568 a-rat
secondary antibody. Sites of BrUTP fluorescence represent sites of active
transcription. Using confocal microscopy we find that the majority of both the
EGFP-RUNX1 and EGFP-RUNX2 foci colocalize with sites of BrUTP incorporation
(Figure 6A and B). The extent ofEGFP-RUNX1 colocalization with BrUT was 73 :t
5% and BrUTP colocalization with EGFP-RUNX1 is 78:t 5% (n=13). The extent of
EGFP-RUNX2 colocalization with BrUTP was 83:t 4% and BrUTP colocalization
with EGFP-RUNX2 is 86:t 2% (n=9). Matching red and green peaks in the same
positions of the line scans (shown below images) demonstrate points of colocalization
between EGFP-RUNX1 or EGFP-RUNX2 and BrUTP labeling. These results
indicate that active transcription occurs at a significant subset of the punctate RUNX
foci. These results taken together with previous findings, which show that several co-
regulatory factors and nascent transcripts associate with RUNX subnuclear foci
suggest that the subnuclear foci may represent transcriptional multi-subunit
regulatory complexes (Zaidi et aI. , 2002; Javed et aI. , 2000; Zeng et al. , 1998; Kundu
et aI. , 2002).
Intranuclear Traffcking of RUNX2 in Living Cells Is Dependent on the C-
terminal Domain
To evaluate whether RUNX1 and RUNX2 are localized to punctate foci in
living cells , we examined the subnuclear organization ofEGFP-RUNX1 and EGFP-
RUNX2 fusion proteins in SaOS-2 cells using time-lapse microscopy. For
comparison, the subnuclear distribution ofEGFP alone was analyzed. To assess
Figure 6. RUNX Proteins Localize to Sites of Active Transcription. SaOS-2 cells
were transiently transfected with (A) EGFP-RUNX1 and (B) EGFP-RUNX2.
Nascent transcripts were labeled with BrUTP for 30 minutes. Confocal microscopy
was used to capture images of the intrinsic green fluorescence ofEGFP and BrUTP
labeling using a rat a-BrdU antibody (red). Merged images show in NMIF
preparations colocalization ofEGFP-RUNX1 and EGFP-RUNX2 with BrUTP
incorporation (yellow) in a significant subset of foci. Images shown are 3-
projections (top) and a center section (bottom). The scale bars equal 10 J.m. Line
scans are shown below the images to show the extent of colocalization of red and
green fluorescence along the white lines indicated in the merged 3D projections.
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movement of the foci , we captured time-lapse images every 10-30 seconds for 20-
minutes using exposure times of 1 00 or 200 miliseconds. Only those cells that
exhibited significant signal above background were analyzed. The results show that
cells expressing EGFP alone produce a diffuse fluorescence signal with comparable
intensity in the cytoplasm and nucleus (Figure 7 A; see supplementary CD for movies
Movie lA). The movement ofEGFP proteins is most clearly observed in the time-
lapse video micrographs. In living cells expressing EGFP-RUNX1 or EGFP-
RUNX2 , we observe punctate domains in the nucleus (Figures 7B and 7C), which are
very similar to those in fixed preparations (see Figure 2). Furthermore , these foci
remain stationary within the nuclear space throughout the 30-minute time of
observation (Figures 7B and 7C; Movies Band 1 C). In the timelapse movies of
cells expressing EGFP-RUNX1 and EGFP-RUNX2 the foci appear to move slightly.
However, this apparent movement is limited relative to the diameter of the nucleus
and may represent either changes in the shape of the foci and/or nuclei or movement
of cells relative to the plane of focus. These results show that the punctate foci
observed in fixed cells are bona fide subnuclear domains that can be visualized in
living cells and that these punctate domains are relatively stable in the nucleus over
time.
To determine whether the C-terminus ofRUNX2 is necessary for the
localization of RUN X proteins to punctate foci in living cells, we analyzed the
RUNX2 deletion mutant lacking the C-terminus (EGFP-RUNX2 361). This fusion
protein displays a diffuse fluorescence signal throughout the cytoplasm and nucleus
(Figure 7D; Movie 1 D), which is similar to EGFP alone (compare Figures 7 A and
Figure 7. RUNXI and RUNX2 Subnuclear Foci Are Stationary in Living Cells
within the Nuclear Space. SaOS-2 cells were transiently transfected with (A)
EGFP; (B) EGFP-RUNXl; (C) EGFP-RUNX2 and (D) EGFP-RUNX2 361
expression vectors. Time- lapse images show pictures captured at 0 , 5 , 10 , 15 and 20
minutes (A) or 0 , 5 , 10, 20 , and 30 minutes (B , C , and D) using 100 milliseconds (A
and B) or 200 milliseconds (C and D) exposure times. Arrowheads (in B and C)
illustrate examples of stationary RUNX subnuclear domains. RUNX proteins do not
localize to the nucleoli (dark spots). Scale bars equal 10 /lm.
EGFP
o min. 5 min. 10 min. 15 min. 20 min.
8 EGFP-RUNX1
o min. 5 min. 10 min. 20 min. 30 min.
C EGFP-RUNX2
o min. 5 min. 10 min. 20 min. 30 min.
o EGFP-RUNX2 361
o min. 5 min. 10 min. 20 min. 30 min.
7D; Movies 1A and lD). However, the fluorescence intensity ofEGFP-RUNX2tl361
was greater in the nucleus than in the cytoplasm (Figure 7D). Moreover, the
subnuclear distribution ofEGFP-RUNX2tl36l is very different from the punctate foci
observed for wild-type RUNX1 and RUNX2. Thus , our results indicate that the C-
terminus is rcquired for localization ofRUNX2 into punctate subnuclear dOJ;nains.
Deletion of the C-terminus of RUNX2 Increases the Intranuclear Mobilty of
RUNX2 Proteins
The relative mobility of the EGFP-RUNX fusion proteins was determined by
using Fluorescence Recovery After Photobleaching (FRAP) analysis. SaOS-2 cells
were transiently transfected with EGFP-RUNXl , EGFP-RUNX2 , EGFP-
RUNX2tl361 or EGFP alone. In FRAP , a defined area in the nucleus of cells
expressing each of these proteins was photobleached with a laser beam for lOO ms
and the recovery of the fluorescence was determined. Photobleaching represents the
irreversible loss ofEGFP fluorescence. The recovery of the fluorescence in the
photobleached area represents the movement of unbleached molecules into the
photobleached area. The recovery kinetics provide an indication of the association of
the RUNX protein with other nuclear components. The half-time of recovery is the
time on the recovery curve (fluorescence intensity vs. time) at half the maximal
height of recovery and represents the speed at which the EGFP-RUNX proteins
move. The immobile fraction is the percent of the initial fluorescence that is not
regained after recovery and represents the percent of proteins that do not move in the
time of the experiment.
Recovery of the fluorescence signal in the entire bleached area was
determined by capturing sequential images following photobleaching and calculating
the half-time of recovery and percent immobile fraction as described in the Chapter 1
Materials and Methods (Figure 8; Table 1). The estimated half-time of recovery of
EGFP-RUNX1 and EGFP-RUNX2 proteins , respectively, is calculated to be 10.2:t
6 (n=5) and 10.7 :t l. l (n= 10) seconds and the mean percent immobile fraction is
calculated to be 20.0:t 2.8% and 26. 1 :t 7.1% (Table 1). These results suggest that
75-80% ofEGFP-RUNX1 and EGFP-RUNX2 proteins move very quickly through
the nucleus and 20-26% are immobilized by interacting with the nuclear architecture.
These findings were reproduced in independent experiments (n=15). We observed
that the punctate foci containing EGFP-RUNX1 and EGFP-RUNX2 proteins
recovered after photobleaching with a similar morphology as before photobleaching
and in the same location (Figures 8A and 8B; see Movies 2A and 2B), indicating that
EGFP-RUNX proteins are rapidly exchanging at subnuclear foci. Additionally, we
analyzed the dynamic exchange of RUNX factors at specific foci in the
photobleached area (boxed areas in Figures 8A and 8B show examples; Table 2)
compared to the entire photobleached area. For EGFP-RUNX1 and EGFP-RUNX2
the mean half-time of recovery of the foci was similar to that of the entire
photobleached area (Table 2). The mean percent immobile fraction for the foci is
29. 7:t 4.5% for EGFP-RUNX1 and 32.1 :t 7.9% for EGFP-RUNX2. The percent
immobile fraction for the foci is slightly higher than that for the entire photobleached
area, suggesting that EGFP-RUNX1 and EGFP-RUNX2 may be more tightly bound
to the foci than the diffuse area around the foci , which may reflect association to the
Figure 8. RUNXI and RUNX2 Dynamically Associate with Sub nuclear Foci in
Living Cells in a C-terminal Dependent Mechanism. SaOS-2 cells were
transiently transfected with (A) EGFP-RUNXl; (B) EGFP-RUNX2; (C) EGFP-
RUNX2 361 and (D) EGFP expression vectors. Pre-bleached images are shown. The
circles represent the entire photobleached areas in which the recovery rates were
calculated. The black boxes (in A and B) represent the area encompassing the foci
within the photobleached area in which the recovery rates were also determined.
Shown images were captured before photobleaching and 1 , 3 , 5 , 10 and 45 seconds
after photobleaching. The white bars correspond to a scale of 10 microns. (E)
Recovery curves of the proteins are shown as relative fluorescence intensity vs. time.
From these curves the half-time of recovery and percent immobile fraction were
calculated as described in the Methods. The line at a relative intensity of 1.
represents the fluorescence intensity before bleaching.
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nuclear matrix and/or co-regulatory proteins at subnuclear foci. Thus , these results
indicate that RUNX proteins undergo dynamic exchange at the stationary subnuclear
punctate domains.
We then assessed the effect of deleting the C-terminus on the relative mpbility
ofRUNX2. RUNX2 proteins that have the C-terminus deleted (EGFP-RUNX2 361)
exhibit a mobility comparable to that ofEGFP alone. EGFP and EGFP-RUNX2 361
proteins (Figures 8C and 8D; see Movies 2C and 2D) are completely mobile, since
the percent immobile fraction is zero (Table 1). The relative recovery curves of
EGFP-RUNXl , EGFP-RUNX2 , EGFP-RUNX2 361 and EGFP proteins are shown
in Figure 8E and represent the initial recovery curves ofthe entire photobleached area
before correcting for the extent of photo bleaching of the entire nucleus. The
estimated half-time of recovery is .c600 miliseconds for EGFP-RUNX2 361
and.c400 milliseconds for EGFP alone (Table 1). Both EGFP-RUNX2 361 and
EGFP are almost completely recovered within 1 second after photobleaching (Figures
8C and 8D; Table 1), indicating that EGFP-RUNX2 361 and EGFP are highly
mobile. The increased mobility of RUNX2 361 compared to full length proteins
suggests that deletion of the C-terminal domain perturbs the association of RUN X
proteins with subnuclear foci in living cells. One plausible interpretation of our
finding is that the C-terminus together with its interacting proteins contributes to the
stabilization of RUN X subnuclear foci. Another interpretation is that the mobility 
RUNX factors may be retained at subnuclear foci by the interaction of the C-terminus
with the nuclear matrix and/or co-regulatory proteins.
DISCUSSION
In this study, RUNX transcription factors were shown to associate
dynamically with stationary subnuclear foci in living cells. Furthermore , the C-
terminal segment of RUN X factors , which contains the nuclear matrix targeting
signal (NMTS), regulates intranuclear mobility by increasing the association of
RUNX factors at their subnuclear foci in living cell . Both RUNX1 and RUNX2
proteins , which support development of different tissues and specification of distinct
cell types , localize to the same foci when co-expressed exogenously in the same cell.
This result suggests that homologous targeting signals present in the C-termini of
RUNX proteins (Zeng et aI. , 1997; Zaidi et aI. , 2001) may direct RUNX factors to
common subnuclear domains. Moreover, our findings together with previous results
show that RUNX subnuclear foci contain co-regulatory factors and nascent
transcripts , suggesting that these subnuclear foci may represent multi-subunit
complexes to regulate transcription (Zaidi et aI. , 2002; Javed et al. , 2000; Zeng et al.
1998; Kundu et al. , 2002).
Multi subunit transcription complexes appear to be dynamically assembled
from RUNX proteins and co-regulatory factors at subnuclear foci. This is supported
by the findings that a subset of RUNX foci colocalize with sites of active
transcription (Chapter 1 , Figure 6) and that RUNX interacting proteins such as CBFp
are also targeted to RUNX foci (Chapter 1 , Figure 5; Zaidi et aI. , 2002; Kundu et aI.
2002). CBFp interacts with RUNX proteins , but does not bind directly to DNA , and
increases RUNX-mediated transcription activity (Speck and Stacy, 1995; Wang et al.
" '-.,
i'"
1993; Ogawa et aI. , 1993a; Harada et aI. , 1999; Kundu et aI. , 2002). Furthennore
several co-regulatory proteins , including TLE, Smad and YAP have been shown to '
colocalize with RUNX subnuclear foci (Javed et aI. , 2000; Zaidi et aI. , 2002;
unpublished data from S. K. Zaidi). Taken together, these results suggest that
subnuclear foci may represent sites of transcription containing multi-subunit
transcription factor complexes.
The C-tenninal truncation of RUN Xl and RUNX2, which removes the
intranuclear targeting signal , results in a lethal phenotype in vivo, suggesting that the
tennini of RUN X proteins are essential for functional activity (North et aI. , 1999;
Choi et aI. , 2001). The C-tenninal segment of RUN X proteins appears to reduce the
mobility of these proteins by mediating association with nuclear architecture, perhaps
by supporting in situ fonnation of complexes. Interactions of the C-tennini of RUNX
factors with co-repressors and co-activators are important for regulation of
transcription (Hanai et al. , 1999; Javed et aI. , 2000; Lutterbach and Hiebert, 2000).
Our results presented here together with previous data suggest that RUNX proteins
assemble into macromolecular complexes with co-regulatory proteins at nuclear
matrix associated sites to regulate gene transcription (Berezney and Wei, 1998;
Lutterbach and Hiebert, 2000; Stein et aI. , 2000a; Javed et aI. , 2000; Zeng et aI.
1997; Zeng et aI. , 1998; Zaidi et aI. , 2001). We propose that the functional activity of
RUNX proteins at subnuclear foci may critically depend on the spatial-temporal
availability of co-factors.
Foci that contain RUNX transcription factors remain stationary within the
nuclear space , but are dynamic structures with which RUNX proteins continuously
associate and disassociate. Our results suggest that immobilization of these
subnuclear domains within the nuclear space may reflect association with the nuclear
matrix. Previous commentaries have argued that some subnuclear structures could be
artifacts resultng from the fixation and/or extraction procedures (Pederson, 2000), as
opposed to functional compartments that support gene expression (Penman, 1995;
Stein et aI. , 2000b; Wei et aI. , 1998; Cook, 1999; Stenoien et aI. , 2000b; Nickerson
2001). Here , we show that these RUNX transcripti9n factor domains are observed in
both fixed and living cells and that a subset of these foci represent active sites of
transcription (as revealed by BrUTP labeling). Moreover, subnuclear foci in cells
overexpressing RUNX proteins are comparable to subnuclear foci with endogenous
RUNX proteins in that they are both punctate and nuclear matrix associated (Chapter
, Figure 3; Prince et aI. , 2001). Thus , our findings suggest that the RUNX domains
are functional subnuclear structures.
Our observation that RUNX proteins continuously and rapidly shuttle into and
, out of the dynamic , yet spatially stable foci may reflect a mechanism for the
organization and reversible formation oftranscriptional complexes in situ. However
the high percent immobile fraction obtained for RUNX1 and RUNX2 (20-26%),
suggests that a fraction of RUNX proteins is immobilized by association with the
nuclear architecture in a C-terminal dependent mechanism. The mobility of RUN 
transcription factors into the stationary subnuclear domains occurs within the same
time scale as the mobility ofthe alternative splicing factor (ASF) fused to green
fluorescent protein (GFP) into splicing factor domains (Phair and Misteli , 2000;
Krhlak et aI. , 2000). These recent studies show that ASF-GFP rapidly associates
with splicing compartments and its mobility is 100 times slower than GFP alone
(Phair and Misteli, 2000; Krhlak et al. , 2000). It has been well established that
processing of gene transcripts occurs within specific domains (SC-35 "speckles ) in
the nucleus , which reflects the spatial compartmentalization of the splicing ma hinery
(Xing et aI. , 1993; Spector, 1993; Phair and Misteli , 2000; Krhlak et al. , 2000). Our
data indicate that at least some tissue-specific transcription factors are similarly
compartmentalized within the nucleus in living cells. Other nuclear proteins, such as
GFP-Histone H2B (Kanda et al. , 1998; Phair and Misteli , 2000) and GFP- Iamin B
receptor (Ellenberg et al. , 1997) are extremely immobile in the nucleus and are less
mobile that RUNX proteins. Taken together, these results suggest that attachment to
the nuclear architecture immobilizes nuclear proteins.
Thus , we conclude that the dynamic association of RUNX factors to stationary
subnuclear foci through a common C-terminal signal provides a biological
mechanism for the formation of essential tissue related and gene specific regulatory
complexes.
Effect of the Nuclear Matrix Targeting
Signal on the Subnuclear Distribution
and Mobility of RUNX2
INTRODUCTION
A defined 31 to 38 amino acids nuclear matrix targeting signal (NIyTS)
located in the C-terminus of RUN X proteins is required for association ofRlJX
transcription factors with the nuclear matrix (Tang et aI. , 1999; Zeng et aI. , 1997;
Zaidi et aI. , 2001). The NMTS was characterized in RUNX1 and RUNX2'
biochemical fractionation and in situ immunofluorescence assays using a series of
deletion mutants (Zeng et aI. , 1997; Zaidi et aI. , 2001). The NMTS sequence is
homologous in all three RUNX proteins (Zeng et aI. , 1997). Nuclear matrix targeting
signals have been characterized in other proteins including, the glucocorticoid
receptor (GR), Pit- , YY1 and ETO , however these sequences are not similar to the
RUNX NMTS (Tang et al. , 1998; Mancini et al. , 1999; Barseguian et aI. , 2002; 
McNeil et aI. , 1998). The crystal structure ofthe RUNX1 NMTS has a loop-tum-
loop structure , suggesting that the two finger-like loops may associate with the
nuclear matrix (Tang et aI. , 1999). In addition to the NMTS , the C-terminus of
RUNX proteins contains several interaction sites for co-regulatory proteins. Specific
combinations of these co-regulatory factors synergize with RUNX proteins to activate
or repress specific genes (Lutterbach and Hiebert, 2000; Westendorf and Hiebert
1999; !to, 1999).
Several results in Chapter 1 lead to the question of whether the NMTS has an
effect on the intranuclear mobility and subnuclear distribution of RUNX2. First, we
demonstrated that RUNX subnuclear foci co-localize with sites of active
transcription. Second, deletion of the C-terminus ofRUNX2 (EGFP-RUNX2 361),
which removes the NMTS and several co-regulatory factor interaction domains
created several effects on the transactivation potential, subnuclear distribution and
mobility of RUNX2. Specifically, the transactivation potential ofthe osteocalcin
promoter by EGFP-RUNX2 361 is reduced three-times compared to wild-type
EGFP-RUNX2. The subnuclear punctate foci are no longer observed after deletion of
the C-terminus. EGFP-RUNX2 361 is not associated with the nuclear matrix.
Finally, the intranuclear mobility ofEGFP-RUNX2 361 is increased 25-fold
compared to wild-type EGFP-RUNX2. Taken together, these results suggest that
interaction oftheC-terminus with the nuclear matrix and/or co-regulatory proteins
reduce the intranuclear mobility of RUN X proteins to regulate gene expression at
subnuclear foci. However, the region of the deleted C-terminus responsible for the
interaction that decreases the mobility ofRUNX2 is unkown. Therefore , we
hypothesized that the RUNX NMTS may reduce the mobility of RUNX proteins
through association with the nuclear matrix to support transcriptional control.
To determine whether the NMTS influences the mobility of RUNX proteins
we generated two proteins with single point mutations in the NMTS ofRUNX2
(R383A and Y413A in the Type I isoform). Fluorescence microscopy, time-lapse
microscopy and fluorescence recovery after photobleaching (FRAP) analysis were
used to determine their subnuclear distribution and mobility compared to wild-type
RUNX2. The results show that the RUNX2 NMTS point mutant proteins (i. , R383A
and Y413A) have a decreased ability to associate with the nuclear matrix in
comparison to wild-type RUNX2. However, the NMTS point mutations have no
measurable effect on the intranuclear mobility ofRUNX2 compared to wild-type
:I;,.
..:fi
protein. Moreover, the subnuclear distribution ofthe NMTS mutants is similar to
wild-type RUNX2. These results show that the mobility and subnuclear distribution
ofthe RUNX2 NMTS point mutants R383A and Y413A are similar to those of wild-
type RUNX2. Hence , the single amino acid substitutions at amino acids 383 aI)d 413
are ineffective and do not change the mobility ofRUNX2. Rather, the mobility may
be influenced by the association of co-regulatory proteins that bind to the C-terminus
independent of the NMTS point mutations. Alternatively, the entire NMTS may be
required to decrease the mobility ofRUNX2.
MA TERIALS AND METHODS
Cell Culture
Human osteosarcoma SaOS-2 cells (American Type Culture Collection
(A TCC), Manassas , VA) were maintained in McCoy s 5A medium supplemented
with 15% (v/v) fetal bovine serum (FBS), 100 Units/ml Penicilin, 100 g/ml
Streptomycin and 2 mM L-glutamine at 37 oc in a humidified 5% CO incubator.
Medium was changed every 2-3 days.
Plasmids
HA-RUNX2 R398A and HA-RUNX2 Y428A contain mutations in the NMTS
of the til- (Type II) isoform (528 amino acids) ofRUNX2 at amino acids R398 and
Y 428 (Zaidi et al. , 2002). Because the Type II isoform has a 15 amino acid extension
on its N-terminus compared to PEBP2aA (Type I isoform), these mutations are
equivalent to the mutations R383A and Y413A in the Type I isoform ofRUNX2 (513
amino acids), which is cloned into EGFP-RUNX2 (Figure 1). The C-termini of the
Type I and Type II isoforms are exactly the same. Therefore , we replaced the C-
terminus ofEGFP-RUNX2 with the C-termini ofRUNX2 containing either of the
two NMTS mutations to generate the constructs EGFP-RUNX2 R383A and EGFP-
RUNX2 Y413A. Briefly, plasmid DNAs encoding HA-RUNX2 R398A, HA-RUNX2
Y428A and EGFP-RUNX2 were digested with BstEII and EcoRI. The 1 kb C-
terminal BstEII/EcoRI fragment for each of the NMTS mutations was isolated and
ligated to the 5.7 kb EGFP-RUNX2 BstEII/EcoRI fragment, creating EGFP-RUNX2
''':''*
Figure 1. Generation of EGFP-RUNX2 NMTS Mutants. The HA-RUNX2
NMTS mutant constructs contained the ti/- (Type II) isoform ofRUNX2 (528 amino
acids) and the EGFP-RUNX2 construct contained the PEBP2aA (Type I) isoform of
RUNX2 (513 amino acids). HA-RUNX2 R398A and Y428A and the EGFP-RUNX2
constructs were digested with BstEII and EcoRI. The C-terminus ofEGFP-RUNX2
(BstEII/EcoRI fragment) was replaced with the BstEII/EcoRI fragment containing the
R398A and Y428A creating EGFP-RUNX2 R383A and Y413A NMTS mutants. The
difference in numbers are created because of the 15 amino acid extension in the N-
terminus ofthe Type II isoform compared to the Type I isoform. Dotted lines e.......
show equivalent amino acids in the Type I and Type II isoforms. Broken lines (----
represent BstEII and EcoRI restriction sites.
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R383A and EGFP-RUNX2 Y413A. Both clones were sequenced using the
automated ABI Prism 377 DNA sequencer (Applied Biosystems, Foster City, CA). '
Western Blot Analysis
SaOS-2 cells were plated at a density of 1.0- 1.5 x 10 cells in I 00 m plates
and transfected with 4 J.g of expression plasmid, 10 J.l of Plus reagent and' 15 J.l of
Lipofectamine reagent (Invitrogen, Carlsbad, CA). Cell pellets were collected and
lysed as described in Chapter 1. For each sample 20 J.g of total proteins were
separated on a 10% SDS-PAGE gel. EGFP proteins were detected using amou
monoclonal GFP antibody (Clontech; 1 :10 000 dilution). HA-tagged proteins were
detected using a mouse monoclonal HA antibody (SantaCruz Biotechnology, Santa
Cruz, CA; I :5 000 dilution). RUNX proteins were detected with a rabbit polyclonal
antibody to RUNX2 (Ab-1; Oncogene , Boston, MA; 1: 1 0 000 dilution). Appropriate
HRP-conjugated secondary antibodies (Santa Cruz Biotechnology, Santa Cruz, CA;
1 :10 000 dilution) were detected using the Western Lightning chemiluminescence kit
(NEN , Boston, MA). Cdk2 protein was detected using a rabbit polyclonal a-cdk2
antibody (Santa Cruz Biotechnology, Santa Cruz, CA; 1 :5 000 dilution) as a control
for protein loading.
In situ Immunofluorescence
SaOS-2 cells were grown on 0. 5% (w/v) gelatin-coated coverslips and
cultured to 70% confluency. Cells were transiently transfected with 0.5 J.g of
expression plasmid, 3 J.l Plus reagent and 2. 5 J.l Lipofectamine reagent (Invitrogen
102
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Carlsbad, CA). Cells were harvested 18-20 hours post transfection. Whole cell (WC),
cytoskeleton (CSK) and nuclear matrix-intermediate filament (NMIF) preparations
were performed as described in Chapter l. Cells were counted for retention of
RUNX proteins in the NMIF preparations in two experiments.
Time-Lapse Imaging
SaOS-2 cells were plated at a cell density of 1.0 x 10 in 100 mm plates
containing gelatin-coated 40 mm coverslips (Bioptechs, Butler, P A). Cells were then
transiently transfected using 1-4 f.g of either EGFP-RUNX2 , EGFP-RUNX2 R383A
or EGFP-RUNX2 Y413A expression plasmids , 10 f.l Lipofectamine reagent and 15
f.l Plus reagent (Invitrogen, Carlsbad, CA). Coverslips were assembled into the FCS-
2 closed cell chamber (Bioptechs , Butler, P A) in which a peristaltic pump (Instech
Laboratories Inc, Plymouth Meeting, PA) was used to perfuse complete McCoy s 5A
media without phenol red (US Biological , Cleveland, OH) and 10 nM Mitotracker
Red dye through the chamber. Cells were maintained at 37 C and time- lapse images
were captured every 20-30 seconds for 20-30 minutes and processed as described in
Chapter 1. Exposure times for EGFP fusion proteins were 100-200 milliseconds.
The number of cells with each of the three different subcellular distributions
categorized as punctate , punctate/diffuse and diffuse cells, were counted.
Significance between the wild-type and NMTS mutants and between the subcellular
distributions were determined using the analysis of variance (ANOV A) and multiple
pair-wise comparisons in the Tukey s studentized range test and Bonferroni t-test.
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Fluorescence Recovery After Photobleaching (FRAP) Analysis
SaOS-2 cells were plated in T -25 flasks at a density of 1.0 x 10 cells/fask
and cultured until 70% confluency. Expression plasmids 
(2Ilg) were tran iently
transfected using 5 III of Lipofectamine and 4 III Plus reagents (Invitrogen, Carlsbad
CA). Transfected cells were and plated in coverslip live cell chambers and fRAP
analysis was performed as in Chapter 1 except that images of fluorescence' recovery
were captured every second for 30-60 seconds using 200 milisecond exposure times.
The half-time of recovery (t ) and the percent immobile fraction were calculated as
described in Chapter 1. The recovery rates were calculated for the entire
photobleached area. Adobe Photoshop and Microsoft PowerPoint were used to
assemble the digital images. Standard errors were determined as the standard error of
the mean (SEM). Significance between wild-type RUNX2 and the NMTS mutants
and between the subnuclear distributions was determined using the analysis of
variance (ANOV A) and multiple pair-wise comparisons in the Tukey s studentized
range test and Bonferroni t-test.
Movies on Supplementary CD
QuickTime Movies 4A-C and 5A-C (available on the Supplementary CD)
show the time-lapse images corresponding to Figures 4A-C and 5A-C. Time-lapse
images were captured using 200 ms exposure times Movie 4A, every 30 seconds for
30 minutes; Movie 4B , every 30 seconds for 30 minutes; Movie 4C , every 20 seconds
for 30 minutes; Movie 5A, every 30 seconds for 30 minutes; Movie 5B , every 20
seconds for 20 minutes; and Movie 5C , every 20 seconds for 20 minutes. QuickTime
104
Movies 6A- , 7 A- , 8A-C show cells corresponding to those captured in Figure 6A-
, 7A- , 8A-C for FRAP analysis. Movies 6A- , 7A- , 8A-B show sequential
images captured before bleaching and every second for 60 seconds after
photobleaching. Movie 8C shows sequential images captured before bleaching and
every second for 30 seconds after photobleaching.
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RESUL TS
Generation ofEGFP-RUNX2 Nuclear Matrix Targeting Signal Mutant Proteins
We have shown that deletion ofthe C-terminus , which removed the nuclear
matrix targeting signal (NMTS) and several co-regulatory proteins interaction
domains , increased the mobility ofRUNX2 (see Chapter l). Therefore , we
determined whether the NMTS by itself has an effect on the mobility ofRUNX2.
We created R383A and Y413A mutations in the NMTS ofEGFP-RUNX2 (Figure 1)
based on the RUNX2 NMTS point mutations that were previously demonstrated to
decrease nuclear matrix association and transactivation of the osteocalcin promoter
compared to wild-type RUNX proteins (Zaidi et aI. , 2002; unpublished results). The
R383A mutation in EGFP-RUNX2 is located N-terminal to the RUNX2 NMTS
whereas the Y413A point mutation in EGFP-RUNX2 is located in Loop II of the
NMTS crystal structure (Figure 1) (Tang et al. , 1999).
. To determine whether the EGFP-RUNX2 NMTS mutant proteins were
expressed, western blot analysis was performed using SaOS-2 whole cell extracts
transiently transfected with wild-type EGFP-RUNX2 , EGFP-RUNX2 R383A and
EGFP-RUNX2 Y413A (Figure 2). Both GFP (Figue 2A) and RUNX2 (Figue 2B)
antibodies were used to detect the EGFP-RUNX fusion constructs and an HA
antibody (Figure 2A) was used to detect HA-RUNX2 R398A and Y428A (Type II
isoform). EGFP-RUNX2 361 and EGFP were used as controls for expression. An
a-cdk2 antibody was used as a control for protein loading (Figure 2 bottom panels).
The results show that the EGFP-RUNX2 NMTS mutants have the same molecular
mass and are expressed at comparable levels as the wild-type EGFP-RUNX2 protein.
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Figure 2. EGFP-RUNX2 NMTS Mutants Are E pressed at Similar Levels as
Wild-Type EGFP-RUNX2. Wild-type and mutant EGFP-RUNX fusion proteins as
indicated above each lane were transfected in SaOS-2 cells and whole cell extracts
were subjected to western blot analysis. (A) A monoclonal mouse GFP antibody was
used to detect the EGFP-RUNX fusion proteins and an HA antibody was used to
detect the HA-RUNX2 NMTS mutants. Arows indicate expressed proteins , which
are labeled above the lanes. (B) A rabbit polyclonal RUNX2 antibody was used to
detect RUNX2 protein. Endogenous RUNX2 is labeled with the lower arrow. The
upper arrows indicate EGFP- and HA-tagged RUNX fusion proteins. (C) A rabbit
polyclonal RUNX1 antibody was used to detect EGFP-RUNX1 , overexpressed
Untagged-RUNX1 and endogenous RUNX1 protein (arrows). (A, B , C) Cdk2
antibody was used as a control for protein loading.
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Furthermore , the expression levels ofEGFP-RUNX2 and EGFP-RUNX2 361 were
equivalent in SaOS-2 cells (Figure 2), which were different than in HeLa cells (see
Chapter 1 , Figure 1) where the expression level ofEGFP-RUNX2 361 was higher
than that ofEGFP-RUNX2.
To assess whether the EGFP-RUNX2 NMTS mutants are associated with the
nuclear matrix, wild type EGFP-RUNX2 and mutant proteins EGFP-RUNX2 R383A
(Figure 3A) and EGFP-RUNX2 Y413A (Figure 3B) were expressed in SaOS-2 cells
and whole cell (WC), cytoskeleton (CSK) and nuclear matrix-intermediate filament
(NMIF) preparations were performed. The results show that the NMTS mutants have
a punctate subnuclear distribution and are associated with the nuclear matrix (Figure
3A and B). However, the percentage of cells with wild-type and NMTS mutant
RUNX2 proteins retained in the nuclear matrix was determined by counting cells
using fluorescence microscopy. The results demonstrate that the percent of cells in
which RUNX proteins are retained in the nuclear matrix is less for the NMTS mutant
proteins compared to wild-type RUNX2 proteins (Table 1). In 95% of cells
expressing wild-type EGFP-RUNX2 , EGFP-RUNX2 is associated with the nuclear
matrix (NMIF /WC ratio, Table I). However, in 27% of cells expressing EGFP-
RUNX2 Y413A and in 60% of cells expressing EGFP-RUNX2 R383A, the NMTS
mutant proteins are associated with the nuclear matrx. The percent of cells scored as
positive (associated with the nuclear matrix) may decrease because overall, there may
be a decrease affnity of the nuclear matrix associated proteins in each cell such that a
substantial fraction fall below threshold. These results demonstrate that the NMTS
point mutations decrease , but do not abolish, nuclear matrix association of RUNX2
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Figure 3. EGFP-RUNX2 NMTS Mutants Are Retained in the Nuclear Matrix.
SaOS-2 cells were transiently transfected with (A) EGFP-RUNX2 R383A or (B)
EGFP-RUNX2 Y413A. Whole cell (WC), cytoskeleton (CSK) and nuclear matrix-
intermediate filament (NMIF) preparations were performed. (A and B) Left panels
show EGFP fluorescence images captured using a FITC fiter. Cells were stained
with DAPI (0. 05 Ilg/ml) (right panels). Chromatin digested NMIF preparations show
no DAPI staining.
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and that the Y413A mutation is more effective in decreasing nuclear matrix
association than the R383A mutation.
The Subnuclear Distribution of RUNX2 Nuclear Matrix Targeting Signal
Mutants Is Similar to Wild-type RUNX2 in Living Cells
To evaluate the mobility of the foci and the subnuclear distribution of the
EGFP-RUNX2 NMTS mutant proteins in living ceps compared to wild-type EGFP-
RUNX2 , SaOS-2 cells were transiently transfected with EGFP-RUNX2 , EGFP-
RUNX2 R383A and EGFP-RUNX2 Y413A constructs and time-lapse microscopy
was used to observe the distributions. Images were captured every 20-30 seconds for
20-30 minutes to determine the movement of the subnuclear foci in cells expressing
the NMTS mutants (Figure 4-5A; see Supplementary CD for Movies 4-5A). The
results demonstrate that the RUNX2 NMTS mutant foci are stationary (Figure 4-5A;
Movie 4-5A), which is similar to wild-type RUNX2. Moreover, three different
subnuclear distributions were observed for the RUNX2 NMTS mutants , which were
designated punctate, punctate/diffuse and diffuse (Figures 4 and 5A-C and see
Movies 4 and 5A-C). The differences in the subnuclear distribution were initially
thought to be an effect of the NMTS mutations. However, after examination of cells
expressing wild-type EGFP-RUNX2 , the three distributions were also observed for
wild-type RUNX2 in living cells. The distinctions between sub nuclear distributions
were made by observing living cells in the fluorescence microscope. Thus, the
assignent to each category was subjective. The criteria for distinguishing between
the different subnuclear distributions were the following: 1) the punctate distribution
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Figure 4. EGFP-RUNX2 R383A NMTS Mutant Expressing Cells Show Three.
Subnuclear Distribution Patterns in Living Cells. SaOS-2 cells were transiently
transfected with EGFP-RUNX2 R383A NMTS mutant and time-lapse microscopy
was performed in living cells. Time-lapse images show three different subnuclear
distributions (A) punctate (B) punctate/diffuse and (C) diffuse. (A, B , C) Images are
shown for 0 , 10 20 and 30 minutes.
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EGFP-RUNX2 R383A
A. Punctate
o min. 5 min. 10 min. 20 min. 30 min.
B. Punctate/Diffuse
o min. 5 min. 10 min. 20 min. 30 min.
c. Diffuse
o min. 5 min. 10 min. 20 min. 30 min.
Figure 5. EGFP-RUNX2 Y413A NMTS Mutant Expressing Cells Also Show
Three Subnuclear Distribution Patterns in Living Cells. SaOS-2 cells were
transiently transfected with EGFP-RUNX2 Y413A NMTS mutant and time-lapse
microscopy was performed in 1iving cells. Time-lapse images show three different
subnuclear distributions (A) punctate (B) punctate/diffuse and (C) diffuse. Images
are shown for (A) 0 , 5 , 10 20 and 30 minutes and (B , C) 0 , 10 , 15 and 20 minutes.
116
EGFP-RUNX2 Y413A
A. Punctate
o min. 10 min. 20 min. 30 min.5 min.
B. Punctate/Diffuse
o min. 10 min. 15 min. 20 min.5 min.
c. Diffuse
o min. 15 min.10 min. 20 min.5 min.
contained a great number of bright punctate subnuclear foci and very little diffuse
staining (Figure 4A and SA); 2) the diffuse pattern contained mostly diffuse
fluorescence signal in the nucleus and 0-2 subnuclear foci (Figure 4C and ,5C); and 3)
the punctate/diffuse distribution was intermediate between the first two types a
contained several subnuclear foci surrounded by diffuse fluorescence signal (Figure
4B and 5B). The percentage of cells expressing the wild type and mutant proteins in
each ofthe subnuclear distribution patterns were counted in living cells (Table 2).
The results show that there are no significant differences between the wild-type and
NMTS mutant proteins (using multiple pair-wise comparisons in the Tukey
studentized range test and Bonferroni t- test ? 0.05). Furthermore, there is no
statistical difference between each of the subnuclear distributions in living cells
(Table 2; ? 0.05). These results suggest that the NMTS point mutations R383A and
Y 413A do not effect the overall subnuclear distribution of RUNX2.
Point Mutations in the Nuclear Matrix Targeting Signal Have No Measurable
Effect on RUNX2 Intranuclear Mobilty
Deletion of the RUNX2 C-terminus increases the mobility ofRUNX2 (see
Chapter 1), suggesting that the mobility ofRUNX2 is constrained by association of
the C-terminus with the nuclear matrix and/or co-regulatory proteins. 
hypothesize that nuclear matrix association may be responsible for reducing RUNX
mobility. Therefore, we examined the mobility ofthe EGFP-RUNX2 NMTS point
mutants compared to wild-type EGFP-RUNX2 using FRAP analysis. Wild-type and
mutant proteins were expressed in SaOS-2 cells by transfecting 2 /-g of the expression
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constructs. Photobleaching experiments were performed as described in the Materials
and Methods and in Chapter 1. The methods for calculating the half-time of
recovery for the punctate and diffuse distributions were slightly different. ,The half-
time of recovery ofthe NMTS mutants with a punctate subnuclear distribution yvas
calculated with the same formula as for wild-type EGFP-RUNX2 , whereas that of the
NMTS mutants with a diffuse subnuclear distribution was calculated with the same
formula as for EGFP-RUNX2 361. The two formulas shown in the Materials and
Methods of Chapter 1 were derived from the same original formula however, for the
punctate distribution the constant (t ) was derived from the slope ofthe graph (Ih ioo
vs. time), which was determined from the fluorescence intensities inside the
photobleached area, and for the diffuse distributions t was calculated using a
comparison of the fluorescence intensities inside the photobleached areato a region
outside the photobleached area.
The reason for using two different formulas was that the recovery of the
proteins with a diffuse distribution was extremely fast and the CCD camera speed
was not as high as the movement of the proteins. Therefore, when the half-time of
recovery of the proteins in the diffuse distribution was calculated by the same formula
as for the punctate distribution, the half-time ofthe proteins in the diffuse distribution
was no different than that of the punctate distribution, which did not appear to be true
from comparing the images of the recovery of the proteins (see Figures 6 and 8).
Furthermore, for the diffuse distribution it was easy to find an area outside the
photobleached area that had a similar intensity as inside the photobleached area since
the fluorescence intensity of the proteins in the diffuse distribution was fairly uniform
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over the nucleus. However, in the punctate cells , it was very difficult to find an area
outside the photobleached area that was a similar intensity as inside the
photobleached area because the intensity was different in every area of the nucleus
and the signal 're covered much slower than diffuse signal. Therefore , different ways
of ca1culating the half-time of recovery for the punctate and diffuse subnuclear
distributions using two formulas derived from the same original formula were
necessary. Furthermore , the half-time of recovery or the proteins with a
punctate/diffuse subnuclear distribution could not be determined since the ca1culated
half-time of recovery using the formula for the punctate distribution did not appear to
reflect the recovery in the images. In addition, it was also diffcult to find an area
outside the photobleached area that was a similar intensity as inside the
photobleached area using the formula for the diffuse subnuclear distribution.
Images of the recovery of wild-type and NMTS mutant EGFP-RUNX
proteins, shown for the punctate (Figure 6), punctate/diffuse (Figure 7) and diffuse
(Figure 8) distributions , demonstrate that the diffuse fluorescence recovers faster than
the punctate fluorescence (see Supplementary CD; Movies 6A- , 7 A- , 8A-C).
Only cells with a punctate subnuclear distribution were used for ca1culations of the
recovery rates of wild-type EGFP-RUNX2 protein, since at the time the FRAP
experiments were performed it was not established yet that the wild-type protein also
had the three types of subnuclear distributions in living cells. However, for the
EGFP-RUNX2 NMTS mutants , the half-time of recovery and percent immobile
fraction were ca1culated for each of the types of subnuclear distributions. The results
show that wild-type EGFP-RUNX2 proteins expressed in SaOS-2 cells had an
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Figure 6. Punctate Subnuclear Distribution Recover Slower than in the Other
Subnuclear Distributions. SaOS-2 cells were transiently transfected with (A) 
EGFP-RUNX2 , (B) EGFP-RUNX2 R383A or (C) EGFP-RUNX2 Y413A. Images of
cells with a punctate subnuclear distribution are shown. Cells were replated in
coverslip chambers for FRAP analysis. Pre-bleached images are shown. The circles
represent the entire photobleached areas in which the recovery rates were calculated.
Shown images were captured before photobleaching and 1 , 3 , 5 , 10 and 60 seconds
afterphotobleaching. The white bars correspond to a scale of 10 microns.
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EGFP-RUNX2
EGFP-RUNX2 R383A
EGFP-RUNX2 Y413A
Figure 7. FRAP Analysis of Punctate/Diffuse Subnuclear Distribution. SaOS-
cells were transiently transfected with either (A) EGFP-RUNX2 R383A or (B)
EGFP-RUNX2 Y413A and images for cells with a punctate/diffuse subnuclear
distribution are shown. Cells were replated in coverslip chambers for FRAP analysis.
Pre-bleached images are shown. The circles represent the entire photobleached areas
in which the recovery rates were calculated. Shown images were captured before
photobleaching and 1 , 3 , 5 , 10 and 60 seconds after photobleaching. The white bars
correspond to a scale of lO microns.
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EGFP-RUNX2 R383A
EGFP-RUNX2 Y413A
Figure 8. EGFP-RUNX2 NMTS Mutants in a Diffuse Subnuclear Distribution
Are More Mobile than in the Other Subnuclear Distribution. SaOS-2 cells were
transiently transfected with (A) EGFP-RUNX2 R383A , (B) EGFP-RUNX2 Y413A or
(C) EGFP-RUNX2 361 and images for cells with a diffuse subnuclear distribution
are shown. Cells were replated in coverslip chambers for FRAP analysis. Pre-
bleached images are shown. The circles represent the entire photobleached areas in
which the recovery rates were calculated. Shown images were captured before
photobleaching and 1 , 3 , 5 , 10 and 60 seconds after photobleaching. The white bars
correspond to a scale of 10 microns.
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EGFP-RUNX2 R383A
EGFP-RUNX2 Y413A
EGFP-RUNX2 361
' ' '';
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estimated mean half-time of recovery of7.9:! 0.5 seconds and a mean percent
immobile fraction of 35.3 :! 5.2% calculated from two experiments (n=23) (Table 3).
These values are similar to those in Chapter 1. Moderate variations in quantitation
are to be expe ted because of cellular or experimental differences. The half-time of
recovery and percent immobile fraction of the R383A and Y413A NMTS mutants for
the punctate distribution were not significantly different than those of wild-type
RUNX2 
(p:; 
05 using multiple pair-wise comparisons in the Tukey s studentized
range test and Bonferroni t-test). These results suggest that the NMTS mutations
have no measurable effect on the mobility of RUNX2 (Table 3).
Interestingly, the half-time of recovery of the NMTS mutant proteins in a
punctate distribution are significantly different than that of the diffuse distribution 
-cO.05). Furthermore, the percent immobile fractions for each ofthe three
subnuclear distributions are significantly different (Table 3; -c 0.05). In addition
the mobility of the NMTS mutants in the diffuse subnuclear distribution is
significantly less mobile than EGFP-RUNX2L1361 (Table 3; compare percent
immobile fractions; -c 0.05). This result suggests that the NMTS point mutations
affect the mobility to a lesser extent than deleting the whole C-terminus. Therefore, a
subset of the NMTS mutant proteins may be interacting with components of nuclear
architecture and becoming immobilized for a short period of time. Furthermore
further decreases in mobility may be contributed by interactions of other regions of
the C-terminus with nuclear components. The results show that RUNX proteins are
more mobile in the diffuse distribution, where there are no foci formed and more
immobile in the punctate distribution, where there are more foci (Table 3). One
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interpretation of these results may be that at the subnuclear foci the C-terminus of
RUNX transcription factors binds to a component of the nuclear architecture and
retains RUNX2 to regulate gene transcription. However, the entire NMTS and/or
other regions 6fthe C-terminus (e. , co-regulatory protein interaction domains) may
be necessary to immobilize RUNX proteins.
Because differences in the subnuclear distribution of the RUNX2 proteins
were observed, we assessed whether these differenc;es may be due to variation in
fluorescence intensities of the nuclei. Therefore , the mean pre-bleached fluorescence
intensities of the entire nuclei were calculated for EGFP-RUNX2 and EGFP-
RUNX2 361 (Figure 9A), and for each of the subnuclear distributions ofthe EGFP-
RUNX2 R383A (Figure 9B) and EGFP-RUNX2 Y413A (Figure 9C) mutants. The
integrated fluorescence intensity of each nucleus was determined by multiplying the
intensity of the nucleus by the number of pixels in which the intensity was integrated.
The exposure time of each image was 200 ms. The results show that the diffuse
distribution correlates with a lower level of fluorescence intensity. Moreover, the
punctate distribution correlates with a higher level of fluorescence (Figure 9). Thus
these results suggest that the concentration of RUN X proteins in the nucleus may
have an effect the formation or size of the punctate foci.
132
Figure 9. Punctate Subnuclear Distribution Correlates with a Higher
Fluorescence Intensity. FRAP analysis of the mean pre-bleached fluorescence
intensity of the nuclei was graphed for (A) EGFP-RUNX2 and EGFP-RUNX2 361
and each subnuclear distribution of (B) EGFP-RUNX2 R383A and (C) EGFP-
RUNX2 Y413A. In (A), EGFP-RUNX2 expressing cells were only punctate (n=23)
and EGFP-RUNX2 361 expressing cells were only diffuse (n=10). In (B), the
number of nuclei observed (n) expressing EGFP-RUNX2 R383A in the punctate
distribution equals 11 , in the punctate/diffuse distribution is 7, and in the diffuse
distribution is 10. In (C), the number of nuclei observed (n) expressing EGFP-
RUNX2 Y 413A in the punctate distribution is 16 , in the punctate/diffuse distribution
is 1l , and in the diffuse distribution is 12. Bar graphs equal mean :t SEM.
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DISCUSSION
In this study, we show that two specific point mutations in the NM!,S of
RUNX2 (i. , R383A and Y 413A) decrease association with the nuclear matrix
However, these mutations have no measurable effect on the mobility and subnuclear
distribution ofRUNX2. The similarities between the mobility of wild-type RUNX2
and the RUNX2 NMTS point mutants suggest that these single point mutations may
be less effective in decreasing the nuclear matrix association than is necessary to
observe a difference in the mobility in living cells. Several possible interpretations
could be drawn from these results. The entire NMTS may be involved in association
with subnuclear domains. It is plausible that creation of either different single point
mutations in the NMTS , a combination of several NMTS point mutations or an 
NMTS internal deletion may result in a difference in the mobility compared to wild-
type RUNX2 protein. FRAP analysis could be performed on these alternative
mutants to determine if this interpretation is valid. An alternative interpretation
which is supported by the result that there is no difference in the mobility with the
NMTS mutants, could be that the interaction ofthe C-terminus ofRUNX2 with co-
regulatory proteins may be more important than its association with the nuclear
matrix to account for the decrease in mobility ofRUNX2 compared to that of the C-
terminal truncated RUNX2 (EGFP-RUNX2 361) observed in Chapter 1. This
conclusion is consistent with the findings that several co-regulatory factors interact
with RUNX proteins in their C-termini and that the interaction sites were deleted in
EGFP-RUNX2 361 (see General Introduction, Figure 3). However, whether the
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NMTS mutations altered interaction with co-regulatory proteins has not been
evaluated except with Smad and YAP proteins (Zaidi et al. , 2002; unpublished results
from S. K. Zaidi). A region of the Smad interaction site overlaps with the NMTS (see
General Introduction, Figure 3). However, the Y 428A NMTS mutation in the
RUNX2 native protein did not affect the interaction ofRUNX2 with Smad proteins
by co-immunoprecipitation assays (Zaidi et al. , 2002). Interaction of the NMTS
mutant proteins with other co-regulatory proteins could be established by co-
immunoprecipitation assays to validate this interpretation. Another possibility is that
the large immobile fraction of the punctate subnuclear distribution could represent
association of RUN X proteins with stable subnuclear foci by interaction with
transcription factor complexes. This concept is supported by the result that RUNX
proteins are more mobile in the diffuse subnuclear distribution, which does not
contain subnuclear foci.
It would be expected that the mutations in the NMTS would result in an
increase in the mobility of RUNX2 proteins. However, we observed no difference in
the mobility between the NMTS mutants and wild-type RUNX2. Two considerations
may help to explain these results. First, the point mutations did not completely
abolish nuclear matrix association. Therefore, deletion of the entire NMTS may have
a more substantial effect on the mobility of RUNX proteins. Second, RUNX proteins
may transiently associate with subnuclear foci and therefore be in constant flux with
subnuclear foci. In addition, the C-terminus of RUN X proteins may associate with
co-regulatory proteins that form a large multi-subunit complex , which may slow
down the mobility of RUNX proteins.
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Two mechanisms for the movement of nuclear proteins are plausible , a
diffusional mechanism, which does not require energy or a non-diffusion, directional
mechanism , in which proteins may be targeted by a specific signal (Mistel , 2001;
Krhlak et al. , 2000; Phair and Misteli , 2000; Shop land and Lawrence , 2000). ,While
our results show that RUNX proteins are targeted to certain subnuclear sites, they
may move to these sites initially by either a directed movement or a more random
diffusion followed by specific retention. It would be useful to distinguish between
these two mechanismsin the future , and to examine the role of the NMTS specifically
in the possibility of directed movement.
The differences observed in each of the subnuclear distributions for the
mobility ofRUNX2 may reflect an increase in protein concentration. This is
supported by the results that the lower fluorescence intensity correlates with a diffuse
subcellular distribution and that the higher fluorescence intensity, which represents an
increase in protein concentration, correlates with a punctate distribution. These
results suggest that the formation of punctate subnuclear foci may be related to the
level of protein in the nucleus. It should be noted that the punctate RUNX foci are
observed with endogenous levels of expression in fixed SaOS-2 cells (see Chapter 1
Figure 3) and fixed human osteoblastic cells (Prince et al. , 2001), which has a similar
appearance as EGFP-RUNX1 and EGFP-RUNX2 foci. An increase in protein
concentration may result in an increase in flow of freely mobile RUNX proteins into
the subnuclear foci , thereby increasing the size and intensity of the subnuclear foci.
The majority of the RUNX subnuclear foci are associated with sites of
transcription (see Chapter 1 , Figure 6), indicating that these punctate foci may
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represent multisubunit complexes. The increase in the number of punctate foci as
RUNX protein concentration is increased may reflect an increase in number of
transcription factor complexes , and therefore an increase in gene expression.
However, not all of the RUNX foci are associated with sites of transcription. RUNX
sites not actively involved with transcription may be sites of storage or transcriptional
repressIOn.
Several limitations of the FRAP experimen s exist. First, the speed of the
CCD camera was slower than the mobility of the proteins in a diffuse distribution.
Therefore, two formulas were necessary to calculate the half-time of recovery.
Second, a light fluorescence microscope was used instead of a confocal microscope
for the FRAP analysis , and thus the out-of-focus light was not removed from the
images. Finally, the mobility of wild-type RUNX2 in the punctate/diffuse and diffuse
subnuclear distributions were not determined to compare to the punctate distribution.
Therefore , further studies may be necessary to conclusively determine whether the
NMTS is responsible for the retention of RUN X proteins at subnuclear foci , since the
question still remains whether nuclear matrix association is the cause of
immobilization of RUN X factors.
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The RUNX Inducible Osteocalcin
Promoter Expresses Enhanced Green
Fluorescent Protein Specifically in the
Osteoblastic Lineage of Transgenic
Mice
The OC- EGFP transgenic mice were generated and characterized in collaboration
with Thomas Owen, Ph.D. at Pfizer, Groton, CT. 
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INTRODUCTION
RUNX2 transcription factors are highly expressed in bone cells and regulate
several bone specific genes , including the osteoca1cin (OC) gene, during osteoblast
(OB) differentiation. To assess the in vivo regulation of osteoca1cin by RUNX 
proteins , we generated transgenic mice expressing enhanced green f1uoresc nt protein
(EGFP) under control of the OC promoter. The OC- EGFP mice create a useful tool
for evaluating the in vivo regulation of osteocalcin by RUNX2 and for developing
potential new drugs for the treatment of bone diseases , such as osteoporosis.
The osteoca1cin protein is a 1 O-kDa protein, which is synthesized only '
osteoblasts (OBs) and is secreted from OBs into the mineralized bone extracellular
matrix. OC is undetectable in early osteoprogenitor cells in bone and its expression is
induced in committed osteoblasts. Preosteocytes and osteocytes in mature bone
continue to express OC at significant levels (Lian et aI. , 2001). In early stages of
normal osteoblast differentiation in vitro (day 3), osteoblasts are in a proliferation
period, where they express high levels of histone and collagen type I genes, but do
not express OC. Basal levels of OC are expressed in post-proliferative osteoblasts.
OC mRNA and protein expression are induced in cultured OBs in late stages of
osteoblast differentiation during bone matrix maturation (day 12 of cultures) and
mineralization (day 19 of cultures). During these stages , mineralized bone nodules
form in OB cultures and a temporal expression of other bone-specific phenotypic
markers , alkaline phosphatase and osteopontin, are also induced (Owen et al. , 1991).
Basal expression of the OC gene involves several responsive elements in the
proximal promoter, including the TAT A box (located from -42 to -39) and the OC
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Figure 1. Schematic ofthe Rat Osteocalcin Gen Promoter. Regulatory
sequences and their cognate binding factors are shown for the active osteocalcin gene
transcribed in differentiated osteoblasts. The TAT A box is the site of interaction with
the transcription machinery. OC Box I is a 24 nt domain containing a homeodomain
binding site (e. , Msx- , Dxl-5) and a site for an osteoblast-specific binding protein
(OCBPl). Other functional regulatory elements include glucocorticoid response
element (GRE) and one responsive to transforming growth factor (TGRE).
Recognition motifs for RUNX proteins are shown with sites A and B flanking the
vitamin D response element (VDRE) and site C located in the proximal promoter.
During basal transcription, the VDRE is occupied by AP- 1 and YY1 proteins as
indicated. In the active gene , the positioned nucleosome is shown and the DNase I
hypersensitive sites (DHS) spanning the proximal and distal regulatory domains are
illustrated.
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box I (located from -99 to -76) (Figure 1). The TATA box binds TFIIB , TFIID and
the transcription machinery. The homeodomain proteins (e. , Msx- , Dlx-5 and
CDP/cut) repress OC expression by interaction with the OC box in early stages ofOB
differentiation' (Hoffiann et aI. , 1994; Towler et aI. , 1994b; Ryoo et aI. , 1997; van
Gurp et aI. , 1999). However, heterodimerization ofMsx-2 with the homeodomain
protein Dlx- , which is expressed in differentiated OBs has been shown to disrupt
DNA binding and thereby relieve the repression bY homeodomain proteins (Lian et
al. , 2001; Ryoo et aI. , 1997; Zhang et aI. , 1997; Newberr et aI. , 1998). The
osteoblast specific binding complex (OCBP1) also interacts with the OC box to
induce basal transcription (Stein et aI. , 1997; Hoffmann et al. , 1996).
Transcriptional activation ofthe OC promoter critically involves the
association of RUN X proteins with the three RUNX binding sites (Sites A, B , and C)
as well as the enhancer vitamin D response element (VDRE
, -
461 to -445), which
binds the vitamin D receptor (VDR)-retnoid X receptor (RXR) heterodimer complex
(Figure 1; Stein et aI. , 1997). During basal expression or when the OC promoter is
inactive , the VDRE is occupied by the YY1 protein and c-jun and c-fos AP- 1 factors
which inhibitOC expression (Lian et aI. , 2001). Induction ofOBs with 1 25-(OH)2
vitamin D3 results in the upregulation of OC. Maximal expression of the OC
promoter results from interaction of the VDR/RXR heterodimer with the VDRE upon
vitamin D3 induction. The VDRE is located in between RUNX sites A and B (-604
to -599 and -440 to -435) in the distal promoter, which are required for induction of
the OC promoter by vitamin D3 (Javed et al. , 1999; Stein et al. , 1997). RUNX Site C
135 to -130) is located in the proximal promoter. The RUNX sites were originally
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identified as nuclear matrix protein (NMP-2) associated sites (Bidwell et aI. , 1994).
Initial characterization ofNMP-2 revealed that it is a RUNX-related transcription
factor further identified as RUNX2/AML3 , which is highly expressed in o teoblasts
(Merrman et aI. , 1995; Banerjee et aI. , 1997). RUNX proteins associate with tqe
nuclear matrix , linking the OC promoter DNA to the nuclear architecture (Zeng et al.
1997). This complexity of transcriptional activity of OC during OB differentiation in
vitro necessitates an understanding of OC expression in vivo.
Transgenic and knockout mice are important for determining the in vivo
function of OC in bone differentiation. However, the function of osteocalcin is stil
unkown. OC-deficient mice are normal at birth, viable , fertile and have no skeletal
patterning defects or ectopic bone formation (Ducy et aI. , 1996). These mutant mice
develop a higher bone density compared to their wild-type littermates over time
indicating that the lack of osteocalcin leads to increased bone formation. These
results may provide a therapeutic model for osteoporosis, which is characterized by a
decrease in bone mass due to increased bone resorption and decreased bone
formation.
Expression of the OC promoter fused to a reporter gene in transgenic mice can
create a useful tool for OC expression as a marker to assess osteoblast growth and
differentiation and bone metabolism in vivo and to examine the regulation of OC by
RUNX proteins in vivo. Therefore, we used enhanced green fluorescent protein
(EGFP) as a reporter gene driven by the OC promoter to produce OC-EGFP
transgenic mice, since EGFP has intrinsic fluorescence properties, which can be
visualized by fluorescence microscopy of whole bone or ex vivo osteoblast cultured
-' '
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cells. Our results show that EGFP is expressed from the OC promoter in a cultured
osteosarcoma cell line, but not in a kidney cell line, and is induced by vitamin D3.
Furthermore , EGFP is expressed in tails ofOC-EGFP transgenic mice , which allows
for phenotyping by visualization of the green fluorescent tail using fluorescence
microscopy. Our results demonstrate that OC-EGFP transgenic mice specifically
express EGFP in osteoblasts and osteocytes in bone tissues. Moreover, EGFP is
expressed in mineralized bone nodules of differenti ted bone marrow derived from
transgenic mice. Taken together, these results show that active osteoblasts are
marked with EGFP , which can be easily visualized in tissue sections and
differentiated osteoblasts , suggesting that the OC-EGFP transgenic mice are a good
model for studying the in vivo effects of RUN X on OC expression and for developing
potential drugs therapies for bone diseases that effect OB growth, differentiation and
metabolism in vivo.
______--
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MA TERIALS AND METHODS
Cell Culture
Rat osteosarcoma ROS l7/2.8 cells (Henr Korehberg, Massachusetts qeneral
Hospital , Boston, MA) and monkey kidney COS-7 cells (American Type Culture
Collection (ATCC), Manassas , VA) were maintained in completed F12 with 5% (v/v)
fetal bovine serum (FBS) or DMEM medium with 10% FBS , respectively, at 37 oC in
a humidified 5% CO incubator. Both media contained 100 Units/ml Penicilin, 100
g/ml Streptomycin and 2 mM L-glutamine and was changed every 2-3 day.
Plasmids
pSROEGFP containing the - 7 kb rat osteocalcin (OC) promoter fused to
EGFP reporter gene was cloned in a 3-step process (Figure 2). The first step was to
insert a palindromic adaptor containing a HindIII site into the NheI site ofpEGFP-C3.
To insert the adaptor, the pEGFP-C3 vector (Clontech, Palo Alto, CA) was digested
with NheI and the linearized vector was gel extracted using QIAquick gel extraction
kit (Qiagen, Valencia, CA). The adaptor was produced from a 12-nt oligo with the
palindromic sequence 5' CTAGCAAGCTTG-3' which contained two NheI
overhangs on either side of a HindIII site. The oligo was heated to 65 oC for 5
minutes , slow cooled to room temperature and placed on ice to self-hybridize the
oligo. The adaptor was ligated to the NheI digested pEGFP-C3 vector resulting in the
'""
clone pEGFP-C3-HindIII. The second step was to remove the HindIII site from the
multiple cloning sequence by self-ligating the BglI/BamHI digested pEGFP-C3-
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Figure 2. Generation ofthe Osteocalcin Promoter-EGFPExpression Vector. A
three-step cloning process was used to produce the pSROEGFP construct, which
contained the enhanced green fluorescent protein (EGFP) reporter gene fused to the-
1.7 kb rat osteocalcin (OC) promoter. First, a palindromic adaptor (sequence shown
below) containing an internal HindIII site flanked by two NheI overhangs was
inserted into the pEGFP C3 vector (Clontech; top left), which was digested with
NheI. The resulting clone was named pEGFP-C3-HindIII (top right) and was
subsequently digested with BglI and BamHI and self-ligated to remove the HindIII
site in the multiple cloning sequence. The resulting vector was called pEGFP-HindIII
(middle right). pEGFP-HindIII and pSROCAT (middle left), which contains the
chloramphenicol acetyl transferase (CAT) reporter gene drven by the OC promoter
were digested with HindIII and MluI. The HindIII/MluI fragment of pSROCA 
containing the OC promoter (PSRO) was fused to the HindIII/MluI fragment of the
EGFP gene replacing the CAT gene with the EGFP gene and creating the final
construct pSROEGFP (bottom). Restriction sites used for digestion are in bold print.
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HindIII vector. The resulting clone was pEGFP-HindIII. The last step was to clone
the EGFP cDNA into pSROCAT , which contains the -1.7 kb rat osteocalcin (OC)
promoter fused to the chloramphenicol acetyl transferase (CAT) gene (Hoffman et al.
1996), by replacing the CAT gene with the EGFP gene. pSROCA T and pEGFP-
HindIII were digested with HindIII and MluI. The HindIII/MluI EGFP fragment and
the OC promoter and vector backbone (PSRO) were gel extracted using the QIAquick
gel extraction kit (Qiagen) and ligated together to gynerate pSROEGFP. pSROEGFP
was sequenced using Sequenase version 2.0 DNA sequencing kit (Amersham
Pharmacia, Piscataway, NJ) with the SITE C top strand primer (5'
GTCACCAACCACAGCA TCCTTTG-3 '
In situ Immunofluorescence
ROS 17/2.8 and COS-7 cells were grown on 0. 5% (w/v) gelatin-coated
coverslips and were transiently transfected using DEAE-Dextran method. Briefly,
025 mg/ml ofDEAE-Dextran and 0.05 mg/ml chloroquine were mixed with 10 ml
of serum-free F12 or DMEM media. 1 J.g ofpSROEGFP DNA was added to 0.5 ml
of media plusDEAE-Dextran and Chloroquine and incubated with the cells for 3
hours at 37 oC rocking plates every 30 minutes. The media was aspirated and the
cells were shocked for 90 seconds with 10% glycerol in F12 or DMEM media. ' Cells
were washed twice with IX PBS and feed with F12 medium supplemented with 5%
charcoal-stripped serum for ROS cells or DMEM supplemented with 10% charcoal-
stripped serum for COS-7 cells either with or without 10- M 1 25-(OH)2-vitamin D3
treatment and incubated at 37 oC for 24 hours. Cells were fixed using 3.
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formaldehyde in PBS, permeablized with 0.5% Triton X- 100 in PBS and DNA was
stained with 0. 05 J.g/ml DAPI. Cells were mounted in Vectashield antifade mounting
media (Vector Laboratories , Burlingame , CA). Fluorescence images were captured
using a Zeiss ICM 405 microscope with a 40X Nikon Plan-Apo 40 oil objective (1
A.) or a 100X Zeiss F100 oil objective (1,25 N.A.), a 100 W Hg lamp and a Zeiss
MC80 Dx 35 mm camera using Kodak Ektachrome 400X fim (Eastman Kodak
Company, Rochester, NY). The software applications to prepare scanned images
were Adobe Photoshop and Microsoft PowerPoint.
Northern Blot Analysis
ROS 1712. cells were plated at 0.6 x 10 cells/lOO mm plate and incubated
until 80% confluent. Cells were either untransfected or transiently transfected wIth
lO J.g pSROEGFP and 40 J.l of Superfect reagent (Qiagen) and allowed to recover for
4 hours following transfection in completed F12 media. The medium was replaced
with F12 supplemented with 2% charcoal-stripped serum and antibiotics either with
or without 10- M 1 25-(OH)2-vitamin D3 treatment and incubated for 24 hours at 37
C. Cells were washed and scraped in 1 ml PBS. mRNA was isolated from the cell
pellets using the PolyA mRNA Isolation kit (Roche, Indianapolis, IN). Briefly, the
cell pellets were resuspended in 1.5 mllysis buffer mix and DNA was sheared
mechanically by passing through a 21-gauge needle on ice. 1.5 J.lofbiotin-labeled
oligo (dTho was added to the cell lysate. The cell lysate was then added to the
washed streptavidin-coated magnetic particles and incubated at 37 C for 5 minutes.
The magnetic particles were separated from the fluid using a magnet and washed 3
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times. The mRNA was eluted from the magnetic particles with 25 III of redistiled
water. 0. Ilg mRNA was lyophilized and resuspended in 14 III of sample buffer (1.
III lOX MOPS , 2.8 III 37% formaldehyde , 8 Jll100% formamide , 2.4 III bromophenol
blue dye , 0.2 III 10 mg/ml ethidium bromide). 0. Ilg ofmRNA was loaded on a 1 %
agarose gel and 6.29% formaldehyde in IX MOPS (0.2 M MOPS , 0. 05 M sodium
acetate , 0.01 M Na EDTA). mRNA separated on the gel was transferred onto a
Hybond-N+ nylon membrane (Amersham Pharmacia, Piscataway, NJ) overnight in
20X SSC. The membrane was crosslinked for 30 second with UV light and
prehybridized with 10 ml prehybridization solution (for 50 ml total volume , 1.25 ml
of 1 M KP0 (pH 7.4), 12.5 ml of 20X SSC , 10 III of 10 mg/ml salmon sperm DNA
(Sigma, St. Louis, MO), 25 ml of 100% formaldehyde and 5 ml of 10% SDS). 84 ng
ofEGFP probe (NheI/XhoI fragment ofpEGFP-C3) was boiled with 10 III 9-mer
random primer from the Prime it II kit (Stratagene , La Jolla, CA) in a 33 III total
volume for 5 minutes and slow cooled to room temperature. 10 III 5X dCTP primer
buffer (Stratagene , La Jolla, CA), 50 IlCi dCTP (Perkin Elmer, Boston, MA) and
5 Units of Klenow enzyme (1 Unit/Ill) (Stratagene, La Jolla, CA) were added to the
probe and incubated 15 minutes at 37 C. Excess p was removed by passing the
probe through a Sephadex G-25 Quick Spin column (Roche, Indianapolis, IN). The
probe was resuspended in 50 III hybridization buffer (prehybridization buffer and
10% Denhardt solution), boiled for 5 minutes , added to 10 ml of hybridization
solution and incubated at 42 with the membrane overnight in a hybridization oven.
The blot was washed 3 times with a low stringency buffer (2X SSC , 0. 1 % SDS) at
room temperature and exposed to film 2 hours to overnight at -70 C. Blots were
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stripped with O. lX SSC and 0.5% SDS by boiling for 5 minutes and reprobed with
the OC probe tBamHIIEcoRI fragment of the rat OC plasmid pOC3.4 (Lian et al.
1989)J and the human glyceraldehyde- phosphate dehydrogenase (GAPI?H) probe
tHindIIIIEcoRI fragment of the pmdm23 plasmid (Nakao et aI. , 1994)J.
FACS Analysis
ROS 17/2.8 cells were plated at 0.6 x 10 cells/1 00 mm plate and incubated
until 80% confluent. Cells were transiently transfected with 10 Ilg pSROEGFP and
40 III of Superfect reagent (Qiagen) and allowed to recover for 4 hours following
transfection in completed F12 media. The medium was replaced with F12
supplemented with 2% charcoal-stripped serum and antibiotics either with or without
10- M 1 25-(OH)2-vitamin D3 treatment and incubated for 24 hours at 37 oC. Cells
were trysinized using 1 ml Trysin- 25% (Invitrogen, Carlsbad, CA) for 1-
minutes at 37 oC and counted. 1 x 10 cells were centrifuged at 1000 rpm for 5
minutes and resuspended in 400 III PBS. Flow cytometric analysis was performed by
the Core Flow Cytometry Facility at the University of Massachusetts Medical School
Worcester, MA. Twenty thousand cells were counted to determine the percent of
EGFP expressing cells with high, medium, or low expression levels. Calculations of
percent EGFP expressing cells were averages from two experiments:! S.D. (n=5).
..?:.
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Preparing the Rat Osteocalcin Promoter-Enhanced Green Fluorescent Protein
(OC-EGFP) DNA Fragment for Microinjection to Generate OC-EGFP
Transgenic Mice
pSROEGFP was digested with BamHI and MluI to release the OC-EGFP
DNA fragment and ApaLI to cut the vector backbone into smaller fragments since the
OC-EGFP fragment and the backbone were of similar sizes. The OC-EGFP fragment
needed to be extremely pure for microinjection in tJ:e pronuclear stage embryos
therefore the digested DNA was then extracted by phenol: chloroform (1: 1) and the
residual phenol:chloroform was extracted by ethyl ether (equilibrated with water) (1: 
vol). The residual ethyl ether was evaporated by incubation in a 70 oC water bath for
5 minutes. The DNA was ethanol precipitated three times and loaded on a 0.
agarose gel. The OC-EGFP fragment was gel extracted with QIAquick gel extraction
kit (Qiagen). The OC-EGFP DNA was then further purified using Elutip columns
(Schleicher and Schueil , Keene , NH) and the transgenic mice were generated as
described in (Owen et aI. , 2001). Briefly, the purified OC-EGFP DNA was
microinjected into pronuclear stage FVBIN embryos at a concentration of 0 ng/M-l
in 10 mM Tris-Cl pH 7.4 and 0.1 mM EDTA. Microinjected embryos were
transferred to pseudopregnant CD'-l females. At weaning, genomic DNA was
isolated from by phenol: chloroform extraction and the founder transgenics were
identified by PCR using primers that span the 3' end of the OC promoter and the 5'
end of the EGFP gene. Founder mice were breed to FVBIN mates and the transgenic
lines were maintained. Transgenic mouse line "F" was the only line in which the
EGFP fluorescence could be visualized by fluorescence microscopy for phenotyping.
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Histology
Histology was performed as described in Owen etal. (2001). Briefly, mice,
were sacrificed by CO inhalation. Tissues were removed, fixed in 4%
paraformaldehyde and stored in 0. 5% paraformaldehyde at 4 until processing. For
cryosectioning, tissues were mounted in OCT (Miles Inc. , Elkhart , IN; 10. 24% (w/w)
polyvinyl alcohol; 4.26% polyethylene glycol; 85.50% nome active ingredients) and
frozen using a Gentle Jane snap freezing system (Instrumedic Inc. , Hackensack, NJ).
Frozen blocks were mounted on a Leica CM3000 cryostat and 5 Jlm sections were
cut. Sections were imaged using an Olympus BH-2 fluorescence microscope system
(Melvile , NY).
Bone Marrow Cell Culture
Bone marrow cultures were generated as described in Owen et al. (2001).
Briefly, mouse femur and tibia bone marrow from 8 week old transgenic mice was
extracted, triturated, passed through a 100 Jlm mesh filter and plated in complete
MEMa media supplemented with 15% fetal calf serum (FCS) and antibiotics in 6-
well dishes at a density of 3 x 10 cells/well. Cells were fed on day 4 by replacing
one-half of the plating media and from day 8 onward were fed with
MEMa supplemented with 10% FCS , 50 Jlg/ml L-ascorbate and 2 mM sodium
inorganic phosphate to induce osteoblast differentiation.
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RESUL TS
Generation of Osteocalcin Promoter-EGFP Reporter Construct
Transgenic mice expressing EGFP under control ofthe osteocalcin (OC)
promoter may be useful to study the in vivo function of RUN X proteins in bone
development and to develop drugs to treat bone diseases such as osteoporosis and
osteopenia. Therefore , to produce transgenic mice ,expressing EGFP under the
control of the - 7 kb rat osteocalcin (OC) promoter, we generated an OC-EGFP
expression construct termed pSROEGFP (Figure 2 and 3A). pSROEGFP was
generated by 3-step cloning process, which replaced the chloramphenicol acetyl
transferase (CAT) gene inpSROCAT (Hoffman et aI. , 1996) with enhanced green
fluorescent protein (EGFP) (Figure 2). First, an adaptor containing a HindIII site was
inserted 5' of the EGFP start site in the pEGFP- C3 vector (Clontech) so that the
EGFP gene could subsequently be cloned into the HindIII site at the 3' end of the OC
promoter. Second, the HindIII site was removed from the multiple cloning sequence
of the resulting pEGFP-C3-HindIII construct, so only a single HindIII site was
remaining. Lastly, the resulting pEGFP-HindIII construct and pSROCAT were
digested with HindIII and MluI and the EGFP gene was fused to the 3' end of the OC
promoter replacing the CAT gene with the EGFP gene (Figure 2).
, ".. .
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Expression of EGFP Under the Control of the Osteocalcin Promoter Is Induced
by Vitamin D3
To assess whether the pSROEGFP construct tissue-specifically expressed
EGFP under control ofthe OC promoter, we transjently transfected rat osteosa:rcoma
ROS l7/2.8 cells and monkey hdney COS-7 cells wjth pSROEGFP (Fjgure 3A) and
treated the cells with 1 ,25-(OH)2 vjtamin D3 for 24 hours. Since OC is expressed
only in osteoblasts , we expeCt that EGFP would be specifically expressed jn ROS
l712. cells , but not COS-7 cells. The results show that EGFP is expressed from the
OC promoter in ROS l712. cells, but not in COS-7 cells by in situ fluorescence
microscopy. Furthermore, as a positive control, EGFP was express by a CMV
promoter jn COS-7 cells. Taken together, these results suggest that EGFP under
control of the OC promoter is spedfically expressed in bone cells in vivo (Figure 3B).
An overall jnduction of the OC promoter by vitamin D3 was not observed by in sjtu
immunofluorescence since the number oftransfected cells by DEAE-Dextran
transfection method was very low (transfectjon effciency= 1 %) and the expression
levels ofEGFP varied from cell to cell ejther wjth or without vjtamin D3. However
since the endogenous OC promoter is induced over basal levels by vitamin D3 (Lian
et aI. , 200l), we expected that the pSROEGFP expression construct would be induced
by vitamin D3. Therefore , to determine whether expression ofEGFP mRNA under
control ofthe OC promoter was indeed induced by vitamin D3
, we performed
northern blot analysis of ROS 17/2.8 cells transfected wjth pSROEGFP in the
presence or absence of vitamin D3. The results show a l7-fold induction of EGFP
157
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Figure 3. EGFP Is Expressed Under Control oqhe Rat Osteocalcin Promoter in
Osseous, but Not in Non-Osseous Cell Lines. (A) Schematic of the pSROEGFP
expression construct containing the - 7 kb rat osteocalcin promoter fused to
enhanced green fluorescent protein (EGFP) is illustrated. Shown are binding sites for
RUNX (Sites A, B and C), the vitamin D responsive element (VDRE), CCAAT/
enhancer binding protein (C/EBP), and the OC box I and the TAT A box. (B)
pSROEGFP was transiently transfected in rat osteosarcoma ROS 17/2.8 cells and
monkey kidney COS 7 cells. EGFP (green fluorescence, left panels) is expressed in
ROS 17/2. 8 cells , but not in COS-7 cells. DAPI (0.05 /.g/ml) stains the DNA in the
nucleus (right panels). Images shown are from 24-hour 1 25-(OH)2 vitamin D3
treatment. No difference was observed between the fluorescence of the untreated and
the 24-hour vitamin D3 treatment for both cell types.
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Figure 4. EGFP mRNA Expressed from the Ost ocalcin Promoter Is Induced by
Vitamin D3 in Rat Osteosarcoma Cells. ROS 17/2.8 cells were either untransfected
or transiently transfected with pSROEGFP and treated either with or without vitamin
D3 in charcoal-stripped serum for 24 hours. Cells were harvested and Poly A mRNA
was isolated from cell pellets. 0.7 Jlg ofmRNA was loaded on a 1 % agarose- 29%
formaldehyde gel and was transferred onto a nylon membrane. The membrane was
probed with labeled EGFP , OC and GAPDH DNA probes and the
autoradiographs are shown. The bands were quantitated using the phosphoimager.
Fold vitamin D3 induction was determined by normalizing to GAPDH expression
levels.
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mRNA expression by vitamin D3 in cells expressing pSROEGFP using a probe for
EGFP (Figure 4). As a control , the expression of endogenous OC mRNA was
induced 10 to 73-fold by vitamin D3 (Figure 4), which is consistent with previous
results (Breen bt aI. , 1994; Lian et aI. , 2001). The fold induction was normalized to
GAPDH mRNA levels. Furthennore , to detennine whether the EGFP protein levels
were induced by vitamin D3 , ROS 1712. cells were either untransfected or
transfected with pSROEGFP and treated either with or without vitamin D3. EGFP
expressing cells were sorted by F ACS analysis for high, medium and low expression
levels (Figure 5). The F ACS analysis dot plots show an increase in the number of
cells with high expression levels after vitamin D3 treatment (Figure 5A). Calculations
of the percent ofEGFP expressing cells show no change in the number oflow
expressing cells (6-7% of population; Figure 5B). However, an increase in the
percent of medium expressing cells (from 4% to 6% of the population) and high
expressing cells (from 1 % to 4% of the population) was observed in the presence of
vitamin D3 (Figure 5B). This increase by vitamin D3 treatment was only observed
by dividing the population into low, medium and high expressing cells, which
suggests a reason why no overall induction was observed with vitamin D3 treatment
in the entire population of cells by immunofluorescence microscopy. Taken together
these results suggest EGFP mRNA and protein levels are induced by vitamin D3.
Furthermore , the OC-EGFP construct expresses in specifically in bone cells in vitro.
Therefore , the OC- EGFP construct is a good candidate to generate transgenic mice.
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Figure 5. EGFP Protein Expression from the Osteocalcin Promoter Is Induced
by Vitamin D3. ROS 17/2.8 cells were either untransfected or transiently transfected
with pSROEGFP and treated either with or without vitamin D3 in charcoal-stripped
serum for 24 hours. Cells were harvested for F ACS analysis by trysinization and
resuspended in PBS without fixation. (A) Dot plots from the F ACS analysis are
shown for untransfected ROS 17/2.8 cells (top), pSROEGFP transfected cells without
vitamin D3 treatment (left), or pSROEGFP transfected cells with vitamin D3
treatment (right). The EGFP expressing cells in the dot plots were sorted into low
medium (med) and high fluorescence levels (boxes). Several cells were observed
with a very high expression level (high box on top) with vitamin D3 treatment and
were included in the calculations for the high expressing cells. (B) From the dot plots
above the mean percentage of EGFP expressing cells in each of the expression levels
with and without vitamin D3 treatment was calculated from two experiments (n=5).
The error bars represent standard deviations.
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Preparation ofthe Osteocalcin Promoter-Enhanced Green Fluorescent Protein
(OC-EGFP) DNA Fragment for Generation of OC-EGFP Transgenic Mice
Transgenic mice expressing EGFP under control of the OC promoter would
be expected to specifically express EGFP proteins in bone cells , since OC is a Qone-
specific protein. EGFP provides a sensitive marker for bone formation, which can be
visualized by fluorescence microscopy in vivo. Therefore , we prepared the
BamHI/MluI OC-EGFP DNA fragment by digestion with BamHI, MluI and ApaLI
(Figure 6). Digestion with ApaLI was utilized to cut the vector backbone into smaller
fragments since the backbone had a similar molecular weight as the OC-EGFP 
fragment. The BamHI/MluI OC-EGFP fragment was purified by phenol: chloroform
extraction, ethyl ether extraction, ethanol precipitations , gel extraction and column
purification (Figure 6). The purified OC-EGFP fragment was microinjected into
pronuclear stage embryos , which were then transferred into pseudopregnant female
mice. Although 5-8 mouse lines were positive by PCR for the OC-EGFP transgene
only line "F" produced visually detectable levels of EGFP in the tails of transgenic
mice for phenotyping by fluorescence microscopy (Figure 7; Owen et al. , 2001).
Expression ofEGFP in cryosections of the tibia, calvarium, femur and kidney of28-
day old transgenic and wild-type mice was assessed by fluorescence microscopy
(Figure 8; Owen et aI. , 2001). The results demonstrate that EGFP was specifically
expressed in osteoblasts and osteocytes of bone tissues in transgenic mice.
Furthermore , no EGFP expression was observed in the kidney of transgenic mice or
in the femur or kidney of wild-type mice (Figure 8; Owen et aI. , 2001). Northern blot
\. 
't\-
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analysis was performed on OC-EGFP mRNA and endogenous OC mRNA extracted
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Figure 6. Protocol for Preparing OC-EGFP DNA Fragment to be
Microinjected into Female Pseudopregnant Mice. The pSROEGFP clone was
digested with BamHI and MluI to release the OC- GFP fragment of DNA from the
vector backbone. However, the vector backbone fragment was about the same size
as the OC-EGFP fragment. Therefore , the vector backbone was digested with ApaLI
to cut it into smaller fragments. The DNA in the digestion reaction was extracted with
phenol:chloroform (1:1). The residual phenol:chloroform was then extracted with
ethyl ether, which was equilibrated with water. The residual ethyl ether was
evaporated by incubation in a 70 oc water bath for 4-5 minutes with the lid open.
The DNA was then ethanol precipitated with 100% ethanol, centrifuged and washed
with 70% ethanol three times. The DNA was dissolved in TE and loaded on a 0.
agarose gel and the separated OC-EGFP DNA fragment was gel extracted. The OC-
EGFP DNA was further purified using Elutip columns. The purified DNA was
microinjected into pronuclear stage embryos, which were then transferred to
pseudopregnant female CD- 1 mice to produce the OC-EGFP transgenic mice.
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Protocol for Preparing OC-EGFP DNA fragment
to Produce Transgenic Mice
Clone pSROEGFP
Digest pSROEGFP with BamHI , Mlul and ApaLi
Phenol:Chloroform (1: 1) Extract DNA
Ethyl Ether (equilibrated with H20) Extract DNA (1:1 vol)
Heat in 70 C water bath , 4-5 minutes , with lid open to boil excess ether
Ethanol Precipitate (3 times)
Load DNA on a 0. 7% agarose gel
Gel extract OC-EGFP DNA fragment gel slice with QIAquick gel extraction kit
Purify OC-EGFP DNA fragment using Elutip Column
Generate and Analyze OC-EGFP Transgenic Mice
Figure 7. OC-EGFP Transgenic Offspring were Phenotyped by Identification of
Green Fluorescent Vertebrae Tails. The mouse tail vertebra on the right is from
line "F" OC-EGFP transgenic while the vertebra on the left is from a non-transgenic
littermate. The ability to see the green fluorescence by microscopy eliminates the
need for genotyping and allows for rapid phenotyping of the snipped tails.
Magnification = 20X.
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Figure 8. EGFP Is Specifically Expressed in the Osteoblast Lineage 
Cryosections of 28 Day Old Transgenic Mice. Tissues were removed from
sacrificed mice and fixed in 4% paraformaldehyde. Fixed tissues were mounted
frozen, cryosectioned in 5 m increments and visualized by fluorescence microscopy.
GFP is expressed in osteoblasts 'and osteocytes in the tibia, calvarium and femur, but
not in the kidney of28 day old line "F" transgenic mice (left and middle panels). No
expression was observed in either the femur or kidney of non-transgenic littermates
(right panels). Magnification = 400X for tibia section and 200X for all other sections.
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Figure 9. EGFP Is Expressed in Differentiated Osteoblast Cells Derived from
Bone Marrow Cultures of OC-EGFP Transgenic Mice. Mouse femur and tibia
, I
bone marrow from 8 week old transgenic mice was extracted and plated in 6-well
dishes at a density of 3 x l0 cells/well. Osteoblast cells were differentiated using L-
ascorbate and sodium inorganic phosphate. Bone marrow cultures on Day 12 (left)
show that multilayered cells are starting to form (Visible) and show a few weakly
fluorescent cells by fluorescence microscopy (EGFP). By Day 14 (middle),
multilayered bone nodules are visible and EGFP expressing cells are readily observed
by fluorescence microscopy in bone nodules. By the late stages of differentiation
, (Day 20 , right), GFP is stil detectable in osteoblasts in mineralized nodules but its
expression level appears to be decreased. No GFP was observed in cells located in
between the nodules.
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from calvaria osteoblasts derived from OC-EGFP mice (Owen et aI. , 2001). The
results show that EGFP and endogenous OC were expressed concurrently during
osteoblast differentiation. This result suggests that the OC-EGFP transgene is
properly expn:\'ssingEGFP during OB differentiation. Bone marrow cultures from 8-
week old mice were extracted from OC-EGFP mice and placed under conditions for
osteoblast differentiation (Figure 9). Expression of EGFP protein was visualized by
fluorescence microscopy. The results show that EGFP protein was induced at day 
in culture, which correlates with the onset of multilayered nodule formation (Figure
9). Moreover, EGFP was highly expressed in differentiated multilayered mineralized
nodules at 14 and 20 days in culture (Figure 9), which correlates with the appearance
of bone nodules and endogenous OC gene expression in matrix maturation and
mineralization stages of osteoblast differentiation (Owen et aI. , 2001; Lian et al.
2001). EGFP is specifically expressed from the OC promoter in osseous, but not non-
osseous cells in transgenic mice from embryonic day 17.5 to 1 year old (Owen et aI.
2001). Taken together, these results suggest that the OC-EGFP transgenic mouse line
F" is a good model to study growth and differentiation of bone development.
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DISCUSSION
In this study, we demonstrate that enhanced green fluorescent prot in (EGFP)
is expressed under the control of the osteocalcin (OC) promoter specifically in
osteoblastic cells in vitro and is induced by 1 25 (OH)2 vitamin D3. Furthermore
OC-EGFP transgenic mice were generate and were shown to express EGFP
specifically in osteoblasts and osteocytes in bone tissues. Genotyping of transgenic
mice expressing EGFP was not necessary, since the EGFP expressing mice were
directly phenotyped by observing the intrinsic green fluorescence of EGFP in the
vertebrae of tail snips using fluorescence microscopy. Bone marrow extracted from
OC-EGFP transgenic mice that were treated ex vivo to differentiate osteoprogenitor
cells into osteoblasts show EGFP induction when bone nodules begin toform arid
endogenous OC is induced (Day 12-14 of culture). The expression EGFP under
control of the OC promoter is consistent with previous results of the expression of
endogenous OC and the formation of bone nodules with ex vivo cultures (Lian et al.
2001). It has been suggested that EGFP may be toxic to cells, however expression of
the EGFP protein does not appear to have any toxic effects on the OC-EGFP
transgenic mice. These mice are viable and express EGFP for at least 1 year after
birth.
The OC-EGFP transgenic mice could be used to study regulation ofOC 
RUNX in vivo and to characterize the effect of potential new drgs on bone
formation and resorption. These drugs may be utilized in therapeutic treatment of
bone diseases such as osteoporosis and osteopenia. Osteoporosis and osteopenia are
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bone diseases caused by a decrease in bone mass due to an increase in bone
resorption and a decrease in bone formation. Patients with osteoporosis and
osteopenia are subjective to multiple bone fractures. Osteoclastic bone resorption and
osteoblastic bone formation are coupled processes that are influenced by many
factors , which could contribute to bone diseases. Bone loss is brought about by an
imbalance between bone resorption and bone formation (Rodan et aI. , 2002).
Therapies for osteoporosis to date involve drugs tha,t inhibit bone resorption (Russell
et al. , 2001). However, future drug therapies could involve drugs that activate and
recruit osteoblasts to form bone. High throughput screening assays could be used to
develop these potential drugs to treat osteoporosis and osteopenia. Our results show
that osteoblasts could be visualized easily using fluorescence microscopy in OC-
EGFP transgenic mice. The recruitment of OBs expressing EGFP in response to
treatment with a potential drug could be observed in OC- EGFP transgenic mice in
vivo. It may be possible that a drug, which regulates RUNX expression levels and
subsequently regulates bone phenotypic markers , such as OC may increase bone
formation and be important for the treatment of osteoporosis and osteopenia. OC-
EGFP mice may be used to study the effects of potential drugs on the regulation of
OC by RUNX proteins.
Taken together, these findings suggest that the OC-EGFP transgenic mice are
a good model for determining the effects of possible therapeutic drugs for the
treatment of bone diseases and the in vivo function of RUN X-mediated regulation of
OC.
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Model for the Transient Association of RUNX Transcription Factors with
Subnuclear Sites
In this study, our key findings are that RUNX transcription factors
dynamically associate with stationary subnuclear domains in a C-terminal dependent
mechanism in living cells (Chapter 1). Furthennore , two point mutations in the
NMTS that decrease nuclear matrix association have no measurable effect on the
subnuclear distribution and mobility ofRUNX2 in Fving cells (Chapter 2).
Moreover, RUNXl and RUNX2 are targeted to common subnuclear domains
(Chapter 1). The RUNX partner protein, CBF , is also targeted to these subnuclear
foci (Chapter 1), which appear to represent sites of active transcription
, although their
relationship to individual genes or gene organization remains to be resolved (Chapter
1). In addition, OC-EGFP transgenic mice were generated, which create a useful
tool for studying the in vivo function of RUN X-mediated osteocalcin regulation and
for developing new drugs for treatment of bone diseases.
RUNX proteins are associated with the nuclear matrix at subnuclear foci
through the NMTS (Zeng et aI. , 1997). The association of RUN X transcription
factors with the nuclear matrix at the subnuclear domains suggests a link between
gene expression and nuclear architecture (Stein et aI. , 1998; 2000b). The nucleus is
compartmentalized into functional cellular substructures and several nuclear
components involved in gene expression, DNA replication and splicing have been
shown to reside in different subnuclear compartments (Nickerson et al.
, 1995; Stein et
aI. , 2000b; Lamond and Earnshaw, 1998; Cook, 1999; Berezney et aI. , 2000; Misteli
and Spector, 1998; Dundr and Misteli , 2001). However, little is known about how
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these cellular processes are integrated into the nuclear architecture and their spatial
and temporal organization in the three-dimensional nucleus (Dundr and Misteli
2001). This study provides insight into the spatial and temporal localization and
mobility of RUNX transcription factors within the nucleus and suggests a relati,onship
between nuclear architecture and gene expression.
We show in Chapter 1 that RUNX factors localize to nuclear matrix-
associated subnuclear foci and that a majority (70-80%) of RUN X subnuclear foci are
associated with sites oftranscription, which is consistent with previous results and
results obtained concurrently with these studies (Zeng et aI. , 1997; 1998; Zaidi ' et aI.
2001; Tang et aI. , 1999). RUNX subnuclear foci may contain transcription factor
complexes , since co-regulatory proteins and nascent transcripts localize to RUNX
sites (Chapter 1; Zaidi et aI. , 2002; Javed et aI. , 2000; Kundu et aI. , 2002).
Furthermore , RUNX subnuclear sites that are not associated with transcription, may
be sites of storage or transcriptional repression. The assembly of RUNX proteins into
multi-subunit transcription factor complexes appears to be very dynamic since RUNX
proteins are highly mobile (half-time ofrecovery= 6- 10 seconds) (Chapter 1).
However, about 20-35% of RUN X proteins are immobilized in the nucleus possibly
by interacting with the nuclear architecture. How transcription complexes assemble
onto genes is an emerging question. Recently, in vivo kinetic modeling of RNA
Polymerase (Pol) I transcription ofthe ribosomal RNA genes, which are located in
the nucleolus, showed that the RNA Pol I machinery is highly dynamic (Dundr et aI.
2002). RNA Pol I subunits enter the nucleolus as separate subunits and rapidly
exchange between the nucleoplasm and ribosomal transcription sites. Assembly of
!i,
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the RNA Pol I machinery is highly inefficient in vivo with the rate-limiting step
assumed to be the successful formation of the elongation complex (Dundr et aI.
2002). These results suggest that localization of the subunits to the RNA Pol I
transcription complex at the transcription site is random, that effcient formation of
multi-subunit complexes is very low and that the RNA Pol I subunits move by
diffusion.
In contrast to the interpretation that nuclear proteins , such as the Pol I subunits
and alternative splicing factor, ASF , move in a diffusional mechanism (Phair and
Misteli , 2000; Dundr and Misteli , 2001; Dundr et aI. , 2002), our results suggest that
RUNX factors may move in a directional mechanism targeted by the association of
the C-terminus with the nuclear matrix and/or co-regulatory proteins. This is
consistent with the conclusions that nuclear proteins may be constrained by the
nuclear architecture, such as the nuclear matrix (Krhlak et aI. , 2000; Stenoien et aI.
2001). The high percent immobile fraction obtained for RUNX1 and RUNX2 (20-
35%) suggests that a portion of RUN X proteins is immobilized by association with
the nuclear architecture or within foci in a C-terminal dependent mechanism (Chapter
1 and 2). We show that RUNX proteins are targeted to subnuclear foci through the
terminal domain. RUNX proteins constantly flow into and out of RUN X foci. 
rapid exchange of proteins between nuclear compartments and the nucleoplasm has
been shown for several nuclear compartments , which are in constant flux (Dundr and
Misteli 2001). We show that RUNX proteins also rapidly exchange between RUNX
subnuclear foci and the nucleoplasmic pool.
The model from our studies shows a transient association of RUNX
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transcription factors with subnuclear sites , of which a subset colocalize with sites of
active transcription and co-regulatory factors. Therefore, the subnuclear foci may
contain transcription factor complexes (Figure l). The RUNX subnuclear foci are
postitionally stabilized in the nucleus by association with a structural componeJ)t or
perhaps a specific acceptor protein in the nuclear matrix. However
, the association of
RUNX factors with subnuclear foci is highly dynamic, reflecting a rapid exchange of
transcription factors with the nucleoplasmic pool. Moreover
, a fraction (20-35%) of
RUNX factors are immobilized at subnuclear foci through the C-terminus. The
mobility of RUN X transcription factors may be reduced though the association of the
RUNX C-terminus with the nuclear matrix and/or co-regulatory proteins. The NMTS
in the C-terminus of RUN X factors is important for targeting RUNX factors to the
nuclear matrix and to sites of transcription (Chapter 1; Zeng et aI.
, 1997; 1998). '
propose that RUNX transcription factors dynamically assemble into transcription
factor complexes and transiently reside in subnuclear domains for short periods of
time. However, the R383 and Y413 amino acids that were mutated in the NMTS
were not responsible for constraining the mobility since they had no measurable
effect on the mobility of RUNX factors (Chapter 2). Therefore
, either the entire
NMTS or co-regulatory protein interaction domains in the C-terminus may be
necessary to constrain the mobility of RUNX proteins. Furthermore
, the targeting of
RUNX factors to the nuclear matrix may involve an interaction with common
acceptor protein(s), as RUNX factors contain a common intranuclear targeting signal
and we show that RUNXI and RUNX2 are targeted to common subnuclear domains
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Figure 1. A Model for the Transient Association of Transcription Factors with
Subnuclear Protein Complexes. RUNX subnuclear foci (aqua and pink ovals) are
nuclear matrix associated. Aqua ovals represent RUNX associated subnuclear
tra scription factor complexes and pink ovals represent RUNX storage sites. The
nuclear matrix is represented by the black hatch marks. The pool of nucleoplasmic
RUNX transcription factors (green background) is rapidly moving. RUNX
subnuclear foci are positionally stabilized within the nuclear space. The limited
movement of the subnuclear foci is shown by the black arrowheads in the nucleus of
the whole cell (left). An area of the nucleus , represented by the purple box, is
enlarged on the right and shows multi-subunit transcription complexes t aqua ovals
(RUNX subnuclear foci) with pink circles (RUNX proteins) and purple and black
circles (RUNX associated co-regulatory proteins)). RUNX proteins (pink circles)
dynamically associate with RUNX subnuclear foci (arrows) through a C-terminal
dependent mechanism by interacting with the nuclear matrix and/or co-regulatory
proteins. The mobility of RUNX transcription factors is slowed down by this
interaction. The mobility of RUNX into and out of storage sites is indistinguishable
from transcription factor complexes by FRAP experiments.
- ,
182

(Chapter 1). However, other interpretations from this result may be that multiple
RUNX proteins accumulate at a site containing a single acceptor protein by creating
multiple interactions with several co-regulatory proteins localized at that focus.
Alternatively, lhe acceptor protein(s) that may have its own recognition motif(s) for
RUNX and for the nuclear matrix may serve as an organizing center for transcription
factor complexes.
Dynamics of Nuclear Proteins
Recent studies here and from other laboratories using GFP-tagged nuclear
proteins uncovered the highly dynamic nature ofthe nucleus (Chapters 1 and 2; Phair
and Misteli, 2000; Krhlak et al. , 2000; Stenoien et al. , 2000a; Stenoien et aI. , 2001).
Alternative splicing factor (ASF) fused to GFP has a diffusion coeffcient (D) of 0.
J.mls and was demonstrated to be approximately 100 times slower than GFP alone
(Krhlak et al. , 2000; Phair and Misteli , 2000). Similar results were obtained for the
mobility of ASF-GFP fusion protein in two individual studies (Phair and Misteli
2000; Krhlak et al. , 2000), but they differed in their conclusions (Shopland and
Lawrence, 20(0). One interpretation was that the mobility of ASF-GFP is consistent
with free diffusion and that the ASF proteins do not associate with any structural
component (Phair and Misteli, 2000). Alternatively, the reduced movement of ASF-
GFP proteins compared to GFP alone is consistent with a transient association with
structural sites such as the nuclear matrix (Krhlak et al. , 2000). The question of
whether ASF proteins are slowed down by association with nuclear architecture has
yet to be determined (Shopland and Lawrence , 2000). In Chapter 1 , we show that the
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mobility of RUN X nuclear proteins is constrained by the C-terminal domain , which
contains the NMTS and several co-regulatory protein interaction domains , suggesting
that association with the nuclear architecture and/or co-regulatory proteins, is
important for reducing the mobility of RUNX transcription factors.
Nuclear matrix association oftranscription factors in living cells has been
demonstrated using the estrogen receptor a fused to GFP (ERa-GFP). ERa-GFP has
a diffuse nuclear distribution in the absence of estrogen. In the presence of ligand
ERa becomes associated to the nuclear matrix in subnuclear sites (Stenoien et aI.
2000a). Using FRAP analysis , it was shown that unligated ERa is highly mobile
(half-time of recovery .: 1 second). Treatment with estrodiol decreases the mobility
of ERa to a half-time of 5-6 seconds , which correlates with increased association
with the nuclear matrix. Treatment with proteasome inhibitors or an estrogen
antagonist immobilizes ERa to the nuclear matrix (half-time= 5-20 minutes)
(Stenoien et al. , 2001). These results suggest that association with the nuclear
architecture retards the movement of nuclear factors , which supports our data from
Chapter 1 that the C-terminus of RUN X proteins which contains the NMTS and co-
regulatory factor domains reduces the mobility of RUNX proteins.
Cellular and Physiological Signifcance
Our results show that the intranuclear traffcking of RUNX transcription
factors , which are necessary for development of hematopoietic and osteogenic tissues
is dynamic. RUNX factors move into and out of sites of transcription within seconds
and appear to be constrained by association with the nuclear architecture.
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Compartmentalization of the nucleus appears to be important for cellular processes
such as gene expression, replication and splicing. We find that compartmentalization
of RUN X transcription factors into subnuclear foci may have functional significance
for gene expression, since RUNX foci contain nascent transcripts as shown by BrUTP
incorporation and co-regulatory proteins. Our results provide insight into how RUNX
factors move and are targeted to sites of transcription, which is a necessary cellular
function.
One limitation of overexpressing RUNX proteins in the in situ
immunofluorescence studies is that it is not known whether every RUNX focus is
formed at a specific gene. One indication is that active transcription is occurrng at
70-80% of RUN X foci , which suggests that a majority of the foci are localized to
specific genes. However, these experiments expose new questions such as: Is only
one gene localized to each focus or are there many genes? How many of the genes
are active in each focus? Are proteins specifically associating with genes or other
nuclear proteins at subnuclear foci? Answers to these questions may be important to
evaluate in the future.
RUNX proteins are important transcription factors, which are required for
tissue-specific development. The genes regulated by RUNX factors are necessary for
differentiation and development of bone and hematopoietic tissues. The roles of
RUNX genes in development are demonstrated by gene ablation studies in mice and
by the human diseases that occur from mutations in these genes. Knockout 
RUNX2 proteins or deletion of the C-terminus ofRUNX2 results in loss of bone
formation in mice. In addition, bone-specific genes, such as osteoca1cin, are not
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activated by RUNX2. Thus , RUNX2 deficiency causes a defect in osteoblast
maturation (Komori et al. , 1997; Otto et aI. , 1997; Choi et aI. , 2001). Mutations in '
RUNX2 have also been implicated in human bone diseases , such as cleid cranial
dysplasia (CCD), suggesting a biological requirement for RUNX2 proteins in b,one
development at post-natal stages (Mundlos et aI. , 1997; Zhang et al. , 2000). RUNX1
is necessary for hematopoietic development in RUNX1 deficient mice, demonstrating
that the hematopoietic genes activated by RUNX1 during hematopoietic
differentiation are not properly regulated (Wang et aI. , 1996a; Okuda et aI. , 1996;
North et al. , 1999). Chromosomal translocations of the RUNX1 gene result in human
acute leukemias (Speck and Stacy, 1995). Furthermore, the C-termini of RUN Xl and
RUNX2 were demonstrated to be necessary for hematopoiesis and skeletal
development, respectively, since C-terminal truncated proteins produce similar
phenotypes as RUNX1 and RUNX2 null mice (North et aI. , 1999; Choi et al. , 2001).
Thus , these results indicate the physiological importance of RUNX proteins and their
terminal segments in tissue-specific development.
The third chapter lays the foundation to study the physiological events directly
in an in vivo context. This chapter includes work demonstrating a new tool for the
study of RUN X-regulated osteocalcin (OC) gene expression during osteoblast
differentiation. We generated transgenic mice expressing EGFP under control of the
OC promoter. Our results in vitro show that EGFP protein is specifically expressed
in an osteoblastic cell line and that EGFP mRNA and protein are induced by vitamin
D3. Furthermore , the OC-EGFP transgenic mice express EGFP specifically in the
osteoblast lineage. Moreover, EGFP is expressed in mineralized bone nodules in
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osteoblast differentiated bone marrow cells derived from transgenic mice. These
results suggest that the OC-EGFP transgenic mice provide a good model for studying
RUNX-mediated osteocalcin regulation.
Taken 'together, our findings presented in this thesis show that in living cells
RUNX transcription factors dynamically associate with stationary subnuclear foci
which represent sites of active transcrip60n
, in a C-terminal dependent mechanism to
regulate gene expression. Moreover, RUNXI and RUNX2 are targeted to common
subnuclear domains , reflecting the similarities in their subnuclear targeting signal.
Furthermore , RUNX subnuclear foci appear to represent sites of transcription
containing co-regulatory proteins and nascent transcripts. These conclusions provide
a mechanism for how RUNX transcription factors may associate with subnuclear foci
to regulate gene expression. In addition
, OC- EGFP mice provide a useful tool to
develop drgs for treating bone diseases and studying the in vivo effects of RUN 
mediated osteocalcin regulation.
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Saturability of Nuclear Matrix
Associated RUNX Sites
INTRODUCTION
Factors involved in cellular processes including replication, transcription and
mRNA splicing are associated with the nuclear scaffold at specific sites within the
nucleus (Nickerson etaI. , 1995; Stein et aI. , 2000b; Lamond and Earnshaw, 1998;
Cook, 1999; Berezney et aI. , 2000; Misteli and Spector, 1998). Nuclear
compartmentalization may be maintained at least in part by association with the
nuclear matrix (Stein et aI. , 2000b). The nuclear matrix consists of a network of
highly branched 10-nm filaments and is comprised of insoluble proteins , hnRNA and
DNA that is associated at matrix attachment regions (MARs) (Fey et al. , 1984; 1986;
Davie , 1997; Nickerson et aI. , 1995). Several nuclear matrix associated proteins have
been discovered including B23 and hnRNPs, which are involved with RNA
metabolism, Lamins, NuMa, PML and RUNX (Zeng et aI. , 1997 , Zeng et al. , 1994;
Zaidi et aI. , 2001; Tang et aI. , 1999; Stein et al. , 2090b; Chang et al. , 1995; Barboro et
aI. , 2002; Mattern et aI. , 1996; Goldman et al. , 2002). RUNX proteins are associated
with the nuclear matrix in a punctate distribution (Zeng et al. , 1997 , Zaidi et aI. , 2001;
Tang et aI. , 1999). To date , none of the known nuclear matrix associated proteins has
displayed a filament-like staining pattern by immunohistochemical studies (Nickerson
et aI. , 1995; Stein et al. , 2000b). These findings suggest that the nuclear matrx may
consist of multiple protein complexes interacting with each other in a manner that
produces the 10-nm intermediate filament structures; however when only one protein
is observed at a time it appears punctate in nature.
Since RUNX1 and RUNX2 are targeted to common subnuclear domains
(Chapter 1), we hypothesize that RUNX proteins bind to a specific acceptor protein at
190
nuclear matrix-associated docking sites. One approach to assess the validity of this
working model is to examine whether RUNX sites are saturable and whether non-
physiological sites or compartments can be occupied after forced expression of
RUNX proteins.
In this study, we find with increasing protein concentration the RUNX foci
increase in size , but the number of foci slightly decreases using in situ fluorescence
microscopy. Furthermore , RUNX proteins do not appear to compete with high
concentrations of competitor for nuclear matrix sites, which suggest that RUNX foci
may not be saturable. However, localization of RUN X in the cytoplasm by in situ
immunofluorescence and extraction of RUN X in non-physiological compartments in
the biochemical fractionation assays at high concentrations of protein suggests that
RUNX sites may be saturable. The results obtained produced opposing conclusions
as to whether RUNX sites are saturable and therefore , were not able to be interpreted.
However, the results may reflect a gradual accumulation of RUN X proteins at
subnuclear foci.
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MA TERIALS AND METHODS
In situ Immunofluorescence
SaOS-2 cells were grown on 0. 5% (w/v) gelatin-coated coverslips in 6-well
plates and cultured until 70% confluent. Cells were transiently transfected using the
LipofectAMINE Plus method (Life Technologies, Grand Island, NY) with increasing
concentrations (0. , 0. 5 or 1 /lg) of expression plasmids maintaining a total DNA
concentration of 1 /lg using empty vector. Whole cell (WC), cytoskeleton (CSK) and
nuclear matrix-intermediate fiament (NMIF) preparations were performed and
fluorescence images were captured as previously described (Chapter 1 , Materials and
Methods). Cells were counted for level of expression and for whether the subcellular
distribution was cytoplasmic and nuclear or only nuclear. To calculate the number
and the size of the foci , 10- 13 planes ofZ-series images were captured in 0. /lm
increments. The stack of images was combined into one image using the average
Stack Arthmetic function and the out of focus light was removed with the 2D
deconvolution function using the nearest neighbors function in MetaMorph.
Deconvoluted images were thresholded and counts of the number and size ofthe foci
were determined using the Integrated Morphometry Analysis drop-in. The integrated
intensity of the nuclei before deconvolution was determined by selecting the nuclei
with the polygon region tool and using the Region Measurements function to
calculate the intensity of the selected region.
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Biochemical Subcellular Fractionation
HeLa cells were plated at 1.0 x 10 cells per 100 mm plate and transfected
using Superfect at 80% confluence with 1 J-g EGFP-RUNX2 and increasing
concentrations (0 , 16 J-g) ofuntagged-RUNX2 maintaining a total DNA
concentration of 17 J-g with empty vector. Cel1s were harvested l2-20 hours
following transfection. Cells were washed twice with PBS , scraped in 1 mlofPBS
and placed in a 1.5 ml microcentrifuge tube. Plates were washed once with 500 J-l of
PBS and the 1.5 ml of cells were centrifuged at 3600 rpm ( 880 g) for 5 minutes.
The supernatant was aspirated and the pellets were resuspended in 300 J-lof
mammalian lysis buffer (8 M Urea, 0. 1 M NaH2P04, 0. 1 M Tris-HCl pH 8. , IX
Complete Protease Inhibitor, 25 mM MG 132 proteosome inhibitor) for whole cell
fractions (Flowchart A). For CSK, DNase and NMIF fractions, a second plate was
harvested as above and the pel1et was extracted twice on ice for 15 minutes each with
150 J-l CSK buffer (100 mM NaCl , 0.3 M sucrose , lO mM pipes , pH 6. 3 mM
MgCh, 1 mM EGTA, 0. 5% Triton X- 100 , 2 mM Vanadyl Ribonucleoside Complex
(VRC), IX Complete Protease Inhibitor, 25 mM MG132 proteosome inhibitor).
Following each extraction the cells were centrifuged for 5 minutes at 3600 rpm and
the supernatants were pooled as the CSK fraction. The pellets were digested twice for
30 minutes each in 150 J-l of digestion buffer (CSK buffer with 50 mM NaCl) with
400 Units/ml of RNase-free DNase I (Roche , Indianapolis, IN) rocking at room
temperature. The cells were centrifuged for 5 minutes at 3600 rpm. Following the
second 30 minutes digestion, DNA and soluble proteins were extracted with 0.25 M
aIIonium sulfate on ice for 10 minutes and centrifuged for 5 minutes at 3600 rpm.
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Flowchart A. Schematk of Bjochemjcal Subcellular Fractjonatjon Method. Two
plates were transfected, one plate for the whole cell (WC) fraction and the other plate
for the sequential extractions of the cytoskeleton (CSK), chromatin (DNase) and
nuclear matrix-intermediate fiament (NMIF) fractions. The plates were scraped in
PBS , centrifuged at 3 600 rpm for 5 minutes. The WC pellet was lysed in
mammalian lysis buffer for 5 minutes on ice. The cell pellet from the second plate
was extracted with CSK buffer twice to remove soluble proteins and the supernatants
after centrifugation were pooled as the CSK fraction. The pellet after the second
CSK extraction was digested with DNase I twice and then extracted with 0.25 M
ammonium sulfate to remove chromatin. The supernatants after centrifugation were
pooled as the DNase fraction and the cell pellet was dissolved in UMN buffer as the
NMIF fraction.
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The supernatants were pooled as the DNase fraction. The pellets (NMIF fraction)
were resuspended in 300 l ofUMN buffer (8 M Urea, 2% -mercaptoethanol , 2%
NP- , lX Complete Protease Inhibitor, 25 mM MG132 proteosome inhibitor).
Equivalent cell numbers for each fraction were loaded on an 8% polyacrylamide gel.
Proteins were detected using a mouse monoclonal RUNX2/Cbfal antibody (a gift
from Y. !to , National University of Singapore; 1 :2 000 dilution) and an HRP-
conjugated (X-mouse secondary antibody (Santa Cruz Biotechnology, Santa Cruz
, CA;
1 :2 000 dilution).
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RESUL TS
Saturabilty of Nuclear Matrix-Associated RUNX Sites
Previous results in cell-free systems have shown that the estrogen receptor and
crude , but not partially purified , dexamethasome receptor complexes bind to the
nuclear matrix with high affnity and that the binding sites are saturable (Satoh et aI.
1986; Metzger et al. , 1990). To assess whether the nuclear matrix-associated RUNX
sites are saturable within a cellular context, we performed both biochemical
subcellular fractionation and in situ immunofluorescence assays. For the biochemical
subcellular fractionation studies, our strategy was to overexpress a constant
concentration (1 Jlg) ofEGFP-RUNX2 and determine whether the nuclear matrix
association ofEGFP-RUNX2 could be competed by overexpressing increasing
concentrations (0 8 and 16 Jlg DNA) ofuntagged-RUNX2 protein in HeLa cells in
100 mm plates , which do not contain endogenous RUNX proteins. IfRUNX sites
were saturable , then we would expect that as the concentration ofuntagged-RUNX2
increases , association ofEGFP-RUNX2 with the nuclear matrix wil decrease and
EGFP-RUNX2 wil be displaced to either the DNase or CSK fraction since untagged-
RUNX2 wil compete with EGFP-tagged RUNX2 for the nuclear matrix docking
sites. Calculations combined from four experiments show that as the concentration
ofuntagged-RUNX2 increases , relative levels ofEGFP-RUNX2 in the CSK and
DNase fractions decrease , and in the NMIF fraction increase (Figure 1B). This result
suggests that the RUNX sites may not be saturable. However, EGFP-RUNX2 and
RUNX2 are extracted in the CSK and DNase fractions at higher concentration of
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competitor, which shows that EGFP-RUNX proteins may be displaced by the
competitor into the soluble and chromatin fractions by competing for nuclear matrix
sites (Figure lA and C). This result suggests that RUNX sites may be saturable and
that RUNX may be occupying non-physiological compartments at higher
concentrations of the proteins. The interpretation of our results was confounded by
the observation that the expression of RUNX2 was not linear with the DNA
concentration and appeared to influence EGFP-RUNX2 levels. The amount of
EGFP-RUNX2 associated with the nuclear matrix was shown to increase as the
concentration ofuntagged-RUNX2 increased (Figure 1A and C). It is likely that
untagged-RUNX2 may influence the expression levels ofEGFP-RUNX2 by
associating with a RUNX consensus binding site at nucleotides 619-625 in the
complementary strand of the CMV promoter in the pcDNA3 vector (Invitrogen) into
which EGFP-RUNX2 was cloned. Thus , the experimental limitations of this
approach have confounded the interpretation of the results.
In another strategy to determine whether RUNX sites are saturable, we
performed in situ fluorescence microscopy with SaOS-2 cells transfected in 6-well
plates with increasing concentrations (0.25 , 0. 5 and 1. flg) of expression vectors
encoding EGFP-RUNX fusion proteins or EGFP alone and performed WC, CSK and
NMIF preparations. The total DNA concentration was maintained at flg using
empty vector. Because RUNX proteins are nuclear proteins, we would expect that
cytoplasmic localization of EGFP- RUNX proteins may represent occupancy of a non-
physiological compartment. Therefore, the number of cells expressing EGFP-RUNX
fusion proteins either in the nucleus only or in the cytoplasm and nucleus
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Figure 1. Nuclear Matrix-Associated EGFP-RUNX2 Is Not Compete
Increasing Concentrations ofUntagged-RUNX2. HeLa cells were transiently
transfected in 100 mm plates with a constant amount (1 
Jlg) ofEGPP-RUNX2
expression plasmid and increasing concentrations (0
, 8 and 16 Jlg) of untagged-
RUNX2 maintaining the total DNA concentration at l7 
Jlg. Biochemical WC , CSK
DNase and NMIP fractions were performed as described in Flowchart A and the
Materials and Methods. Equal cell equivalents were loaded on the gel for each
fraction. (A) Western blot analysis was performed using a mouse monoclonal
RUNX2 antibody (Y. !to , Japan; 1 :2 000 dilution) to detect both EGPP-RUNX2 and
untagged RUNX2 proteins on the same membrane. A lighter exposure of the
untagged-RUNX2 bands is shown under the western blot. (B and C) The membrane
was exposed to the Storm 840 Phospho imager (Molecular Dynamics, Sunnyvale, CA)
while emitting chemiluminesence light to quantitate the bands. An average from four
experiments of the phospho imager values are shown in (C) for each fraction. (B) The
average of the WC fractions were normalized to 1 by dividing by themselves since
the amount of protein in the WC fraction should approximately equal the total amount
of protein in the CSK + DNase + NMIP fractions. The CSK, DNase and NMIP
fractions were divided by the total amount of protein all three fractions (C+D+N=
CSK + DNase + NMIP) to show the relative amount of protein in each ofthe
fractions at each DNA concentration. Error bars represent standard deviations (S.
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were counted. The results for EGFP-RUNX1 (Table 1) and EGFP-RUNX2 (Table 2)
are averages from two experiments (:t S. ). The results show that as the
concentration ofEGFP-RUNX1 (Figure 2A; Table 1) or EGFP-RUNX2 (Figure 3A;
Table 2) increases a higher percentage of cells exhibit cytoplasmic staining in WC
CSK and NMIF preparations. Furthermore , the results demonstrate that the
fluorescence intensity of the cells with cytoplasmic and nuclear staining increases
with increasing concentrations ofEGFP-RUNX1 (I;igure 2B; Table 1) and EGFP-
RUNX2 (Figure 3B; Table 2). In addition, as the DNA concentration increases , the
percent of cells with dim nuclear expression decreases (Table 1 and Table 2).
However, the cytoplasmic staining appears to be in the form of insoluble protein
aggregates (Figures 4A and B; shown in the g image , but are also observed to a
lesser extent in the 0.25 g and 0. g transfected cells). The aggregates were also
observed in the CSK and NMIF extracted cells transfected with EGFP-RUNX2 361
(Figure 5A; Table 3) and EGFP alone (Figure 5B; Table 4). These results suggest
that RUNX sites may be saturable. However, the increase of the cytoplasmic
aggregates at J g of protein makes it diffcult to interpret these results since this
insoluble aggregate maybe an artifact from overexpression of the EGFP protein and
may be caused by dimerization of the EGFP molecules or may localize in the
cytoplasm because nuclear import was inhibited or nuclear export was increased.
In another approach to assess whether RUNX sites are saturable, we
determined the number and size of the foci as the protein concentration increases. Z-
series images of nuclei in NMIF preparations with different concentrations (0. , 0.
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Figure 2. The Amount of EGFP-RUNXI Protein in Cytoplasm Increases as the
DNA Concentration Increases. SaOS-2 cells were transiently transfected in 6-well
plates with increasing concentrations (0.25 , 0. 5 and 1.0 /Jg) of EGPP-RUNX1 '
expression plasmid. WC , CSK and NMIP preparations were performed on coverslips
and the cells were counted using fluorescence microscopy for Bright, Medium and
Dim expressing cells in either the nucleus only or the cytoplasm and nucleus (see
Table 1). (A) The percent of bright, medium and dim expressing cells were combined
for nuclear only staining (blue bars) and for cytoplasmic and nuclear staining (red
bars). (B) The percent of bright cytoplasmic and nuclear stained cells for each DNA
concentration (yellow, 0.25 /Jg; red 0.5 /Jg; blue, 1.0 /Jg) and cell preparation were
plotted. At least 100 transfected cells were counted per experiment in two
experiments. The error bars represent S.
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Fjgure 3. The Number of Cells wjth EGFP-RUNX2 Protejn jn Cytoplasm
Increases as the DNA Concentratjon Increases. SaOS-2 cells were transiently
transfected in 6-well plates with increasing concentrations (0. , 0. 5 and 1. g) of
EGFP-RUNX2 expression plasmid. WC , CSK and NMIF preparations were
performed on coverslips and the cells were counted using fluorescence microscopy
for Bright, Medium and Dim expressing cells in either the nucleus only or the
cytoplasm and nucleus (see Table 2). (A) The percent of bright, medium and dim
expressing cells were combined for nuclear only staining (blue bars) and for
cytoplasmic and nuclear staining (red bars). (B) The percent of bright cytoplasmic
and nuclear stained cells for each DNA concentration (yellow, 0. 25 g; red 0.
blue, 1. g) and each cell preparation were graphed. At least lOO transfected cells
were counted per experiment in two experiments. The error bars represent standard
deviations.
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Figure 4. Cytoplasmic Staining is Predominately in the Form of Insoluble
Globular Aggregates. SaOS-2 cells were transiently transfected in 6-well plates
with increasing concentrations (0. , 0. 5 and 1. /lg) of (A) EGFP-RUNXl and (B)
EGFP-RUNX2. WC and NMIF preparations were performed on coverslips and 'the
cells were imaged using fluorescence microscopy. Images were captured using the
MetaMorph Imaging Software at 400 ms exposure times. Globular cytoplasmic
aggregates are shown in l.
/lg WC images however, were also observed at lower
DNA concentrations.
209

Figure 5. Insoluble Globular Cytoplasmic Aggregates Appear to Be an Artifact
from Overexpressing of EGFP. SaOS-2 cells were transiently transfected in 6-well
plates with increasing concentrations (0. , 0.5 and l.O /-g) of (A) EGFP-
RUNX2 36l and (B) EGFP expression plasmids. WC and NMIF preparations were
performed and the cells were imaged using fluorescence microscopy with the
MetaMorph Imaging Software at 400 ms exposure times. Globular aggregates in the
cytoplasm are shown in 0. 5 and 1.0 /-g NMIF images. EGFP-RUNX2 36l
proteins were completely extracted in NMIF preparations at the 0.25 /-g DNA
concentration.
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and 1 g) ofEGFP-RUNX2 constructs expressed were captured using MetaMorph.
The stack of images was averaged into a single image and de convoluted using
MetaMorph (see Materials and Methods). The number and size of the 
foci were
determined from the deconvoluted images and the integrated intensities of the nuclei
were determined using the averaged single image before deconvolution. T
e results
show that the mean integrated intensity ofthe nuclei significantly increased as the
concentration of DNA increased (n=9- 10 for each DNA concentration) (Figure 6A).
However, the number of foci and the average size of the foci were not significantly
different as the concentration of DNA increases in a random population of 
cells' at
each DNA concentration (n=9- 10) (Figure 6B and C). The number of foci ranged
from 49- 149 foci per nucleus and the average size of the foci ranged from 0.2 to 0.53
microns (Figure 7 A and B). Moreover, when the integrated intensity of each nuCleus
from all three concentrations (n=29) was plotted against the number of foci for that
same nucleus, the number of foci slightly decreased as the intensity increased (Figure
7 A). When a scatter plot of the integrated intensity of each nucleus from all three
concentrations (n=29) was graphed against the average area of the foci for that
nucleus , then the results show that as the intensity ofEGFP-RUNX2 protein in each
cell increases , the size of the foci increases (Figure 7B). Furthermore
, as the size of
the foci increases the number of foci per nucleus slightly decreases (Figure 7C).
Taken together, these results suggest that the RUNX that RUNX factors may
gradually accumulate at subnuclear foci.
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Figure 6. The' Average Intensity ofthe Nucleus Increases as the Concentration of
DNA Increases. SaOS-2 cells were transiently transfected in 6-well plates with
increasing concentrations (0. , 0.5 and 1.0 Ilg) ofEGFP-RUNX2 expression
plasmid. Z-series images of 9 or 10 cells from NM F preparations were captured
taking 10- 13 planes at 0.5 11m increments using 200 ms exposure times. (A) The
Arthmetic Stack function in MetaMorph was used to produce a single image that the
integrated intensities were determined from. The nucleus was outlined using the
polygon tool and the integrated intensity was determined using the Region
Measurement function. (B) The arithmetic stack was then deconvoluted using the 2D-
deconvolution function with Nearest Neighbors. The deconvoluted images were
thresholded and the number and size of the foci were automatically counted using the
Integrated Morphometry Analysis function. The average (A) integrated intensity, (B)
number of foci and (C) area of the foci were determined for each DNA concentration
(n= 1 0 for 0.25 and 0.5 Ilg; n=9 for 1.0 Ilg). The error bars represent the standard
error of the mean (SEM). Statistical differences were only observed with the
average integrated intensity between 0.25 and 1.0 Ilg of DNA (PoCO.05) using multiple
pair-wise comparisons in the Tukey s studentized range test and the Bonferroni t-test.
216
c UJ
c -
"C G) rn
i!.!
G) ::
c: Z
G).c
cu ..L. 0
25 
Concentration of DNA 
120
100
25 
Concentration of DNA 
0.40
25 
Concentration of DNA 
Figure 7. Scatter Plots for Each Individual Nucleus Show an Increase in the Size
ofthe Foci as the Intensity ofthe Nucleus Increases. SaOS-2 cells were
transfected and Z-series images were captured and processed as described in Figure
10. (A) The number of foci for each nucleus (n=29) was plotted against the
integrated intensity for that nucleus. (B) The average area of the foci for each nucleus
(n=29) was graphed against the integrated intensity for that nucleus. (C) The average
area of the foci was plotted against the number of foci for each nucleus (n=29). (A, B
and C) A trendline (Linear line) was graphed to determine the correlation of one
variable to the other. The equation and the R value of the lines are shown.
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DISCUSSION
Results in this chapter provide the initial findings of an approach to address
whether RUNX proteins bind to a finite number of specific sites and therefore show
saturable binding. Our results show with increasing protein concentration the size of
the foci increases and the number of foci slightly decreases. These results suggest
that RUNX proteins may gradually accumulate at npclear matrix-associated
subnuclear sites with increasing protein concentrations.
The copy number of plasmids that are transfected into each cell, which cannot
be physically controlled, determined the amount of protein that was expressed.
Therefore, each transfected cell had different amounts of protein expressed, which
was observed as bright, medium and dim expressing cells. Although an overall
increase in protein concentration was observed at higher DNA concentrations, the
cells selected for the in situ immunofluorescence experiments were random. In this
random population, no difference was observed for the number and size of the foci
for each of the DNA concentrations as a population. However, on a cell-by-cell basis
there was an increase in the size for the foci at higher protein concentrations
suggesting that the variation of DNA copy number and therefore the protein
concentration in the cell appears to have had an effect on the size of the foci.
The findings from these initial investigations are summarized here and the
technical limitations , which impact the interpretations , are discussed below. 
higher nuclear protein concentrations of RUN X factors, the kinetics ofthe
association/disassociation may favor the association of RUN X factors with the
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subnuclear foci. This is suggested by our findings that the size of the foci is enlarged
at increased protein concentrations. The limit to which the RUNX factors can
associate with the subnuclear foci represents a measure of the saturability ?fthe foci.
We observed a gradual accumulation of RUN X factors at subnuclear foci , sugg sting
that the foci may not have reached the point of saturation. However, the possibility
exists that RUNX sites may be saturable. This is supported by the result that EGFP-
RUNX2 may be competed by untagged-RUNX2 , since at high concentrations of
competitor EGFP-RUNX2 is displaced into the soluble and chromatin fractions in
biochemical subcellular fractionation assays. IfRUNX sites are saturable , then.this
may suggest that RUNX proteins may specifically interact with acceptor proteins at
subnuclear foci and that the number of specific interactions may be limited.
However, ifRUNX sites are not saturable, then this may suggest that RUNX factors
may not specifically interact with an acceptor protein or that the number of acceptor
proteins at the subnuclear foci is not rate limiting.
Future studies wil be needed to address several technical limitations
identified here. First, experimental limitations of the biochemical fractionation were
produced from the confounding issues that the expression ofEGFP-RUNX2 was not
linear with the DNA concentration and the expression ofuntagged-RUNX2 appeared
to influence EGFP-RUNX2levels. Second, in the immunofluorescence microscopy
studies , an insoluble aggregate was observed in the cytoplasm ofEGFP-RUNXl and
EGFP-RUNX2 , which was also observed with the C-terminal deleted RUNX2 and
EGFP alone. Third, the 1 f.g concentration in the immunofluorescence experiments
may have been at a concentration that was expressing the proteins at much higher
221
than physiological levels. It is possible that the EGFP-RUNX fusion proteins may
not have been able to enter the nucleus through inhibition of nuclear import or
because the proteins dimerized through the EGFP molecule. Therefore
, the proteins
may have accumulated in the cytoplasm and aggregated.
These findings suggest that RUNX factors may gradually accumulate at
subnuclear foci. However, further studies will be needed to conclude whether RUNX
sites are saturable.
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